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ABSTRACT
The interaction of the putative excitatory neurotransmitters 
glutamate and aspartate with rat cortical membranes was examined by 
the utilization of a radiochemical binding assay. The specific 
binding of ^H-L-Glu at O^ C reached a maximum after approx 12 mins. and 
was measurable over a pH range of 4 - 9 although pH? was optimal.
The binding was strongly dependent on the presence of K ions and showed
-t-
a biphasic response to the presence of Na ions, being inhibited at 
concentrations below lOmM but stimulated several fold at higher (Na*^ ) 
reaching a maximum at around 40 mM.
It was possible to distinguish two binding sites for glutamate on 
cortical membranes prepared from adult rats. One of these was a low 
density high affinity'site,the other was present at higher concentrations 
and lower affinity and was strongly dependent on the presence of Na\ 
Aspartate also bound to adult cortical membranes with similar character­
istics. Discrimination between these glutamate and aspartate binding 
sites was possible as the binding of these ligands was differentially 
affected by freeze/thawing and by amino acid analogues investigated in 
displacement studies.
The binding of the excitotoxic glutamate analogue kainic acid shows 
characteristics incompatible with its proposed role as a glutamate 
agonist with affinity for the putative post-synaptic glutamate receptor 
site.
The development of glutamate and aspartate binding sites was also 
investigated. The binding of both ligands showed very different 
characteristics in young rats ( 30 days) thqn in adult rats. It was
mmuch, more difficult to distinguish between glutamate and aspartate 
binding sites in these younger animals.
!Ehe binding of glutamate to cortical membranes prepared from 
normal mice and *reeler* mutant mice was also investigated in an 
attempt to localize the binding to a specific cortical area.
CONTENTS
CHAPTER 1
1.1 
1.2
1.3
1.4
1.5
CHAPTER 2
2.1
2.2
2.3
CHAPTER 5 
CHAPTER 4 
4a) 
4b) 
4c) 
4d) 
4e) 
4f) 
4g) 
4h) 
4i) 
4j) 
4k)
INTRODUCTION
Peripheral nervous system v Central nervous 
system.
in Historical perspective.
Criteria for identification of Neurotransmitters.
Critique of Neuro transmitter criteria.
Evidence for the role of glutamate and 
aspartate as transmitters (particularly 
in the cerebral cortex).
experimental APPROACH 
Ontogeny.
Receptor theory.
The binding assay.
materials and methods
ESTABLISHING THE BINDING ASSAY 
Separating bound ligand from free.
Tençerature of incubation.
Estimating the amount of bound ligand.
Time course of the assay.
The effect of pH.
The effect of protein concentration.
Subcellular distribution of the binding.
The effect of sodium.
The dose response to potassium (E^ ).
The dose response to sodium (Na*^ ).
The tissue distribution of the binding sites.
PAGE
2
5
8
14
18
29
45
45
47
59
63
70
70
71
72
72
73 
73 
73 
80 
80 
81 
84
VCHAPTER 5 RESULTS.
5.1 Glutamate binding to adult cortical membranes.
5.2 Development of glutamate binding sites.
5,5 Antagonism of H^—L-Glu binding.
5.4 Kainic acid.
5.5 Aspartate binding.
5.6 The effects of freezing on the subsequent 
binding of glutamate and aspartate.
5.7 The localization of binding sites to specific 
cortical regions 5 studies with the reeler 
mutant mouse.
CHAPTER 6 GENERAL DISCUSSION.
6.1 Critique of binding data.
6.2 Distinct glutamate and aspartate receptors?
CHAPTER 7
EEEERENCES
THE WAY AHEAD.
PAGE
87
87
96
109
152
142
172
177
186 
186 
' 195
203
217
LIST OF TABLES AND FIGURES
TABLE li
l2 
4 2 
4-2
51
52
53
54
55
56
57
List of accepted neurotransmitters.
List of putative neurotransmitters.
The subcellular distribution of glutamate binding.
The distribution of glutamate binding in various tissues.
Summary of kinetic constants derived from various 
studies of glutamate binding.
Antagonism of amino acid induced excitation.
IGf^ values of drugs acting as displacers of 
 ^ 3h-L-G1u binding.
3
Kinetic parameters describing H-L-Asp binding to 
cortical membranes of rats between 3O-5O days old.
10 _  values of drugs acting as displacers of 
^H-L-Asp binding.
The effects of freeze/thawing on the subsequent 
binding of L-Glu and L-Asp to cortical membranes 
prepared from 20 day and 50 day old rats.
3
The binding of H-L-Glu to cortical membranes 
prepared from reeler and mutant mice.
FIGURE
A-2
43
4.4
h
51
52
53
Time course of H-L-Glu binding.
3
The dependancy of H-L-Glu binding on pH.
3
The effect of protein concentration on H-L-Glu binding.
3 3“The dose response of H-L-Glu binding to potassium (K ).
The dose response of H-L-Glu binding to sodium (Na ).
I Q
Na independent H-L-Glu binding to cortical 
membranes prepared from adult (50 day old) rats).
+ 3Na dependent H-L-Glu binding to cortical membranes 
prepared from adult rats.
+ 3The development of Na independent H-L-Glu binding
sites.
vu
FIGURE 5^ The development of Na"^  dependent ^H-L-Glu binding sites.
5c Na independent H-L-Glu binding to cortical membranes
prepared from 20 day old rats.
5g Na"^  dependent ^H-L-Glu binding to cortical membranes
prepared from 20 day old rats.
5y Structural diagrams of certain amino acid agonists and
antagonists.
3
5q Specific binding of H-L-Glu to cortical membranes from
adult rats in the presence of varying concentrations of 
amino acid analogues Log dose/percent inhibition plots.
3
5n Specific binding of H-L-Glu to cortical membranes from
20 day old rats in the presence of varying concentrations 
of amino acid analogues. Log dose/percent inhibition 
plots.
5^ Q Kainic acid binding to cortical membranes prepared
from adult rats.
5^ 2 Saturation curve of the Na"^  independent binding of
^H-L-Asp to cortical membranes prepared from adult rats.
5^ 2 Sc at chard plot of the data in Fig. 522*
2^  ^ Saturation curve of the Na*** dependent binding of
%-L-Asp to cortical membranes prepared from adult rats.
1^4 Scatchard plot of the data in Fig. 52^ *
I 3
52c Saturation curve showing Na independent H^-L-Asp
binding to cortical membranes prepared from 20 day old
rats.
52^  Scatchard plot of the data in Fig.
52y Saturation curve showing Na*** dependent ^H-L-Asp binding
to cortical membranes prepared from 20 day old rats.
520 Scatchard plot of the data in Fig.
_L ?
5n Q Na dependent binding of H-L-Asp to cortical membranes'19 prepared from 50 day old rats.
52q Scatchard plot of the data in 52g •
5g2 Specific binding of ^H-L-Asp to cortical membranes
prepared from adult rats in the presence of varying 
concentrations of amino acid analogues. Log dose/percent 
inhibition plots.
VIII
FIGURE '22 Specific binding of E-L-Asp to cortical membranes prepared from 20 day old rats in the presence of 
varying concentrations of amino acid analogues. Log 
dose/percent inhibition plots.
Structural diagrams of amino acid analogues.
PLATE Electron-micrograph of P2 fraction prepared from 
the cerebral cortex of 6 day old rats.
Electron-micrograph of P2 fraction prepared from 
the cerebral cortex of .10 day old rats.
5 Electron micrograph of P2 fraction prepared
from the cerebral cortex of 20 day old rats.
4 Electron micrograph of P2 fraction prepared
from the cerebral cortex of 50 day old rats.
ABBREVIATIONS
AGh 
AGhE 
A.D.G.P. 
A.M.P. A.
ANS 
L-Asp 
B MAX 
Gi
cGMP ■ 
GNS
D ex. AA
D Of. APV
ED50
EM
EPSP's 
G.A.B.A. 
G.D.E.E. 
G.D.P.
L-Glu
G.T.P.
5-HT
Ibo
IG50 .
Acetylcholine
Acetylcholinesterase
Amino Dicarboxycyclopentate
Amino - 3 hydroxy - 5 methyl isoxazole - 4 
.proprionate
Autonomic nervous system 
L-Aspartic Acid
Maximal number of binding sites 
Gurie
cyclic Guanosine 5* phosphate
Gentrai nervous system
D oc Aminoadipate
D-oc-2-Amino 5~Phosphono valerate
Dose at which 50^ of maximal excitation occurs
Transmembrane potential difference
Excitatory postsynaptic potentials
Garama-aminobutyric acid
Glutamate diethyl ester
Guanosine 5* diphosphate
L-Glutamic acid
Guanosine 5* triphosphate
5 - Hydroxytryptamine
Ibotenic acid
Goncentration at which 50% of maximal inhibition 
occurs
KA Kainic acid
Kd
L.O.T.
L.T.P.
m» e « j)» p.
M.T.H.F.
NMLA
NMDA
P.D.A.
P.N.S.
P.S.P.'s 
I2DA 
Quis 
s.e.m.
S.P.M.
Dissociation constant
Lateral olfactory tract
Long term potentiation
Miniature endplate potential
Me thy1te trahydrifolate
N-methyl-L-Aspartate
N-me thyl-D-Aspartate
2,3, Piperidine dicarhoxylic acid
Peripheral nervous system
Post-synaptic potentials
3, Piperazine dicarhoxylic acid
Quisqualic acid
standard error of the mean
Synaptic plasma membranes
1^1
Publication details:
Some of the data included in this thesis have previously been reported
in the form of communications to various neuroscience meetings and
have formed contributions to text?and journals.
1 Sanderson, C., and Murphy, S. ,'(1978) Glutamate and kainic acid 
binding to synaptic membranes of cerebral cortex from developing 
rats. Proc. ESN 1, 222.
2 Sanderson, C., and Murphy, S.(1980) Development of binding sites 
for glutamate in rat cortex. In 'Multidisciplinary Approach to 
Brain Development' (eds. C. di Benedetta, G. Porcellati, R. Balazs,
G. Gombos), pp. 233-234, Elsevier.
3 Murphy, S., Sanderson, C., and Uzbekov, M. (1980) The appearance 
of 5HT, and glutamate neurotransmitter receptors during brain 
development. In Ontogenesis of the Brain' Vol. 3 pp. 197-204,
(eds. S. Trojan and F. Stastny). Charles University Press, Prague.
4 Sanderson, C., and Murphy, S. (1980) Glutamate binding in the 
rat cortex; kinetics and pharmacological specificity during 
development. Abst. Int. Soc. Dev. Neurosci. 294.
5 Sanderson, C., and Murphy, S. (1981) Aspartate binding in the
rat cerebral cortex at different ages during development. Abst.
8th ISN, 186.
6 Sanderson, C., and Murphy, S. (1982) Glutamate binding in the
rat cerebral cortex during ontogeny. Dev. Brain Res. 2, 329-339.
7 Murphy, S., and Sanderson, C. (1982) Development of glutamate
and aspartate binding sites in the rat cerebral cortex-evidence
for their role in neurotransmission. Proc. 2nd Czechoslovak Neurochem. 
Cong, pp. 23-30.
CHAPTER 1
GENERAL INTRODUCTION
INTRODUCTION
There are many fundamental questions concerning the functioning 
of the mammalian brain that still remain to be elucidated. If an 
answer to any of these questions is possible, it will only be through 
the concerted integrated application of research techniques from many 
different disciplines in the brain sciences. The one concept assumed 
in all the.approaches however, is that of chemical neurotransmission as the 
main method by which an electrical impulse arriving at a nerve ending 
along qn axon can succeed in affecting the next neuron in the pathway, 
although axon and call body are separated by a gap of about 200-500 X - 
the synapse. Because the reaction mechanism by which this occurs is 
so well established at those synapses using Acetylcholine and the
amines dopamine, noradrenaline and serotonin (5ET), it is perhaps easy to 
forget that transmission by these established transmitter substances 
accounts for only about 1% of all synapses in the mammalian brain.
(S^der 1973). This estimate has been arrived at mainly by treating 
brain slices with histochemicals which specifically interact with bio­
chemical components, mainly enzymes of the cholinergic and catechola- 
minergic transmitter systems. However, a 1% sample nay simply not be 
good enou^ to assume that transmission at all synapses occurs in the same 
way. Different chemical mediators could exert their effect by different 
mechanisms. The crucial requirement then is to establish the identity 
of the centrally acting transmitters, but although many substances have 
been suggested for this function, their role remains putative. However, 
among the strongest candidates to emerge for the role of centrally 
active excitatory transmitter are the dicarboxylic amino acids, glutamate 
and aspartate. The work reported in this thesis was initiated to help 
elucidate this putative function for the amino acids in the rat cerebral 
cortex.
The introductory chapter of the thesis first of all critically 
assesses the assumptions that are made concerning the mode of action of 
neurotransmitters because these assumptions strongly influence the choice 
of the experimental techniques to use in the search for novel transmitters. 
The question is; how applicable are these techniques when amino acid 
candidates are being considered as transmitters? The remainder of 
the chapter reviews the accumulated evidence implicating glutamate 
and aspartate as neutretransmitters in the C.N.S. and provides a just­
ification for the experimental approach used throu^out this thesis, 
namely an investigation of the interaction of glutamate and aspartate with
binding sites on brain cell membranes utilizing a radiochemical binding 
assay.
Much of the work is a study of the interaction of glutamate and 
aspartate with brain cell membranes from rats throughout their development 
from neonates to adult (jO days of age). Chapter 2 begins with a 
rationale for this line of study and goes on to consider theoretical 
aspects of receptors; their form, function, and relationship to other 
components of the physiological system they are part of. Finally, the 
binding assay itself is considered, in particular the problems inherent 
in its design and the precautions that must be considered in setting up 
a binding assay. Chapter 3 is a statement of the materials used and 
methods of preparing the tissue utilized in the assay.
Chapters 4 and j are a presentation of results,with Chapter 4 being 
a characterisation of the optimum conditions necessary-, for a qualitative- 
and quantitative study of the interaction of L-glutamate with its binding 
sites. Each section in Chapter 3 is self sufficient, in that there is 
a brief introduction explaining the rationale behind each series of 
experiments and the possible implications of the results are discussed 
before moving on to the next section. There is however a
logical progression from one section to another in terms of the development 
of ideas,although some of this logic is retrospective so that the work is 
not always presented in its chronological position. Chapter 6 is a 
summary of the results together with a critical discussion of the overall 
significance. The thesis finishes,of course, with ideas for future 
experiments that may prove worthwhile.
1.1 Peripheral Nervous System v Central Nervous System
Given that knowledge of the particular transmitter species used at any 
one synapse in the C.N.S. is a prerequisite for establishing the exact 
mechanism by which that transmitter functions,we arrive at a 'chicken and 
egg' situation. In trying to establish the. identity of a transmitter,how 
do we know which biochemical parameters would be most appropriate to 
investigate? This paradox has been overcome by the establishment of guide­
lines or criteria which must be fulfilled before a transmitter role for 
any substance is identified. However, these criteria are very much based 
on extensive experimental data concerning the mode of action of the 
accepted transmitter Acetylcholine, at the sites where .its transmitter 
status was first established - terminals of the parasympathetic nervous 
system innervating smooth muscle and the vertebrate neuromuscular junction. 
Both of these sites exhibit distinct morphological characteristics and a 
nerve impulse initiated in the presynaptic fibre gives rise to an easily 
measurable physiological event, e.g. muscle contraction.
The neuromuscular junction (NMJ), in particular,provides an excellent model 
for neurophysiological and neurochemical analyses. A single afferent axon 
branches only at the point of contact with a muscle fibre to form a discrete 
structure, the motor end plate,composed of several structurally specialised 
junctions. The afferent nerve can be artificially stimulated and changes 
in membrane potential in the specific area served by the incoming nerve can 
be accurately assessed by the careful implantation of recording electrodes 
at the post synaptic site. In vitro preparations maintained in artificial 
media allow for an investigation of the ionic requirements of the mediation 
process and the effect of various chemical agents, administered 
iontophoretically, on the intensity and duration of post synaptic potentials 
(P.S.P's) can be estimated.
In contrast, any neurophysiological or neurochemical investigation 
in the brain is,inevitably, technically much more difficult. The complexity 
of interactions even within any one brain area, the high degree of 
cellular heterogeneity and the paucity of knowledge of the function 
subserved by the majority of neuronal pathways are daunting.
Unlike the muscle fibre any one neuron in the brain is literally 
covered with synaptic boutons up to a few thousand per cell. The 
signals impingeing on the neuron arise from many different brain areas 
in regions which may be far removed from the nerve ending. The cell 
bodies of origin may constitute specialized sensory organs, or intermediary 
ganglia themselves in contact with other brain regions subserving 
specific functions. The.incoming signals are both excitatory and 
inhibitory and are undoubtedly mediated by several different neuro­
transmitter species. Besides these axosomatic interactions there are 
also synapses involving physiologically functional connections that are 
axodendritic or axoaxonic in nature. The process of synaptic transmission 
in the C.N.S, because of this multiplicity of interactions,is also likely 
to involve the participation of mechanisms, for controlling or modulating 
synaptic activity so that the integration of many conflicting signals 
produces the precise physiological response demanded in a particular 
situation. It is not necessary to postulate that these modulatory events 
will occur in the locale of the synapse. Chemical modulators could exert 
their effect,for example, by specifically interacting with the ion channels 
that control the flow of charged particles across the pre- and postsynpatic 
membranes, rather than with the neurotransmitter receptors directly.
The application of experimentaltechniques appropriate in the 
peripheral nervous system (P.N.S.) to a study of the C.N.S. may then, in 
themselves, disrupt the delicate balance of the many integrative processes
involved in the function of a discrete brain area, let alone a single 
neuron. This in turn may make the process of extrapolation from 
experimental data to events in vivo a little more uncertain.
Thus a consideration of the structural differences between the 
central and peripheral nervous system is alone sufficient, in my belief, 
to warrant caution in the application of the criteria for neujro- 
transmitter status. Further criticisms based on the doubtful 
universality of the mechanism by which acetylcholine exerts its effect 
(Werman I966) will be relevant in later sections where I wish to argue 
that acceptance of the criteria may have had a retrogressive and 
damaging effect on research into chemical transmission in the C.N.S. 
However, as the work reported here was initially formulated and 
carried out within the framework demanded by a particular paradigm,
I think it is important to consider from a historical perspective the 
scientific climate within which the criteria were developed.
This allows for the assessment of the validity and usefulness of 
establishing the criteria in the first place, and an understanding of 
how they may have achieved their sacrosanct status. It may also serve 
to justify their continued application, albeit within the context of a 
more critical approach.
91.2 m  HISTORICAL PERSPECTIVE
Despite the morphological simplicity apparent within the 
autonomic and peripheral nervous systems,and the targets they innervate, 
there were still enormous problems in establishing the existence of 
chemical transmission,let alone the identity of the transmitters 
acetylcholine and noradrenaline. I think it is possible to isolate 
two TnflTn reasons for these problems. First of all, when the concept. 
was first suggested early this century there were none of the technical 
aids now taken for granted such as sensitive intracellular electrical 
recording instruments and the electron microscope. Techniques were 
based mainly on those established by classic physiology - the perfusion 
of isolated tissue systems and organs in vitro and the effect on their 
responses of a wide range of experimeni@l manipulations. Perhaps the 
underlying difficulty though, was the need to overcome the dogmatism of 
scientists at that time who rigorously held the view that nervous 
activity was purely an electrical phenomenon. For a quarter of a century 
there was considerable prejudice against the concept of chemical 
transmission even in the face of rapidly accumulating evidence.
Unfortunately it is arguable that winning that particular battle 
may have simply resulted in the replacement of one dogmatic conceptual 
approach with another, which in its turn has slowed down the investi­
gation of the many other chemical substances and modes of action used by 
the nervous system to transmit messages.
One of the first discoveries of electric transmission came from ' 
Dubois Reymond in 1843. At that time it was thought that nervous 
tissue was a continuous sheet of connected cells, the nerve impulse 
being propagated from cell to cell by uninterrupted flow of current
through a continuous medium. Nevertheless, in 1877 Du Dois Reymond 
himself tentatively suggested that chemical molecules may also be 
involved at some stage. At around this same time the brilliant 
Spanish histologist Raman y Cajal was making a series of meticulous 
and perceptive drawings of many different cell types. His study of
nervous tissue revealed that at the point of contact between nerve 
cells there was a small gap. Thus the cell theory was bom, nervous 
tissue was not unifomnly continuous but composed of a network of 
individual units. Nevertheless the concept that transmission of the 
nerve impulse across this gap may be mediated by chemicals was still 
discounted as it was mistakenly assumed that the process of diffusion 
would be too slow to account for the known high speeds of impulse 
transfer in the C.N.S. In retrospect this seeming short-si^tedness 
can be explained by the fact that although Cajals work had revealed 
the presence of intercellular spaces, the limits of resolution of 
microscopes at that time were not sufficient to reveal the structural 
specialization of the synapse responsible for aligning pre-and post 
synaptic membranes in close delineated apposition. The effects of 
nervous stimulation on glandular secretion presented no such problem. 
Both the time of onset of the physiological response and the duration 
occurred over time scales considerably greater in magnitude than the
stimulation of motor activity.
A significant advance came in 1904 when Eliot discovered that an 
adrenal gland extract, adrenaline,could produce the same effects as 
sympathetic nerve stimulation. ' This line of reasoning was followed in 
1907 by Dixon who electrically stimulated a perfused frog heart and 
collected the perfusate during and immediately following stimulation.
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He re-applied the perfusate directly onto the heart hut failed to 
evoke any change in muscle contraction. The definitive difference 
between the two experiments is again only apparent in retrospect. 
Acetylcholine is degraded by acetylcholinesterase quickly following its 
production and secretion into the synaptic cleft.
Dixons failures unfortunately discouraged further endeavours in this 
direction for many years. Serendipity played a part in 1921 when 
Otto Loewi linked two frog hearts in individual organ baths by 
perfusing them with the same medium flowing in through the first heart 
.and out through the second. Electrical stimulation of the first heart 
was followed after a short time delay by a slowing of the heartbeat in 
the second which Loewi interpreted as being due to a chemical agent 
liberated into the perfusing medium from the first heart (see Loewi 1940). 
Although the experimental design and execution were faultless given 
technical facilities available at that time, Loewi too may have failed 
to provoke stimulation of the 2nd heart if he had not, unknowingly, taken 
advantage of a seasonal variation in the ratio of Acetylcholine to its 
degradatory enzyme acetyl-cholinesterase in frogs which during the time 
he carried out his experiment, (Easter) was at its maximum.' (Bacq 1975)*
Subsequent attempts to emulate Loewi's work over the next five 
years only suceeded in arousing controversy. The publication of widely 
differing data using similar experimental operations alternated in 
providing the opposing lobbies (for and against chemical transmission) 
with ammunition! Historical retrospectives on this period from 
scientists eminent in the debate (Bacq,1975 ; Dale,1953) reveal an intense 
polarization of viewpoints with continuous heated and bitter debates.
The tide began to turn in the favour of the theory of chemical 
transmission when routine screening of a variety of conpounds for their
ability to emulate or antagonize the effects of stimulation by the 
sympathetic nervous system revealed the acetylcholine analogue 
eserine to be a potent enhancer of the physiological effects of ACh on 
glandular secretion and smooth muscle contraction. The inclusion of 
eserine in the perfusing medium of subsequent experiments allowed the 
development of highly reproducible experimental methods and led to the 
correct conclusion that eserine exerted its effect by inhibiting a 
synastically active degradatory enzyme for acetylcholine. (See Loewi
1940).
Eserine was subsequently used unquestioningly in all investigations.
At the motor end plate however, this simply led to massive depolarization 
and tetani rather than the smooth graded contraction observed in the 
absence of eserine. This was interpreted critically as evidence that 
eserine had been exerting its effect by acting directly as a toxin and 
not by enhancing synaptic concentrations of Acetylcholine. Application . 
of ACh in the absence of its esterase however (i.e. on denervated 
muscle) did mimic motor nerve stimulation., and a series of experiments 
in the 1950's by Dale and his colleagues culminated in the collection 
and identification of Acetylcholine as the substance released from 
motor nerves on stimulation (Dale 1958).
Research into the nervous system had thus evolved a new branch, 
that of neurochemisti^, which even during its infancy began to 
challenge the dominance of the physiological approach. The two disciplines 
were unfortunately seen by many as noncomplementor^ under the strong 
influence of the leading electrophysiologist of that period. Sir John 
Ecoles, a formidable opponent of chemical transmission as an explanation 
of neuronal communication and a strong adherent of explanations in terms
IZ
of electrical phenomena only.
The swelling tide of technological advancement was against him 
and the advent of the elect on microscope, sophisticated intra-cellular 
recording techniques together with iontophoresis, and histochemical 
techniques all served to confirm the validity of the concept. For the 
first time the complexities of synaptic structure could he seen and 
specific labelling and staining of components of the cholinergic and 
catecholaminergic systems allowed for the localization of storage 
vesicles and metabolizing enzymes to nerve endings.
Ecoles admitted defeat with grace and integrity in 1945;albeit 
with the guidance of the Scientific philosopher Kark Popper. His 
conversion was complete and dramatic (Ecoles, 1970) to the extent that 
he became almost overnight one of the most ardent exponents of the 
concept of Chemical transmission. In the following years he relentlessly 
applied his electrophysiological expertise to the study of the 
mechanisms of chemical synaptic transmission and became one of the most 
brilliant and well respected experimenters in this field. His work led 
to the winning of the Nobel Prize in I963 ,in particular for his 
microelectrode studies of synaptic transmission in the motor neuron 
reflex system (Ecoles I966, I964).
The demonstration of the validity of the concept of chemical 
transmission and the identification of ACh and the catecholamines as 
mediators was arguably one of the major advancements of scientific 
thinking to occur this century. For the first time, brain activity , 
could be described not only in terms of electrical events, but also in 
terms of distinct specific chemical interactions at the exact site of 
communication between two neurons, the synapse. The regulation of
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synaptic activity could now be explained in terms of different signals, 
excitatory and inhibitory impingeing on a cell and mediated by 
different messengers. The advancement, however, was hard won and,with 
the benefit of retrospection it is possible to see the development of 
the criteria as a protection mechanism to shield and defend the birth 
of a new concept in an alien environment.
The original experiments of KLiot, Loewi and Dale were quickly 
followed with others by enthusiastic, though less competent workers, 
leading to claims of synaptic involvement for many substances with 
little or no regard for attempts to control for other explanations in 
the data. The establishment of a coherent scientific methodology for 
neurochemical research was thus seen as essential. Critical objections 
to many investigations only aided the unquestioning acceptance of the 
need for the fulfullment of certain criteria as a prerequesite for 
establishing a role for a substance as a neurotransmitter. The
criteria, initially intended as guidelines of approach, assumed the 
status of rules of investigation and became sacrosanct. The criteria 
applicable for studies on the CNS were originally a simple extension of 
those utilized for peripheral transmitters (Paton, 1958). Although 
extensive criticism (Werman, I966; Johnson, 1971? Orrego, 1979) has led 
to their partial modification, in their present form they unquestionably 
reflect the wealth of knowledge accumulated concerning the mode of action 
of acetylcholine in the autonomic and peripheral nervous systems.
1.3 CRITERIA FOR IDENTIFICATION OF NEUROTRaNSMITTERS
Perhaps the most fundamental of the criteria is that of'identity of 
1
Action, which states that when a transmitter-suspect is applied in the 
synapse it should produce in every respect the same postsynaptic effect 
as the natural transmitter as measured by neurophyslological (e.g. the 
generation of PSP's) and neurochemical (e.g. change in ion movements and 
in 2nd messenger levels) techniques. .A corollary to this is that of 
collectibility. A putative transmitter substance collected upon 
stimulation of the presynaptic neuron and used to stimulate the post- 
synaptic cell with identical results as natural stimulation, offers the 
most comprehensive fulfillment of this criterion.
An extension of the Identity of Action criterion is that of 
pharmacological specificity. The postsynaptic effects of a putative 
^^^nsmitter substance should be mimicked by drug agonists and modifiable 
by antagonist in the same manner as the natural transmitter reflecting 
the structure activity relationship of the transmitter to its receptor on 
the postsynaptic cell membrane.
^ third criterion is that of induced release. The candidate should 
be selectively released from presynaptic nerve endings upon depolarization 
the nerve by physiological means. It must be released in amounts 
necessary to cause the known physiological effect on the postsynaptic cell 
^trectly proportional to the magnitude of stimulation. The release 
process must, also show a dependancy on extracellular calcium concentration 
because influx of Ca ions into the presynaptic nerve terminal upon 
depolarization has been suggested as necessary for release by a process of 
stimulus—release-coupling (Katz, 1969). Evidence for this involvement of
calcium on the release process was obtained by. Katz.and Miledi (1970) 
and Miledi.(1973) in studies on the.release of Acetylcholine from the 
squid giant axon.
The above criterion is essentially presynaptic. and follows on from 
criteria that state that the candidate.must be present in: nerve endings 
thought.to use the substance as their transmitter^together with-metabolic 
enzymes involved in maintaining a transmitter pool from readily available 
precursors.
The balanced physiological effect of transmitters is dependent on 
their rapid.removal from the synaptic cleft on cessation of the depolarizing 
impulse causing their release. Thus a primary criterion is the 
demonstration of some mechanism for rapid termination of the transmitter 
function of the candidate.
A final criterion demands that neurotransmitter candidates should be 
differentially distributed throughout the CNS, so that their varying 
concentrations in different brain regions should parallel the functional 
specification of different projection pathways.
From such considerations the transmitter status of a select group of 
substances has been established as shown in Table 1 according to Iversen 
(1980). Table 2 shows the suggested transmitters together with the 
possible pathways whose activity they mediate.
Accepting the proposition that there is a multiplicity of transmitter 
species utilized in the CNS (Km je vie 1974), and that the criteria are a 
relevant reflection of their mode of operation ,it may be expected that 
following four decades of active research Table 1 should by now include 
many of the candidates in Table 2, That this is not so points I believe
TABLE 1 ACCEPTED NEURQTRMSMITTERS
Amino Acids
Gaima-aminobutyrate^ G ABA 
Glycine
Amines
Acetylcholine 
Dopamine 
N oradrenaline 
Adrenaline 
5 Hydroxytryptamine
TABLE 2
Amino Acids
Glutamate
Aspartate
Proline
Taurine
PUTATIVE NEUROTRANSMITTERS 
Others
Corticotropin 
Growth hormone 
Lipotropin
ot Melanocyte stimulating 
hormone ( MSH) 
Oxytocin 
Vasopressin
PITUITARY
PEPTIDES
Adenosine
Angiotensin
Calcitonin
Glucagon
Insulin
Cholecystokinin CCK
Gastrin
Motilin
Pancreatic polypeptide (PP) 
Secretin 
Substance P 
Vasoactive intestinal 
polypeptide (VIP)
Dynorphin
endorphin
Met-enkephalin
Leu-enkephalin
Kyotorphin
Corticotropin-releasing 
factor (CRF)
Lute iniz ing-hormone-releas ing 
hormone (JjHRH)
Somatostatin
Thyrotropin-releasing hormone
TRH
CIRCULATING
HORMONES
GUT
HORMONES
OPIOID
PEPTIDES
HYPOTHALAMIC
RELEASING
HORMONES
Bombesin 
BradykinîK 
Carnosine 
Neuropeptide Y 
Substance K 
Prolactin
OTHER
PEPTIDES
//
to the need for a major reappraisal of the mechanisms and parameters 
constituting chemical neurotransmission and a reassessment of.the criteria, 
acknowlec^g the possibility that^  in many ways, acetylcholine may be the 
exception to the rules governing the activity of transmitters^  if there 
are rules at all.
1*^  CRITIQUE OF NEUROTRANSMITTER 'CRITERIA
All of the criteria are open to misinterpretation due partly to the 
limitations of the techniques employed in-their study, some of which 
warrant further discussion, hut also due to the particular conceptual 
approach adhered to by each individual researcher. i can achieve no 
better summation of this than a statement by Orrego (1979).
"More dangerous than the inherent defects of the criteria, however, 
seems to be their injudicious application, usually because of an 
overzealous wish to-demonstrate that one's favourite molecule is 
indeed a transmitter."
Orrego (1979) also correctly emphasized the interdependency of the 
criteria. Their strength can only be in their conjunction, the demon­
stration of each being in itself insufficient proof of transmitter 
function. This requirement is essential even for those candidates whose 
locations and proposed function is limited to nervous tissue. This is 
precisely because the unique set of problems defining the limitations of 
each criterion must preclude an accurate assessment of their relevance 
to prove or disprove a transmitter role.
How much more limited then must the criteria be in clarifying such 
a role for substances whose ubiquity throughout the CNS as well as the 
rest of the body is a reflection of a central role in metabolism^ quite 
apart from any proposed synaptic activity. The dicarboxylic amino acids 
glutamate and aspartate emerged as transmitter candidates following a 
series of studies by Hayashi (1952, 1954) on the causation and possible 
treatment of epilepsy. Among other naturally occurring brain constituents 
L-Glutamate (L-Glu) and L-Aspartate (L-Asp) were found to produce 
convulsions in apes and dogs, upon injection directly into the cortex, 
although the experiments could not determine either the site or mode of
action of the convulsants, ' ..
The development of the technique of microelectrophoresis in the late 
1950*s was subsequently exploited by Curtis et al (1959, I96O, I963, I965) 
in a search for new transmitter candidates. Their studies revealed a 
■ series of neuronal excitants endogenous to brain tissue essentially 
similar to those identified as convulsants by Hayashi and dominated by 
L-Glu and L-Asp. In vivo intracellular recording demonstrated that the 
excitatory action of L-Glu was a result of a depolarization of the 
neuronal cell membrane showing many characteristics of naturally occurring 
EPSP's. Significantly, the PSP's differed in some respects from those 
evoked at cholinergic synapses - an inevitable signal for scepticism and 
caution.
The primary criterion of identity of action (Werman, I966; Orrego, 
1979) demands,as neurophysiological evidence,just such a demonstration 
that post-synaptic potentials evoked by iontophoretically administered 
candidates are identical to those produced upon stimulation of the 
presynaptic nerve. In vivo studies in the G.N.S. utilize micropipettes 
closely aligned to the somatic membrane of a susceptible neuron. The 
technique presupposes that in keeping with the mode of action of AGh in 
the P.N.S., the perikaryal membrane is the transmitter receptive component. 
Even if this were indeed the case, neuronal soma in the G.N.S. possess 
innumerable postsynaptic sites undoubtedly receptive to many different 
transmitter species. Although the technique allows for an accurate 
estimate of the amount of any substance released from the pipette, the 
complexity of cellular inter-relationships denies any knowledge of the size 
of the intercellular spaces available for the diffusion of the substance 
and thus its effective concentration at the relevant synapse. Extremely 
large local concentrations of a non-transmitter substance may thus lead to
E.P.S.P. *s by virtue of the applied substance being a weak agonist of the 
true transmitter. Conversely, very low concentrations of an applied 
candidate in the synaptic cleft may be insufficient to raise the membrane 
potential above the threshold for depolarization even though it is indeed 
the transmitter. Low levels of injected substances in the vicinity of the 
synapse could arise not only as a result of passive dilution and diffusion 
effects, but also by active removal of the substance either by enzymic 
action or by uptake into the surrounding cells. This is a very real 
problem with candidates such as the amino acids that serve a general 
metabolic function as uptake mechanisms designed to accumulate the amino 
acids for these functions may also serve to remove the chemical 
artificially introduced into the intercellular space -, There also remains 
the possibility'that an injected substance may cause the release of the 
natural transmitter by its effect on the presynaptic nerve ending leading 
to a false estimate of its transmitter role. These problems may be 
circumvented to some extent during investigations of the effect of AGh in 
different brain regions. First of all,its synaptic activity is known to 
be terminated by a specific clearing enzyme,AGhE;which.can be inhibited 
specifically during experiments. Second, iontophoretically, administered 
AGh has been shown to inhibit its own release,so that levels of AGh in the 
synaptic gap are likely to be uncomplicated by either excessive degradation 
or enhancement by presynaptic release. This mechanism of auto-inhibition 
has not been demonstrated as yet for Glutamate and Aspartate. In addition, 
difficulties encountered in the study of the excitatory effects of these 
amino acids are exacerbated by the fact that excitatory synapses are likely 
to be located on dendrites far removed from the cell body (Szentagothai,1971). 
Evidence for this comes from studies correlating the potency and time course 
of the action of iontophoretically applied amino acids with the degree of 
dendritic arborization (Herz, et al I969; Schwartzkroin and Anderson, I975; 
Zieglgansberger and Ghampagnot, I978).
The collection, identification and.subsequent application post­
synaptic cells of substances released from nerve endings,with the 
demonstration of identical physiological responses as those evoked by 
natural transmission,would indeed represent the most conclusive 
fulfillment of the'identity of action'criterion. Although such studies 
directly established the role of ACh in the ANS the practical relevance 
of such an approach to investigations in the CNS must be seriously 
questioned. The technical problems inherent in the location and isolation 
of the functional nerve in vivo ^ and in the design of the collecting 
apparatus,would seem at the present time to pose insurmountable problems.
The conceptual basis for collectability is also suspect as it requires 
first c : that the transmitter should be produced and released in vast
excess of amounts needed to.evoke the physiological response. If this 
were not so the possibility must exist that concentrations of the 
transmitter in the intercellular fluid may be too low for detection,despite 
the recent development of sophisticated analytical techniques. Secondly, 
the maintenance of measurable amounts of transmitter in the synaptic 
cleft requires at least a partial blockade of the method or methods 
normally used to terminate the.activity of the transmitter after it has 
served.its mediatory function. Again, studies of the transmitter action 
of ACh utilize specific competitive inhibitors of the degradatory enzyme 
AChE,greatly enhancing synaptic concentrations. Unfortunately, ACh seems 
to be the only transmitter studied so far whose synaptic activity is 
terminated by enzyme action. The catecholamines and the inhibitory amino 
3-cid transmitter Gamma— amino butyrate (pABA) are removed from the synaptic 
cleft by rapid high affinity reuptake into the presynaptic ending or into 
the. surrounding cells. If this were true for putative transmitters then 
specific blockers of such uptake would need to be utilized,paradoxically 
demanding prior knowledge of the structural requirements of the proposed 
reuptake systemI
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Based on the assumption that the postsynaptic physiological effect is 
evoked hy a series of events initiated by the interaction of a transmitter 
with a specific membrane bound receptor, that effect should be capable of 
being specifically blocked (antagonized) or mimicked by agents with 
structural similarities to the transmitter. Thus the iontophoretic applic­
ation of such a drug should have identical effects to the interaction of 
the natural transmitter with the postsynaptic membrane and the suspected 
transmitter also exogenously applied. A prerequisite for this criterion 
is that the pharmacological agent should be strictly discriminatory for the 
population of receptors specific for the putative transmitter^  as opposed 
to those for other transmitters impingeing on the cell. The likelihood of 
an agent having this property will be greater if the transmitter has an 
unusual chemical structure unrelated to other naturally occurring brain 
constituents. Thus,specific nicotinic and muscarinic cholinergic antagonists
have been widely used to confirm the transmitter function of AGh at specific 
sites, such as the synapse between spinal motorneurons and Renshaw cells 
(Eccles et al, 195^ )«
Problems arise, however, when the transmitter function of the excitant 
amino acids is being considered because pharmacological agents so far 
discovered seem limited in their ability to discriminate between populations . 
of receptors for Glutamate and Aspartate (Watkins, I978). Thus in this . 
case it is necessary to test the antagonistic efficacy of a long series of 
structurally related compounds and hope for differences in the graded 
potency of their effect on the synaptic action of the two candidates. If
this same series of compounds antagonized the effect of the natural 
transmitter in the same order,then some discrimination between the site of 
action of the two putative transmitters may be possible. Absolute 
identification of a transmitter using this criterion however, is unlikely 
to occur as considerable overlap in the effects of many of the agents must
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be suspected. Nevertheless, it may be possible by this approach to reach 
an understanding of the strict structural requirements of the receptor 
sites which may in turn lead to the development of synthetic discriminatory 
analogues. Thus even with candidates as structurally similar as glutamate ■ 
and Aspartate, this line of approach would seem to be one of the most fruit­
ful in the pursuit of criteria fulfillment.
Any estimation of the synaptic role of candidates that are important 
in general metabolism must seek to discriminate between a neurotrans­
mitter function and biochemical parameters relating to their ubiquitous role 
in chemical homeostasis.. Thus there is the danger that release studies 
in vivo or using tissue slices in vitro may fail to distinguish between 
release of the amino acids at synaptic junctions and that occurring from 
other compartments, perhaps as a result of generalized changes in membrane 
permeability of neuronal and non-neuronal elements during electrical 
activity (Matsui and Yamamoto, 1975; Nadler et al, 1977). Aspartate and 
Glutamate both show a resting release from all neural tissue so far 
studied and the amount of release can be raised by the application of 
extracellularly applied k "^ (50 mM) or eleo-tric field stimulation designed 
to mimic or evoke action potential and thus, pseudo-physiological in nature. 
Thus,the criterion of induced release alone- would seem to be inapplicable 
to a study of the synaptic function of the amino acids, unless it is 
possible to show regional variation in the extracellular levels of 
candidates following the release process. Any such regional variation 
must correspond to areas highly innervated with glutamatergic or aspartergic 
projections and must therefore reflect regional variations in intracellular 
concentrations of the amino acids. Even if release did not show patterns 
classically suggestive of a transmitter role this does not preclude the 
possibility that both amino acids could fulfill a much more generalized 
function in the CNS as well as any specific transmitter role. From a
consideration of their universal excitatory effect on.neurons, this 
general role, speculatively?could be to enhance effectiveness of natural 
neurotransmitters by maintaining postsynaptic membranes just below the 
threshold essential for.depolarization.
The dependancy of the.neurotransmitter release process on extra­
cellular Ca levels is well documented and has been summarized in recent 
reviews (Llinas, 1977? Llinas and Heuser, 1977; Rahamimoff, 1976). Thus, 
the. criterion demands that the release mechanism should be calcium 
requiring. Evidence.for this involvement of Ca^ ^ was first obtained by 
Katz and Miledi (1970),, using the cholinergic squid giant axon. A 
recent review by Kelly.(1979) emphasises that the exact mechanism by 
which.neurotransmitter release occurs is not well established, but all 
theories are based, on investigations within the experimental paradigm of 
the quantai.theory proposed by Katz and coworkers in the early 1950's 
(Fatt and Katz, 1952; Del Castillo and Katz, 1956) and developed into the 
vesicle hypothesis following the description of densely packed vesicles 
in the presynaptic nerve terminal (DeRobertis and Bennett, 1954, 1955)
The quantal. theory was developed to explain the. generation of miniature 
endplate potentials (mepp's) of constant amplitude at the unstimulated 
NMJ. Each mepp was hypothesised as due to the spontaneous release of the 
contents of one synaptic vesicle into the synaptic cleft whilst 
simultaneous discharge of many vesicles in response to the arrival of a 
nerve impulse would generate the endplate potential. Thus,within this 
paradigm the role of Ca is assumed to be due to the peed to overcome an 
bârrier, which, under resting conditions,serves to prevent 
apposition of synaptic vesicles containing transmitter with the cytoplasmic 
surface of the perikaryal membrane. Fusion of the membranes following Ca"^ 
influx through voltage sensitive channels would be followed by exocytosis 
vesicular, contents into the synaptic cleft. The energy barrier itself
ohas been postulated to be due to either electrostatic repulsion between 
the membranes (Dean, 1975) or to a hydration barrier (LeNeveu, et al,
1977). The theory of Katz (I969) and Berl et al.(1973) that the role of 
Ga*^ could be in a stimulus release coupling process has already been 
mentioned, whilst other workers have suggested that Ga"*"^ exerts its 
effect by , • screening of negatively charged phospholipid components
leading to a cross bridging between vesicle and perikaryal membranes.
Unfortunately, however, experimental data supporting the vesicular 
hypothesis is equivocal/ even for Ach at the NMJ, and there is consid­
erable evidence to show that even though the vesicular hypothesis may be 
valid at certain synapses,it may not be for others. Thus it has been 
shown that in the electric oigan of Torpedo, AGh was preferentially 
released from a cytoplasmic pool (which constituted at least 50^  of the 
total AGh) as opposed to a vesicular pool during stimulation in vivo and 
in vitro (Dunant et al, 1972). The explanation of the role of Ga^ in 
such a non-exocytotic scheme is more difficult but could be to activate 
carrier proteins or membrane gates to allow the outward passage of AGh.
The function of the vesicles could be as store of AGh replenishing 
cytoplasmic levels as required, or in the sequestration and ejection of
intracellular calcium. If activation of carriers or opening of "gates"
+ +  'are the methods by which Ga exerts its effects, it is possible if not 
likely, that carriers or channels mediating the transfer of different 
transmitters out of the nerve ending may have differing requirements for Ga^.
Thus, investigations of specific release can only be of limited value 
in providing proof of transmitter status, as long as the conceptual basis 
underlying these investigations is suspect. Significant to this argument 
is the fact that none of the amino acid candidates has been found in
Z .b
synaptic vesicles prepared from cerebral cortex after purification by 
gel filtration (Rassin, 1972; DeBelleroche and Bradford, 1975). It is 
therefore arguable from the above considerations that before specific 
release can be justified as an absolute criterion for neurotransmission, 
considerable effort should be devoted to a clarification of the mechanisms 
mediating release in different types of neural tissue and at different 
synapses. Considerable depth of knowledge concerning the constitution 
of possible storage complexes within the nerve ending is also essential, 
as release of a substance into the synaptic cleft upon physiological 
stimulation may occur because that substance is packaged and released 
with the natural transmitter, acting postsynaptically in a modulatory 
capacity although having no transmitter function of its own.
Werman (1966) also pointed to the possibility that more than one 
transmitter substance may be released from one presynaptic terminal.
Thus two transmitters working synergistically may be necessary to evoke 
P.S.P.’s. In this case the collection and purification of a single 
substance, specifically released from nerve terminals and re-applied to 
the postsynaptic membrane ^would not mimic the physiological event 
exactly, leading to a false appraisal of its role. This is especially 
interesting in view of several reports stating that glutamate and 
aspartate are both released from certain brain areas upon stimulation and 
that they have a synergistic effect when applied iontophoretically at the 
invertebrate I3MJ (McBumey and Crawford, 1979).
The presynaptic criteria demanding localization of transmitter 
candidates,and their metabolizing enzymes,to nerve endings utilizing them 
as transmitters has obvious limitations when substances are considered 
with functional roles in general metabolism as well as any transmitter 
function. Thus for Ach and the catecholamines it is possible to show
restricted location associated with discrete brain areas. This cannot 
be the case for the amino acid candidates whose ubiquity throughout the 
CNS is a reflection of their general metabolic role. Thus the task 
presented by this criterion is not to show presence or absence of 
components of the proposed transmitter system in certain brain areas, but 
to show a quantitative differential distribution and to demonstrate 
conclusively that such differences are due to transmitter excess over 
general metabolic needs. Given that there are concentration gradients 
across brain regions for all CNS constituents, even water, (Dickerson, ' 
1968) there follows the added problem that minor regional variations may 
not be significant in ascribing a transmitter role and that a subjective 
estimate as to the size of the difference that constitutes significance 
must be made (Orrego, 1979). The same author also correctly pointed out 
that there may be transmitters that are ubiquitous simply because they 
mediate the important function of central excitatory (for inhibitory) 
transmitters throughout the CNS. *
Potentially one of the most useful of the criteria in establishing a 
transmitter role for a candidate is the demonstration that there exists a 
metdiod of inactivation capable of rapid removal of the transmitter from 
the synaptic cleft on cessation of the nerve impulse. This is an essential 
requirement as the mode of action of transmitters is to temporarily disrupt 
ionic balance between the inside and outside of the postsynaptic cell 
allowing for hyper-or depolarization, of the cell membrane. If such ionic 
disturbances were allowed to continue for long periods many cellular 
processes relying on the maintenance of osmolarity and local ionic 
changes within veiy narrow limits may be irreversibly disrupted, leading 
to cell damage or death.
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The inadequacies of this criterion would seem to lie in the 
consideration of too narrow a range of potential mechanisms capable of 
fulfilling this role on the one hand, and a lack of consideration of 
alternative functions for such mechanisms on the other. Based on the 
cholinergic and catecholaminergic systems, the presence of a dégradative 
enzyme for the transmitter in the synaptic cleft (analogous to AChE)^  or 
the presence of a high affinity reuptake system , are considered adequate 
for fulfillment of this criterion.
Problems of interpreting the role of inactivating mechanisms again 
only arises when a substance is considered which has other functions in . 
the CNS. Thus,the demonstration of a catabolic enzyme does not necessarily 
mean that the enzyme is used to terminate transmitter activity. Also^ the 
presence of a high affinity reuptake mechanism for the excitant amino 
acids could be due to the necessity for maintaining normal extracellular 
concentrations of glutamate or aspartate below excitotoxic levels, given 
the almost universal excitatory effect of these compounds on nerve cell 
membranes.
Werman (1966) presents evidence for several different inactivation 
methods and it seems plausible, if not likely,that given a heterogeneity 
of transmitter species in the CNS there will also be a heterogeneity of 
mechanisms for terminating their activity.
So this then is the critical framework within which the search for 
new transmitter species must be made and within which experimental data 
relating to such a function must be analysed. If one of the aims of 
neurochemical research is to reach an understanding of the processes 
subseiving higher mental functions, then the most challenging aspect of 
this research is to establish the identity of the transmitters relaying 
information to,and within,the cerebral cortex.
1.5 evidence for glutamate and aspartate as NEURQTRMSMITTERS IN 
THE CEREBRAL CORTEX
The dicarhoxylic amino acids in general,and glutamate in particular, 
emerge as very strong candidates for the role of general excitatory 
neurotransmitter. The evidence 'relating to this role has been considered _
in several excellent reviews (Curtis and Johnston, 1974; Davidson,I976;
Kmjevic, 1974; Johnson, 197^ with much of the suggestive evidence relating 
specifically to their putative function in the cortex (Crawford and Curtis,
1964; Kmjevic, I965; Kmjevic and Phillis, I963). The finding discussed 
previously that glutamate depolarizes nerve cell membranes when applied 
iontophoretically,with similar E.P.S.P's as those produced by known trans­
mitters,is cmcial to this argument. This excitatory effect of glutamate 
is apparent on all brain neurons so far tested, and although this 
universality of effect has been suggested as being non-compatible with a 
neurotransmitter role (Curtis, I965; Curtis and Watkin, 1963)^ more 
detailed analysis has shown a wide variation in responsiveness among 
neuronal populations, some units requiring much higher concentrations of - 
glutamate for depolarization than others (Johnson, 1972). The excitatory 
effect of glutamate is also restricted to^the CNS as it is ineffective in 
depolarizing neuronal elements in the mammalian A.N.S. and P.N.S. (Obata,
1974). Considered in its entirety the data af€ totally in keeping with a 
role for glutamate as the major excitatory transmitter in the C.N.S.
It has been known for some time that glutamate is much more concen­
trated in the brain than in all other body tissues. Whilst this is also 
true of other amino acid transmitter candidates it is not true for non-trans­
mitter amino acids. Thus the brain/serum concentration ratio for G ABA is 
150, for glutamate and aspartate 3OO and for all other amino acids 
1. Potentially more indicative of a neurotransmitter role for Glutamate in the 
cortex is the fact that there is a stepwise increase in Glutamate concentration
from "lower" brain areas to "higher" brain areas ranging from 4.3//moles/g 
in the dorsal root ganglia (where a transmitter function for Glutamate is 
not envisaged) to 12.4^ moles in some cortical areas of the rat brain 
(Johnson and Aprison, 19?l). This distribution pattern is unique for 
glutamate among the amino acids, and although this gradient has been 
correlated with a sigmoidal increase in Op consumption and thus increasing 
levels of metabolic activity,it may also be representative of a greater 
transmitter excess over and above metabolic needs (Johnson, 1978).
A fundamentalsconcept in the investigation of the proposed glutamate 
transmitter system is the discrimination between a metabolic pool of 
glutamate common to all neurons,and a transmitter pool present only in those 
neurons utilizing the amino acid as a mediator of synaptic activity. The 
problem of identifying different pools of glutamate is primary to an 
understanding of how metabolic and transmitter levels of glutamate may be 
differentially regulated. The considerable amount of data concerning the 
problem of compartmentation of glutamate in the G.N.S. is a reflection of 
the firm necessity for an understanding of the complexities of glutamate 
metabolism, prior to any discussion of a possible synaptic role.
Thus,several groups of workers have shown that glutamate metabolism 
in the brain is compartmentalized into two major distinct pools' and that 
the brain is unique in this respect compared to non-neuronal tissue^
(Berl et al, I96I, I962, 1970* Van. den Berg et al, I969; Balazs and Cremer, 
1973* Benjamin and Quastel, 1974; Van den Berg and Honda, 1976aand 1978b). 
The data suggest- a large glutamate compartment associated with high activ­
ity of the enzyme glutamate dehydrogenase which would ensure the anaplerotic 
use of the available glutamate for the maintenance of an active T.G.A. 
energy cycle. The precursor for the glutamate is this large pool, which 
is essentially located in nerve endings,is glucose. A small glutamate
pool,on the other hand, is fed "by exogenously supplied glutamate, aspartate, 
hutyrate, acetate, QO^  and other compounds which feed into a T.G.A. cycle 
at the level of Acetyl CoA with a reduced glycolytic involvement. Trans­
aminases and glutamate synthetase are important to the activity of this 
small glutamate pool, which is characterized hy a rapid turnover of glutamate 
to glutamine, and which seems to he predominantly situated in glial tissue. 
Although this overview represents a simplification of what is undoubtedly 
a complex phenomenon it does suggest a cycle of events involved in the 
putative transmitter function of glutamate separate from its general 
metabolic involvement. Glutamate released from nerve endings,either 
specifically following the arrival of a nerve impulse or spontaneously 
following generalized changes in membrane permeability upon activity, would 
be effectively removed from the synaptic cleft by the high affinity 
reuptake systems present mainly in glial compartments (Henn 1976). Glutamate 
entering neurons by a low affinity passive transport system would be 
reutilized for metabolic purposes. Glutamate accumulated into the glial, 
elements on the other hand would be rapidly converted to glutamine which 
may function as a store for synaptically active neuronal glutamate. Large 
levels of glutamate released from the large pool during continuous excitatory 
stimulation may cause a serious depletion of T.G.A. cycle intermediates and 
thus a breakdown of the energy generating reactions of the cell. If on the 
other hand the glutamate released during nervous activity came from a rapid 
conversion of glutamine to glutamate catalyzed by glutaminase then levels 
of glutamate need not fall below those demanded for continual replenishment 
of T.G.A., cycle reactants. Although neurons do not possess a high 
affinity uptake system for glutamine (Roberts and Keen, 1974) it has been 
shown to pass across synaptosomal membranes very easily by passive 
diffusion given a glial-neuron concentration gradient (deBelleroche and 
Bradford, 1972; Wellbourne, 1974). Although possible differences in 
glutamate compartmentation on a regional basis ha\% not yet been analyzed
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and would indeed be difficult to assess, the contribution of metabolic 
studies to an understanding of the role of the excitant amino acids in 
.the CNS cannot be over estimated.
One of the most important applications of data concerning metabolic 
compartmentation of glutamate in the brain is to the understanding of 
studies designed to show specific release of the amino acid from nerve 
endings thought to utilize it as a neurotransmitter. Before such studies 
can provide supportive evidence for a putative transmitter role for 
glutamate it is essential to show that any release of amino acid is from 
a specific transmitter pool, and does not represent a much more generalized 
release mechanism unrelated to transmitter function and which is perhaps 
part of a homeostatic mechanism designed to maintain extracellular and 
intracellular levels constant (Cox and Bradford 1978).
There have been many reports of a continuous resting release of 
Glutamate and Aspartate from all types of nerve tissue including those 
representative of non-synaptic tissue. The release, obviously unrelated 
to a direct transmitter function, can be increased by the application of 
levels of sufficient to evoke PSP's in- vivo and therefore physiological 
in nature. (Roberts 1974; Weinreich and Hammerschlag, 1975). This is 
presumably as a result of generalized changes in membrane permeability 
during electrical activity. These in vivo findings are relevant to in 
vitro studies which predominantly utilize perfused tissue slices which were 
necessarily composed of a heterogeneity of cell and tissue types.
Although it has been stressed that a strict dependency for Ga*^ of 
the transmitter release process must be demonstrated (Orrego, 1979),the 
non-specific release described above has also been shown to be markedly 
decreased as Ga"^ levels are lowered (Roberts, 1974; Nadler et al, 1977»
Minchin and Iversen, 1974). These findings strengthen the proceeding 
argument (see p. 23) that although a role for Ca^^ in synaptic release is 
probably indisputable the mechanism of its action at different types of 
synapse, its function at non-synaptic locations, and therefore the 
relevance of its use to distinguish between specific and non-specific 
release remain to be elucidated. Thus it has been stated by Johnson., 
(1979) that the most.that can be demanded is that specific release should 
be completely abolished by zero Ca^^.
Thus the problem in release studies is to estimate any specific 
synaptic release over and above the appreciable levels of the amino acids 
already present in the extracellular space or accumulating there by other 
release processes. Thus levels of amino acids released at the synapse as 
a result of neural activity may contribute a very small proportion of the 
total extracellular levels (Matsui and Yamamoto, 1975; Nadler et al, 1977). 
Preloading of the tissue with radiolabelled amino acids and subsequent 
measurement of radioactivity in the medium following application of the 
release stimulus has attempted to overcome this problem. However, it is 
still difficult to interpret data from these studies as comprising 
transmitter release because of the possibility that the isotope could be 
accumulated and released by compartments other than the nerve ending 
(Watkins 1972). As already stated, glial cells possess transport mechanisms 
for the accumulation of amino acids and can be depdhxiiz ed by high 
concentrations of K or by electrical stimulation ; thus they 
may significantly contribute to increased efflux of labelled amino acids 
during release studies - although this efflux is not C a ^  dependent. Even 
if exogenous radiolabelled amino acids are accumulated into pre-synaptic 
nerve endings the possibility remains that they may selectively enter a 
metabolic pool of non-releasable compounds and that the amino acids 
released upon stimulation will be from a separate non-labelled pool 
leading to a failure to delect release.
There have heen attempts to obviate these problems in radically 
different ways. As previously discussed metabolic studies have shown 
that glutamate compartmentation in the brain is segregated into a small - 
(glial) pool and a larger predominantly neuronally located pool which is . 
selectively fed by glucose. Potashner (1976a) exploited this finding by 
using labelled glucose as a precursor of endogenous amino acids in 
guinea pig cerebral cortex slices and was able to demonstrate specific 
evoked release of glutamate and aspartate (and no other amino acids) that 
was drastically decreased in Ga"  ^free medium (Potashner, 1976b).
Although undoubtedly labelling a neuronal pool of glutamate as 
opposed to a glial pool, labelled glucose may nevertheless only partially 
contribute to the pool of releasable glutamate in nerve endings. It has 
been demonstrated by DeBelleroche and Bradford (1977) that the source of 
glutamate released by depolarizing agents is a rapidly depleted cytoplasmic 
pool and not a stored vesicular pool,as is commonly thought to be the case 
for acetylcholine. It has been suggested by these authors,and by 
Hamberger et al (1979),that because turnover from other pools is 
insufficient to maintain levels of releasable glutamate during sustained 
activity, the majority of glutamate released is synthesised denovo.
Neuronal activity is accompanied by an increase in metabolic activity in 
the nerve ending leading to an increased demand for glucose for central 
pathways and consequently a decrease in its ability to replenish cytoplasmic 
pools of releasable glutamate (Watkins, 1973). The neuronal pool of 
glutamate is characterized by.the presence of large amounts of the enzyme 
glutaminase (Bradford and Ward, 1978);and it has been demonstrated by 
isotopic labelling studies that glutamine may be a much more efficient and 
specific precursor for releasable glutamate than glucose (Gotman and 
Hamberger, I978; Bradford et al I978; Hamberger et al, 1979). The 
activity of glutaminase would maintain high glutamate levels both by its direct
catalytic activity and by increasing the contribution of glucose to 
glutamate production as increased both stimulates the activity of the 
glycolytic pathway and allows for an increased synthesis of glutamate via 
transamination with «x-KG (ketoglutarate), Rapid utilization of in this
way, and rapid release of newly synthesized glutamate,would further 
stimulate glutaminase activity by removing end-product inhibition. These 
studies provide convincing support for the view previously discussed that 
the glutamatergic neuron may depend for its activity on a closely woven 
interactive cycle of events involving glia and nerve endings. Gliat 
cells, more particularly astrocytes^  are rich in glutamine synthetase and 
could act as a store of glutamine produced from glutamate taken up from 
the synapse by the high affinity transport mechanisms. Using labelled 
glutamine as a precursor, Hamberger et al, (I978) have shown Ga"^ dependent 
specific release of glutamate from.slices of the dentate gyrus of the 
hippocampus but unfortunately there are no reports in the literature of 
the use of the same labelling paradigm in the measurements of glutamate 
release from cortical slices. The compartmentation studies on the role 
of glutamine are convincing enough to suggest that this would be a worth­
while approach for future release studies.
Other workers have avoided the use of exogenously applied isotopic 
precursors and have measured the total amino acid levels released from 
tissue slices following "physiological" stimulation using sensitive 
analytical techniques to discriminate between pre- and post-stimulation 
extracellular levels. Thus Ga'*~^ dependent specific release of glutamate 
alone has been shown to occur from slices of olfactory cortex (Bradford 
and Richards, 1978) and of glutamate and aspartate from visual cortical 
slices (Glark and Gollins, 1978). Yamamoto & Matsui (I976) have also 
demonstrated release of glutamate from olfactory cortex despite their use
of exogenously applied labelled glutamate, strengthening the candidacy of 
glutamate as excitatory transmitter utilized by the main excitatory 
input into the cortex. The same workers also highli^ted another problem 
with amino acid release studies in that they were unable to demonstrate 
this release in a previous study (Matsui and Yamamato, 1975) and only 
succeeded by utilizing a reported blocker of hi^ affinity glutamate uptake 
sites, L-cysteat^ which they assumed were responsible in their first report 
for the immediate re—uptake of released glutamate leading to static 
levels of extracellular amino acid. Differences in methodology and 
sensitivity of analytical techniques utilized by the two groups of workers 
could account for this finding, but nevertheless the presence of such hi^ 
affinity glutamate uptake systems inust be considered in release studies 
utilizing heterogenous tissue samples.
The problem of heterogeneity, inherent in the use of tissue slices, 
has led to the widespread use of synaptosome preparations consisting of 
morphologically intact and metabolically active ‘pinched’ off presynaptic 
nerve endings, usually with adherent postsynaptic membrane. Thus any 
specific release of amino acids from these preparations must represent 
release from compartments functional in synaptic transmission. Another 
advantage of synaptosomal preps in this context is that release can be 
triggered in the same way by electrical pulses, hi^ potassium concentra^ 
tions or depolarizing agents such as veratrine. The efficacy of different 
physiological stimuli in evoking release in tissue slices varies consid­
erably depending on factors such as the thickness of the slice and levels 
of electrical stimulation (Matsui and Yamamoto,'1975) > or the accèssibility 
of synaptic locations to concentrations (Johnson, 1979; FagS Lane, 
1979). Glial cells in tissue slices are very potent in removing from 
exbra^cellular medium (Henn, 1976, 1975) and may therefore protect 
neuronal membranes ftom this depolarizing Influence.
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The disadvantage of synaptosome preparations in the study of release 
criteria however, as pointed out hy Bradford (1979),is the necessary loss 
of other structures such as the postsynaptic cell and glial cells that may 
helital modulatory influences on the transmission process. This is 
especially important in view of the possible interactive cycle between 
glia and neurons at the glutamatergic synapse outlined above. Although 
synaptosomal preparations are not pure, with the degree of contamination 
by glial elements varying up to (Henn and Hamberger 1973); the functional 
relationship between glia and nerve endings may be disrupted. Nevertheless, 
specific Ga^ dependent release cf glutamate and aspartate from cerebral 
cortical synaptosomes has been shown (DeBelleroche and Bradford, 1972) and 
it is particularly interesting that this release was enhanced when the
synaptosomes were preloaded with glutamate under high affinity conditions
+ -4 -6(i.e. in the presence of Na and concentrations of glutamate of 10 M - 10 M)
that have already been shown to label a unique population of possible
glutamatergic synapses.
Thus although considerable methodological problems are associated 
with the fulfillment of the release criterion leading to contradictory 
reports of the specificity of the release process for the putative transmitter 
amino acids as opposed to others (see Fagg and Lane (1978) for review)^  
the accumulated data ace on the whole an encouraging indicator of a synaptic 
role, at least for glutamate in the cortex.
In view of the difficulty in interpreting many of the metabolic studies 
of the role of glutamate, complementary techniques for the localization and 
visualization of possible glutamatergic nerve endings have proved extremely 
valuable. These techniques exploit the fact that amino acids can be 
transported into nervous tissue by transport mechanisms specific for different 
amino acid groups. All cells in the body,including those of the brain, 
possess these trans-membrane carrier mechanisms to ensure adequate supplies
of all amino acids for protein biosynthesis and central metabolism. These 
carriers have relatively low affinity for their substrates with affinity 
constants in the region of 10 (imM) (Blasberg, I968; Blasberg and 
Lajtha  ^ 196^ ). The search for mechanisms by which the transmitter
amino acids could have their synaptic activity terminated led to the dis­
covery that for these amino acids only, a high affinity transport with a 
Kfi for the substrate of 10 also exists (Snyder et al, 1973; Logan and 
Snyder, 1971» 1972; Balcar and Johnston, 1972; Benjamin and Quastel, .1976; 
Bennett et al, 1972; Divac et al, 1977)»
As the amino acids also subserve a general function it seems unlikely 
that a degradatdry enzyme analogous to AGhE would be used to terminate 
their synaptic activity as the presence of such an enzyme may also interfere 
with supplies of the amino acids for other metabolic functions. The high 
affinity transport systems are also present in low concentrations and would 
therefore be sensitive to levels of amino acid transmitter likely to concen- 
.trate in the synaptic cleft, effectively removing the transmitter from the- 
vicinity of the postsynaptic cell on cessation of the nerve impulse. There 
is a wealth of data supporting such a proposition. All other trans­
mitters  ^with the exception of AGh^seem to be removed from the synaptic 
cleft in such a way. Thus high affinity transport systems have been 
demonstrated for serotonin (Kuhar et al, I97I),noradrenaline(iversen, 1967)^ 
dopamine (Goyle and Snyder, I969) and the established inhibitory amino acid 
transmitter G ABA (iversen and Neal, I968). G ABA is not an amino acid 
generally incorporated into proteins, it's only metabolic role being in 
synaptic function and,consequently,there is no low affinity transport 
system for G ABA in the GNS,strengthening the case for the involvement of 
the high affinity processes in termination of transmitter function. 
Neurophysiological evidence shows that the amino acid glycine is a major
inhibitory neurotransmitter in the spinal cord although it is non-effective 
in hyperpolarizing cortical cells. In accordance with this is the 
finding that glycine is taken up into neural tissue from spinal cord and 
brain stem by both a high affinity and a low affinity system, whereas only 
a low affinity uptake system could be demonstrated in the cortex (Bennett 
et al, 1974; Merman & Aprison I968, Logan and Snyder, I971).
The density of high affinity uptake sites for the excitatory amino 
acids has been directly related to the. increasing intracellular glutamate 
concentration from lower to higher brain areas (Johnson, I978). This 
suggests the possibility that the function of the uptake sites would be Ko 
regulate extracellular levels of glutamate and aspartate maintaining synaptic 
concentrations below those necessary for depolarization. This may be 
essential in the face of a greater potential for leakage of the amino acid 
from neuronal tissue where a high intracellular/extracellular concentration 
gradient exists. In keeping with this is the well documented evidence that 
glia cells represent a major compartment for net accumulation of the amino 
acids by the high affinity process (Henn et al, 1974; Henn, I976; Balcar 
et al, 1977; McLennan, 1976), This does not necessarily preclude a 
synaptic function for the amino acids, as careful modulation of extra­
cellular levels are essential to maintain sensitivity of postsynaptic mem­
branes to transmitter released by depolarization of the presynaptic nerve.
On the other hand^  glial uptake may also be essential were the amino acids 
not physiological transmitters, in order to prevent excitotoxic effects.
Much more indicative of a transmitter role for the amino acids is the 
wealth of data showing that potent high affinity uptake mechanisms also 
occur into synaptosomes (Bennett et al, 1972, 1973; Logan and Snyder, 1972; 
Roskoski, 1978; Iversen and Storm Mathisen, 1976). Moreover, synap— 
tosomes prepared from the cerebral cortex are not uniform in their
capacity to accumulate the am m o acids but can be separated by incomplete 
s^inilibrium sedimentation on sucrose density gradients,into distinct 
subpopulations. Glutamate and Aspartate accumulated under high affinity ‘ 
concentrations can be localized to synaptosomes sedimenting in a less 
dense part of the gradient than those accumulating other amino acids and 
other neurotransmitter species, including GABA (Kuhar and Snyder, 1970; 
Wofsey et al, 1971; Bennett et al, 1972). That this phenomenon is not 
due to an uneven distribution of low affinity sites has been demonstrated 
incubating synaptosomes with the amino acids in the presence and 
absence of sodium. In keeping with the ionic requirements of the transport 
systems for GABA and the catecholamines / the Na"^  dependency of the high 
finity uptake of glutamate and aspartate^in contrast to the low
system which is not sensitive to Na^  ^has been convincingly 
demonstrated in many types of neuronal tissue and would seem to be a 
general rule (Balcar and Johnson, 1972; Bennett et al, 1972, 1973;
Peterson and Raghupathy, 1972; Wheeler, 1976). Thus,in the absence of 
sodium^all ammo acids including glutamate and aspartate are evenly 
distributed throughout the whole sucrose gradient,whereas in its presence 
the unique profile is apparent (Snyder et al, 1973). The accumulated 
data is consistent with the presence of a proportion of glutamatergic 
nerve endings projecting into the cortex and differring in physical 
properties from other nerve endings releasing different transmitter species.
The uptake studies summarised here have been extensively criticised 
on several points that warrant careful consideration (DeFeudis, 1975). 
i^gh affinity transport systems have been found in non-nervous tissue such 
as kidney and yeast (Neal and White, 1978) and may therefore subserve a 
common biological function unrelated to synaptic activity. However, it 
may also be the case that evolutionary advancement has lead to the 
efficient utilization of one system for more than one purpose, although
that begs the question of how the two functions of such a system may be 
differentially controlled. It may be that in some studies apparent uptake 
of radiolabelled substrate may not represent a net accumulation but a ' 
homoexchange with an endogenous pool of the substrate so that the specific 
activity in the extracellular medium falls without any alteration in 
concentration of substrate. Benjamin and Quastel (1976) have suggested 
that although homo- exchange does occur it does so by a different process 
of continually balanced influx and efflux of substances across the cell 
membrane which serves a homeostatic function. Unlike high affinity 
transport, homoexchange is not an energy dependent process and therefore
t>
cannot be prevented by inhibitors of^transport process such as ouabain. 
Nevertheless, the contribution of homoexchange to changes in concentrations 
of exogenously applied putative transmitters remains difficult to estimate 
and control for and may therefore leave room for errors in the inter­
pretation of uptake data. It may also be important to consider that while 
high affinity uptake is sensitive to Na^ ion cone entrâtion in vitro, such 
sensitivity may not be significant in vivo where Na^ concentrations are 
unlikely to change to the extent where it could be a useful control 
mechanism for the process.
So while the demonstration of a high affinity transport process for 
the putative amino acid transmitters in some nerve endings points towards 
a function in synaptic transmission, and a lack of such a system in any 
one area would be difficult to reconcile with transmitter activity, other 
interpretations of the data may be possible. A more coherent approach may 
be to systematically study regional differences in high affinity processes, 
linked.to the functional activity of different projection pathways. 
Following this line of investigation it has been shown that axotomy of the 
corticostriatal pathway leads to a significant decrease in high affinity 
uptake of glutamate into neostriatal synaptosomes (MeGeer et al, 1977) and
into hippocampal synaptosomes after lesioning of the commisural path 
(Storm-Mathisen, 1977). That such differences may be a solid neurochemical 
marker for putative transmitter systems is demonstrated by the fact that ■ 
many axotomies in higher C.N.S. regions did not effect glutamate uptake 
in the projection sites (Margolis et al, 1974; McGeer et al, 1977; Storm 
Mathisen, 1977). Similar studies of possible projection pathways into the 
cortex may show variations in glutamate or aspartate high affinity uptake 
that may correlate with differences in other neurochemical parameters 
such as intracellular concentrations, levels of specific release or 
densities of post-synaptic receptor sites.
Although glutamate and aspartate are extremely effective in eliciting
depolarization.of corticàl neurons upon electrophoretic application (Curtis
and Watkins, 1963)^there are small differences between electrically 
+
stimulated and K evoked changes in membrane potential and changes evoked 
by applied glutamate. In particular, the reversal potential for glutamate 
is significantly different to that of the natural transmitter 
(Zieglgansberger, 1973; Curtis, 1965). . This may be : related'to the 
observation that.excitatory synaptic inputs are differentially located 
being mainly dendritic, whilst iontophoretically applied glutamate will 
excite via perikaryal receptors predominately, so that observed membrane 
depolarizations may be a summation of the effects of receptors with 
different physiological functions, one of which may be unrelated to 
synaptic transmission.. An electrophysiological analysis of the role of 
glutamate is complicated not only due to the uncertainity of the exact 
location at which the amino acid is acting and its function at each site, 
but also due to the probable ability of glutamate and aspartate to 
cross react with each others receptors. Both are flexible molecules and 
such cross reactivity may be due to the ability of their carbon chains to 
fold or extend whilst maintaining their ionizable amino and acidic groups
in the correct alignment for interaction with their opposing binding sites 
on their receptors. If glutamate interacts with its own receptor in an 
extended conformation then the ability of aspartate to bind to these 
glutamate preferring receptors may be limited. So the problem of 
satisfying the postsynaptic criteria for the amino acids becomes one of 
differentiating between sites of interaction of the amino acids with 
nerve cell membranes. If they are to serve a physiological function in 
synaptic transmission^postsynaptic receptors for neurotransmitters should 
exist in low finite numbers.and have a high affinity for their natural 
ligand and thus should saturate at relatively low synaptic concentrations 
of transmitter (Burt 1978).
Kinetic characterisation of binding sites may therefore allow 
discrimination between such receptor sites and those which subserve a 
different function, e.g. transport sites for the accumulation of the 
ammo acids for metabolic purposes. Binding sites for neurotransmitters 
should also exist in a particular conformation so that specificity of 
interaction is ensured — post synaptic events triggered by interactions 
between transmitter and receptor must not be accidently initiated by other 
ligands. Thus the structural requirements for effective interaction shôuld 
be unique for each receptor type. Binding studies utilizing putative 
transmitter agonists and antagonists radio-labelled to a very high specific 
activity is now a well established technique allowing the direct study of 
such interactions (Snyder, 197$; Snyder and Bennett, 1976).
Several workers have investigated in vitro the binding of tritiated 
L-glutamate to membranes prepared from cerebral cortical tissue (DeRobertis 
and DePlazas, 1976; Lahdesmaki and. al, 1977; Michaelis et al, 1974; Roberts 
1974) and other brain areas such as cerebellum (Foster and Roberts;, 1978; 
Sharif and Roberts, 1981), hippocampus (Baudry and Lynch, 1979, I98I) and
Striatum (Vincent and McGeer, 1980). Although such studies have 
demonstrated characteristics of the binding that are at least consistent 
with a neurotransmitter role for glutamate,there is considerable variation 
between the methods used and the findings of the different groups of 
workers. These results are summarized in Table , later in the thesis.
Consideration of the accumulated data reported here in terms of 
fulfillment of the classic neurotransmitter criteria strongly favour a 
synaptic role for glutamate whilst nevertheless highlighting problems of 
experimental design, methods of interpretation and depth of knowledge 
relating to the different approaches.
Despite variable results between different binding assays, the 
increasing emphasis on the application of such methods is a reflection 
of the fundamental need for a definition of the observed excitatory 
^otivity of the acidic amino acids in terms of the molecular events 
specifically initiated by the binding of each putative transmitter species.
CHAPTER 2
EXPERIMENTAL APPROACH
2.1 ONTOGENY
Although the criteria provide guidelines for investigating the 
candidature of putative neurotransmitters it remains essential to demonstrate 
that not only do the requisite individual biochemical parameters exist, but 
that they represent component parts of an integrated neurotransmitter system. 
One valuable approach to this problem is to monitor the concerted development 
of different heurochemical correlates of transmission. The rationale being 
that during brain maturation when complex neuronal circuits are being laid 
down, a better understanding of the functional importance of the processes 
thought to mediate neurotransmission may be obtained by examining ontogenetic 
relationships between the components of a system, as opposed to studying a 
single component in isolation.
An ontogenetic approach to the problem of transmission mediated by 
acidic amino acid candidates can be justified on further grounds. In 
general terms, any information concerning the stage of development at which 
a particular neuronal pathway appears could have important implications for - 
the assessment of the influences of that pathway on subsequent commitment 
of neurons in functionally or morphologically related areas. Neuronal 
activity does appear spontaneously prior to the development of presynaptic 
input, but at least with catecholaminergic neurons it has been shown that 
95% of the functional commitment of the neurons to that particular mode of 
neuro transmission, by differentiation, occurs only after innervation ( Coyle 
1976). It is therefore highly probable that the development of receptors 
on the soma of neurons does have a role in modulating their differentiation. 
Any knowledge of factors controlling such differentiation could have 
important clinical application in monitoring foetal brain development.
A difference in the developmental profile of the processes that 
mediate neurotransmission could also reflect the different functions that 
neuronal circuits perform at various stages during ontogeny. Indeed, the 
pathways that have been rigorously studied ontogenetically, mainly 
catecholaminergic (Coyle, 1974» Olsen et al,' 1973» Coyle and Campochiaro, 
1976; Lamprecht and Coyle, 1972), cholinergic (Coyle and Yammamura 1976; 
Yammamura and Snyder 1974» Simon et al, 1976; Hattori and McGeer, 1973) 
and striatal gabaergic (Coyle and Enna, 1976), do exhibit major differences 
in the time of their appearance and their rate of differentiation.
The cerebral cortex of the rat provides a good model for the study of 
the biochemical correlates of developing transmitter systems because of 
its relative immaturity at birth, Althou^ the neonate possesses the full 
complement of presumptive cortical nerve cells their differentiation is 
incomplete. These neuroblasts are tightly packed together at this stage
and become separated during the course of the first postnatal week by the 
outgrowth of neuronal processes between the cell bodies. The greatest 
contribution to the doubling in cortical thickness during this stage is 
the proliferation of the dendritic tree, although axonal growth is also 
taking place (Caley, 1971) • Simultaneously, there is a dramatic 
increase in soma size characterised by the development of a complex and 
extensive rough endoplasmic reticulum and accompanied by a very high rate 
of protein synthesis. This is reflected in the appearance of specific 
cell surface proteins and glycoproteins involved in a multiplicity of 
roles (e.g. as enzymes, structural proteins and in cell adhesion and 
recognition phenomena) but which undoubtedly include the functioning and 
modulation of transmitter systems. Thus the neurochemical specification 
of synapses is essentially a postnatal event. Neither are the 
definitive physical features of mature synapses present prior to 10 days 
of age, although presumptive synapses are easily identifiable. By 12 days 
of age many mature synapses can be recognized but maximum rates of 
synaptogenesis do not occur until around 20 days (Aghaj anian and Bloom,
1967).
In pursuit of an interest in both the mechanisms by which neuronal 
pathways become specified and the vexed question of whether or not the 
acidic amino acids fulfill a neurotransmitter role in the cortex, this 
thesis reports the utilization of binding assays to characterize both the 
adult features and the ontogeny of pre- and post synaptic neurochemical 
markers that may serve to mediate glutamatergic and aspartergic transmission.
2.2 Receptor Theory
The investigation of the interaction of glutamate and aspartate with 
synaptic membranes utilizing binding assay techniques offers many advantages
as an approach to clarifying their neurotransmitter status. In 
particular,binding assays are based on relatively simple and easily acc-: 
essible technological principles. Innovations in methodology in recent 
years are mainly the result of a firmer theoretical basis concerning the 
probable mechanisms of interaction evolved from earlier studies and 
are relatively independent of the constraints,both practical and finan­
cial,posed by a reliance on increasingly sophisticated technological 
developments inherent in some other approaches. In addition,the
' I  'availability of radioligands labelled to an extremely high specific 
activity has allowed the detection of very low levels of interaction.
Ligand binding studies are invaluable not only in quantifying levels 
of interaction with nerve cell membranes, but also in distinguishing 
■ between and characterizing different types of recognition site on a 
qualitative basis. This can be achieved by many different manipulations. 
For example, the inhibition of any binding of radioligand in the presence 
of analogues may be studied so that the structural requirements of the 
binding sites may be defined. The medium in which the assay is performed • 
can be altered to study the influence of various ions on the binding 
process, and in a similar way the influence of factors such as pH and 
.temperature, over physiological ranges^  may be examined. In addition, 
the influence on the binding of various agents both chemical and enzymic 
with known specific effects on membrane components can be studied to 
gain information on the macromolecular identity of the recognition site.
Such a detailed quantitative and qualitative analysis of recog­
nition sites for the putative transmitters on nerve cell membranes may 
allow a much more decisive discrimination between possible physiological 
roles. Such discrimination becomes vital when transmitter candidates such
4-V
as the excitatory amino acids are considered as they also serve a 
major function in intermediary metabolism apart from any synaptic role 
.and will therefore bind to transport sites subserving this metabolic 
function.
In a wider context and as pointed out by Ariens and De Miranda 
(1979)» the development of.binding assays could have important implic­
ations for the understanding and treatment of disease states, allowing 
as they do for a comparison of the binding capacity of receptor systems 
in normal and pathological conditions and the efficacy of binding of 
various drugs under these different conditions.
Undoubtedly, the most important proviso in the utilization of a 
binding assay and the interpretation of ligand binding data is the 
recognition that what is being studied is simply the initial link in 
an inexorable chain of events that leads to the manifestation of a 
biological response, which in the case of neurotransmitter action is 
almost certainly the opening of membrane ion channels. Binding assays 
must therefore be carried out only within a paradigm suggested by an 
understanding of the receptor concept which attempts to explain the 
initial recognition and binding event in terms of its translation into 
an intracellular response. Information concerning ligand/receptor 
interactions gleaned from in vitro binding studies can only be signifi­
cant if the data is at least compatible with an ability to initiate 
such cellular responsiveness.
As previously mentioned, on the basis of levels of transmitter agonist 
needed to evoke a measurable electrophysiological response in the transmitter 
systems so far studied, it is reasonable to assume that postsynaptic receptors 
for putative transmitters will be present in very low concentrations so that 
they will quickly become saturated with an increase in concentration of 
transmitter and that the affinity for the reaction will be high. In 
addition such interaction must be reversible to account for the observable 
cessation of response on removal of the stimulus.
These two kinetic parameters, maximum density of binding sites and 
affinity constant,cannot be easily estimated from an analysis of dose- 
response curves, however, without making several assumptions as to the 
nature of the coupling mechanism between agonist binding and response.
The relationship of concentration of ligand usedto elicit a response 
is evaluated within the mathematical framework designed to assess substrate- 
velocity relationships for enzymic reactions. This interpretation assumes 
the magnitude of the biological response to be proportional to the number 
of receptors activated by complexing with the ligand, so that the maximum 
response, Qmax, is achieved when all the receptors are occupied with ligand. 
This is based on a fundamental tenet,first proposed by Ehrlich in the first 
decade of this century, that for an agent to act it must be bound. In 
keeping with the law of parsimony the process of receptor/ligand complex 
formation can then be seen as a simple bimolecular interaction where
R + L ■ . RL ------- ; Response
" k-1
Where L is equal to transmitter agonist, R = receptor and RL is receptor 
ligand complex. At equilibrium kl = k-1, so that the equilibrium binding 
constant may be expressed either as an association constant KA or, as used
D I
throughout this thesis,the dissociation constant KD. Then
k-1 (R) (L)KD
kl (RL)
Thus the biological responsiveness of a system, Q,is related to the 
affinity constant of the receptor for its agonist by the following 
equation:-
Q = Qmax X (L)
KD + (L)
which is exactly analogous to the classic Michaelis-Menten equation for 
^^^lysis of substrate-enzyme interaction. The shape of. the dose response 
curve predicted by the equation is thus hyperbolic and the concentration 
agonist giving a half maximal response (ED5o) is equal to the affinity 
constant of the receptor for its ligand. (L) in this case is the total 
concentration of ligand present in the system which is assumed to be equal 
to the free concentration of ligand on the basis that,given a very low 
receptor population,the proportion of bound ligand,and thus receptor ligand 
complex (RL), will be negligably small. However , as previously mentioned, 
the accurate determination of synaptic concentrations of iontophoretically 
applied ligand is extremely difficult. Contributory factors to this
are limited knowledge of the volume of intercellular space into 
wbich the agonist is injected, the location of the active synapse in 
relation to the site of application, the extent of diffusion away from this 
site and the activity of mechanisms designed to remove neuroactive substances 
from the synaptic cleft. So,a major initial assumption is that the 
concentrations of transmitter or agonist reaching the postsynaptic receptors 
is not significantly different from the initial concentration of ligand
specified in terms of the current used for its ejection from the 
micropipette. In addition, although this occuparcytheory of the mechanism
of agonist action has been extensively developed by many workers (Ariens 
and Simonis, 1964; Stephenson, 1956; Stephenson and Barlow, 1970), 
there are several experimental observations that cannot be adequately 
explained by such theories and which render the assessment of kinetic 
parameters difficulty if not impossible^by the direct study of the respon­
siveness of a biological system.
In particular, studies, examining the effect of irreversible antagon­
ists on the response elicited by both hormone (Seelig and Sayers, 1973) and 
neurotransmitters (Van Rossum, 1972) have shown that low concentrations 
of such antagonists do not affect the maximum response elicited by the 
agonist,although this response is reduced at higher concentrations of 
antagonist. This has been interpreted as due to the presence of spare 
receptors or a receptor reserve so that only a certain fraction of the 
total receptor population need be occupied for maximal effect. This 
situation can be rationalised in terms of the effectiveness of systems 
designed to amplify the initial signal of receptor/ligand binding. A 
single ion channel may be opened by any one of a number of activated 
receptors allowing for large changes in transmembrane potential. Thus 
an irreversible blockade of a proportion of those receptors could still- 
be tolerated if others remained free to bind agonist and cause channel 
opening;
Partial agonists are substances capable of binding to a receptor, 
but which are much less efficient in forming an activated complex with 
the receptor (Ariens, 195^ , Ariens & Simonis 1964). For these substances 
maximal response.can only be attained at full receptor saturation. In 
confirmation of the existence of spare receptors the maximal biological 
responsiveness elicited by partial agonists is immediately reduced in the 
presence of the same low levels of antagonist that fail to decrease the 
response to a full agonist.
o o
Many such studies suggest that spare receptor capacity may be a 
general rule (Ariens & De Miranda, 1979; Cuatrecasas and Hollenburg, 1976). 
Accordingly the second authors have estimated that in all cases where more 
receptors are present than the number required for a maximal response, 
the concentration of agonist required for ED5o (concentration eliciting 
half maximal response) will underestimate the true value of the KD.
The situation may also arise, that a minimal proportion of a receptor 
population may need to be occupied before any response at all is detectable 
and that proportionality of response to receptor occupancy only occurs 
after this threshold has been reached (Cuatrecasas and Hollenburg, 1976; 
Hollenburg, 1978). ■ In such a situation it is possible to deduce that the 
ED5o will always overestimate the value of the true KD.
In vitro ligand binding studies obviate these problems (although 
admittedly introducing others!) by using cell free membrane preparations 
so that the initial recognition event can be analysed quantitatively 
without the need for assumptions as to the mechanism of coupling. However, 
although agonist affinities cannot be estimated in vivo, the same is not 
true for antagonist affinities as in this case it is the inhibition of 
responsiveness,rather than responsiveness per se,that is being measured. 
Thus antagonist equilibrium constants can be measured accurately by 
measuring the concentration dependence of that antagonists' ability to 
prevent access of agonist to the receptor. The mathematical model used 
to derive the equilibrium constants (Schild, 1949; Arunlakshana and 
Schild, 1959) rest on the principles of the ' null hypothesis, whereby it is 
assumed that,when the response to one concentration of agonist in the 
absence of antagonist is the same as the response to a higher concentration 
of agonist in the presence of antagonist,then the amount of agonist 
reaching the receptor in the two situations must be identical. The point
here is that antagonist affinities measured in this way provide a 
parameter that should have the same value whether derived from in vivo 
or in vitro studies if the same recognition site is being studied, and thus 
may provide the means of assessing what exactly is being.looked at in 
ligand binding studies I
Also, in vivo experiments analyzing dose effectiveness of ligands, 
although being of very limited use in providing quantitative data 
concerning the nature of the ligand/receptor interaction, can be used very 
effectively in studying the relative potencies of a series of analogues 
to elicit a similar response. In vitro binding studies utilizing the same 
series of analogues should show increasing affinity paralleling increasing 
responsiveness if the same receptor is being measured. Thus once more, 
in vivo studies of responsiveness provide an important context for 
assessing the physiological relevance of the binding estimated in vitro.
In view of the inadequacies of the occupancy theory to provide a 
framework for the. understanding of the biochemical mechanism by which 
transmitters exert their effect, other theories have been developed in an 
attempt to provide both an explanatory paradigm for interpretation of 
physiological and ligand binding data and a conceptual framework, upon 
which ligand binding experiments may be constructed.
Most recent developments in receptor theory, not only.attempt to 
analyse the dynamics of receptor/ligand interactions, but also try to 
account for the subsequent event in the evocation of the physiological 
response, namely the relationship between the activated receptor and an 
effector molecule.
The observation of sigmoid dose response curves in particular, led 
to the development of cooperative models for ligand interaction based on 
their similarity to the sigmoid velocity/substrate relationship exhibited 
by allosteric enzymes. Thus an initial, development was the adaptation of 
the Monod-Wyman-Changeux model for the nature of allosteric transitions 
to account for the complexity of such dose/response curves. The receptor 
is visualized as a membrane localized complex with the ionophore. This 
complex or drug-binding protomer can exist in one of two states, each with 
greatly different affinities for agonists and antagonists. In the absence 
of any ligand, the protomer will adopt an equilibrium between the two 
states, T (closed) and R (open). The affinity of agonists is proposed to 
be much greater for the R state than for the T state. Thus agonist 
binding will shift the equilibrium to the R state leading to channel 
opening.. Antagonists will exert an opposite effect. Such a model also 
accounts for densensitization phenomena where the recognition molecule 
has become uncoupled from the ionophore. The dissociated receptor may 
then exhibit ligand binding affinities different from either the 
associated R or T state which would undoubtedly be reflected in the 
observation of sites with different affinities in in vitro ligand binding 
studies.
Cooperative effects have been incorporated into this model by 
Changeux et al (1970) who proposed that the concerted transition of a 
number of linked protomers to the R state may be necessary before channel 
opening is achieved, the initial binding of ligand to one protomer 
facilitating subsequent binding to other protomers. This is exactly 
analogous to the cooperativity of subunits within the haemaglobin 
quaternary complex upon binding Oxygen. Karlin (1967) alternatively 
proposed that a certain number of independent protomers may need to be in 
the R state simultaneously before channel opening and thus presented an
explanation for the threshold effect not accommodated with^the occupancy 
model. Perhaps the crucial feature of both models is that they provide 
a theoretical framework for evaluating binding data that not only exhibit 
receptor populations that will either bind agonist or^  antagonist with high 
affinity but also with differing affinities (high and low) for any 
particular ligand. Partial agonists in this context would have some 
affinity for both R and T states. These observations imply that during 
the fractionation procedure for isolating membranes from nerve tissue the 
equilibrium between the Rand T fozms will be frozen so that the receptors 
will behave as two distinct populations. In addition, isolation procedures 
performed at different times might certainly be expected to yield different 
proportions of the R and T form depending on the equilibrium position ' 
attained immediately prior to the beginning of the experiment. This may 
account for large variations in the levels of binding between experiments.
However, whilst accounting for many observed in vitro and in vivo 
effects the two-state models do .impose certain restrictions in that they 
presuppose an association of the ligand recognition site with its 
effector.
An extremely elegant model for explaining the relationship between 
the recognition event and the physiological effect was simultaneously 
suggested by Cuatrecasas and Hollenburg (1976) and DeHaen (1976). Both authors 
proposed that the mobility of receptor proteins within their lipoprotein 
environment would be strongly influenced by the binding of antagonists 
and agonists with differing affinities for hydrophobic or hydrophilic 
binding sites on the receptor molecule. This mobile receptor hypothesis 
has been extensively reviewed by many workers (see e.g. Ariens and Miranda 
1979). In essence it proposes that the binding of polar agonists could
alter the interface between receptor molecule and lipid membrane 
components exposing hydrophilic portions that would therefore exhibit a 
tendency to aggregate either among themselves or with other hydrophilic 
membrane components, e.g. ionophores. The binding of non-polar antagonists 
would similarly strengthen and fix the position of the receptor within 
the membrane by favouring the maintenance of hydrophobic interactions with 
the lipid, environment,thus preventing lateral mobility and effector 
activation. The elegance lies in exploiting the current concept of the 
fluid mos aie nature of biological membranes as well as introducing 
considerable flexibility into the possible mechanism of action of 
transmitters. As explained by Hollenburg (1978) such models can account 
for many observed in vivo effects (e.g. denervation supersensitivity, 
evoked by changes in receptor/Effector ratios) and in vitro binding 
effects including different binding affinities (non-linear Scatchard 
plots), negative and positive cooperativity (Hill plots >1 to <1) and 
spare, but potentially equivalent,receptors.
The transduction mechanism by which transmitter/receptor interaction 
is converted to changes in ion gating may however be more complex than 
the mobility theory allows. This conjecture is based on strong evidence 
that receptors for many hormones and neuro-humoral factors (prostaglandins, 
opiates and angiotensin) are linked within the membrane as an oligomeric 
complex with GTP regulatory subunits (N). Binding of hormone to this 
R.N. complex leads to the formation of H.R.N. monomers and has the primary 
effect of increasing the ability of N to bind GTP. Only the H.R.N. GTP 
monomer complex is capable of activating (or inhibiting,depending on the 
nature of N) the effector, (C), be it enzyme or ion gate. This model, 
reviewed and outlined by Rodbell (I98O),allows foir the alteration in the 
activity of a system under different physiological conditions,by changes 
in R.N. subunit structure, by altering R.N./C ratio by effecting the
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degree of coupling between R and N or by controlling the availability of 
GTP. If this reaction mechanism is generally applicable it would mean 
that two ligands (hormone or transmitter and GTP) would be essential 
for physiological action. The observed response would then only be an 
accurate reflection of binding affinity&r the first messenger if GTP was 
present in unlimiting amounts.
The implications of this theory for the interpretation of binding 
studies carried out in vitro are manifold. Evidence from hormone binding 
studies using both isolated membranes and intact cells suggest that the 
^•vailability of G.T.P. may modify the affinity of the receptor for its 
ligand. Thus different Kd estimates may arise in different experimental 
systems depending on levels of the nucleotide. Different agonist affinities 
have also been observed with free receptors as opposed to .R.N. complexes 
with free R having the lower affinity. If this were a general case then 
procedures for isolating membranes for use in in vitro assays may cause 
disruption of R.N. units to a greater or lesser degree leading also to the 
expression of different binding affinities in different studies. Free R 
^^hs may be normally present in the membrane,being formed from dissociation 
of R.N. units and en route for endocytotic removal.
It is thus obvious that ligand binding studies,whilst potentially 
providing essential information concerning the nature of receptor ligand 
interactions,can only do so if they are planned and evaluated within the 
context of a theoretical knowledge of the kinds of receptor model that can 
account for the obsezrved in vivo effect, and the implications, of such models 
for generating complex binding data.
2.3 The Binding Assay
Although in vitro binding assays utilizing putative neurotransmitters 
labelled to a high specific activity may be. the only way of characterising 
receptor sites and quantifying receptor/ligand interactions, it is 
essential that certain precautions derived from theoretical considerations 
are followed. If a measure of the .1^ is to be truly representative of the 
affinity of a ligand for its receptor then it is essential that it should 
be measured when the system has reached equilibrium or steady state, when 
the values of (RL) and thus (R) and (L) maintain a constant value. This 
occurs when the rate of the forward reaction equals the rate of the 
reverse reaction in the bimolecular rate equation. It is therefore 
necessary to establish the physical and biochemical conditions which will 
allow -equilibrium to be achieved, within a realistic timescale. This in 
itself may involve a conflict of interests between optimising the binding 
whilst maintaining the integrity of the reactants.
One of the most crucial criteria for the identification of any 
binding sites measured in the binding assay as transmitter receptor sites, 
is that the binding should be saturable. There should only be a small 
finite number of receptor sites per mg tissue. It is therefore, important 
to quantify this number,or Bmax,where Bmax = (RL) + (R) . The maximal 
number of binding sites is related to the affinity constant by the 
following equation
(RL) =. Bmax (L)
(L) + kd
which is again identical to the classic Michaelis-Menten plot for enzyme 
substrate interactions. A first approximation of the binding constant may 
be obtained by the generation of a ligand displacanent curve, using a 
small concentration of radioligand .in the binding assay and adding
increasing amounts of unlabelled ligand. The concentration of unlabelled 
ligand at which maximum binding is displaced by 50% (IO^ q) should 
(allowing for certain assumptions) approximate to the kd value. A more 
accurate estimate is obtained from saturation studies in which the 
concentration of radioligand is progressively increased in the medium. 
Plotting the amount of radioligand bound per mg tissue at each concentra­
tion (b) against the free concentration (?) will result in a hyperbolic 
curve (assuming a bimolecular reaction). Bmax and the affinity constant 
can be best obtained by transforming the data to fit a linear equation:-
T) Bmax - B
%  = --- F “
which Is the Scatohard equation. Plotting the ratio B/P against (B) 
should give a straight line, if binding is saturable, which crosses the 
r axis at Bma.v and whose slope = Ed. Œhe crucial factor is that it is 
essential to know the concentrations of ligand (bound and free) at 
equilibrium. Œhe simple option is to assume that the actual free 
radioligand concentration is not significantly different from the concen­
tration of added radioligand. However, this assumption is obviously 
only valid when a small proportion (less than ICÇé) of the radioligand is 
bound at equilibrium/' Bennett, 1978) thus enou^ radioligand must be
added to ensure this excess.
The most considerable problem thou^, would seem to be identifying 
that proportion of the total binding that is to physiologically active 
receptors and not to a vast number of non-specific sites. It is very well 
documented from the literature on insulin and opioid binding studies that 
everything sticks to everything. (Cuatrecasas and Hollenberg 1975»
Snyder et al 1975). It is thus essential to account for this non­
specific binding by adding to a 2nd set of tubes containing the radio­
ligand a large excess of the same ligand in a non - radioactive form.
If all the sites on the neuronal membranes are very low affinity binding
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sites present in very large numbers then binding should carry on 
increasing in proportion to concentration, so that the amount of radio 
ligand bound should not be decreased by these high concentrations»
However, if there is present a population of saturable high affinity or 
"specific" sites then the very high levels of non-labelled drug should 
ensure that the labelled ligand is competitively prevented fran binding to 
these sites leading to a reduction in the total amount of bound radio­
activity'. Any radiochemical that is bound will be to low affinity 
unsaturable "non-specific sites". Sub^tracting this amount of bound 
radioligand fran the amount bound in the absence of excess unlabelled 
ligand should lead to an accurate estimate of the specific saturable 
binding component.
The next problem is posed by the selection of a suitable technique
for separating the bound from the free ligand for measurement. As soon
as the equilibrium position is disrupted the bound ligand will begin to
dissociate from its receptor and will be lost, leading to an underestimate
of binding. So the major constraint on the choice of separation, technique
is the rate of dissociation of the receptor/ligand complex. From
theoretical considerations,to avoid the loss of more than 10% of bound
ligand,the separations must be complete in .15 of the time taken for the
receptor ligand complex to dissociate by 50% (t^ ) (Bennett, 1978). The
dissociation half-life is quite clearly related to the affinity of a
receptor for its ligand, higher affinities (lower Kd values) generally
corresponding to slower dissociation rates (Burt, 1978). The rate of >
dissociation may of course also be decreased by lowering the temperature
at which the separation takes place. Compromises are involved with
either of the two main methods of separation ccmmonly employed in binding
studies, namely filtration or centrifugation. Nevertheless, for receptor
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binding studies exhibiting affinity constants of less than 10 M.
centrifugation is the method of choice, as for much of the- time period of 
separation the equilibrium existing at the end of the incubation period 
prevails. (Bennett, 1978). Another important consideration is that 
precautions must be taken to ensure that the radioligand utilized in the 
binding, assay is not metabolised to any appreciable extent. If this were
so then it may be the metabolite which is binding to the tissue being
I
studied and not the added radioligand. This problem may be considerable 
in studies of putative transmitters that play a major role in metabolism, 
such as glutamate and aspartate. Methods of minimising this problem 
include the thorough washing of tissue samples to ensure that there are no 
adhering metabolizing enzymes.and limiting any residual enzyme activity by 
carrying out the binding assay at low temperatures. This last precaution 
may also, of course, considerably affect the rate at which equilibrium 
between the ligand and the receptor is obtained, the decrease in kinetic 
energy at the lower temperatures considerably lengthening the necessary 
incubation time. This then is the theoretical and.methodological 
background upon which the following binding studies were developed and 
carried out.
CHAPTER. 3
MATERIALS AND METHODS OF TISSUE PREPARATION
Materials
The brain membranes used in these experiments were prepared 
from Wistar rats (Strain GFHB)^  O-jO days ..of age. The cerebellar 
mutant mice used in the binding studies were raised on a C37 BL/6 
background with controls coming from a mutant-free strain with the 
same genetic background. Below I5 days it is difficult to recognise 
the mutation on a behavioural basis, and it is only due to the technical
expertise within the animal house at the O.U. that reelers have been
3 3maintained beyond this age. L- H-Glutamate , L- H.~Aspartate and
3
H-kainic acid of varying specific activities (between 6-34Ci/m.mol) 
were obtained from the Radiochemical Central Amersham.Scintillation 
fluid. Cocktail T, was obtained from Hopkins and Williams. All other 
chemicals were obtained from Sigma Chemicals,U.K.
(o lf-
Tissue Preparation
Rats and mice were decapitated and the cerebral cortex was rapidly 
-removed and placed on ice. mite matter and underlying structures were 
carefully dissected off and the tissue was homogenized in 10-20 vols, of 
ice-cold O.52M Sucrose using 6 passes in a glass homogenizer fitted with 
a Teflon pestle. The homogenate was then centrifuged for 10 minutes at 
1,000g and the pellet (crude nuclear fraction) was discarded, to yield
SNl.
Préparation of P2 Fraction
The homogenization of brain tissue in iso—osmotic sucrose solutions 
has been shown to be favourable for the formation of nerve ending particles 
(mittaker and Gray I962). Dendrites and cell bodies swell and disin­
tegrate, at the same time, nerve endings shrink and pull away from their 
attachments. These nerve-ending particles are recovered during sub- 
cellular fractionation proceedures in the same fraction as mitochondria 
i.e. essentially a P2 fraction (Hebb and Whittaker 1958, Gray and
Whittaker I96O, 19^ 2).
The supernatant (SNl) was centrifuged at 12,000g for 20 mins to 
provide a P2 fraction according to classic cell fractionation procedures. 
(See Dave, C de 1959). The resultant pellet was resuspended in a 
hypotonic buffer (20 vols. 5mM Tris SCI pH 8.4) and left on ice for $0 min. 
to ensure lysis of any vesicles present and the release of endogenous 
L-Glutamate. The suspension was then centrifuged for 10 mins. at 
48,000g. The pellet was washed twice by re suspending in 50nM potassium 
phosphate buffer pS 7.1 and recentrifoging. The pellet was finally 
resuspended in the same buffer for use in the binding assay.
Electron micrographs of P2 fractions prepared from rats at different 
age points are shown in Plates 1—4» Although all of the samples are
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necessarily heterogenous, nerve-ending particles are apparent even 
in the fractions prepared from 6 day old rats (Plate l). The 
micrographs show very little tissue in the form of free membrane 
fragments especially in the P2 fractions prepared from rats between 
6 -20 days of age. Mitochondria are present in all fractions 
thou^ the integrity of the organelles is poorly preserved as a 
result of the hypo-osmotic preparation conditions. All of the 
fractions are relatively uncontaminated with myelin, as great care 
was taken to clean the cortices of white matter before the fractionation 
process was carried out.
Preparation of Crude Synaptic Membranes
This procedure is essentially as described- by Simon et al 
(1976) and is as follows. SNl was centrifuged for 20 minutes at 
17,000g. The pellet was resuspended in ice-cold distilled water 
by hand homogenization. This suspension was then centrifuged for 
20 minutes at 8,000g. The supematent fluid along with the soft 
upper layer of the pellet was collected. This supernatant fraction 
was then centrifuged for 20 minutes at The pellet was
washed twice by resuspending in ice-cold distilled water and recentri— 
fuging, before final re suspension in 50mM potassium phosphate buffer 
for the use in the binding assay.
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PLATES 1 - 4
Electron micrograph of fractions prepared from the cerebral cortices 
of rats at different age points.
Plate 1 - 6  day
Plate 2 - 10 day
Plate 3 - 2 0  day
Plate 4 - 50 day (Post-lysis)
Subcellular fractions were fixed in 3% glutaraldelyde in lOOmM sodium 
cacodylate - HCl/lOOmM sucrose buffer (pH 7.4)for 12 hours at 4°C and 
post-fixed in 1.3% osmium tetroxide in 67nM s-collidine (2, 4, 6 - 
trimethyl pyridine) - HCl buffer (pH 7.4) for 2 hours at 4°C and then 
1 hour at 20°C. After dehydration the tissue was infiltrated with 
epoxy resin, embedded, cured and ultrathin sections (60 -90nm) cut on a 
Reichert DM U3 microtome. Sections picked up on 200 mesh uncoated 
copper grids were stained in a saturated solution of ufanyl acetate 
in 35% methanol followed by lead citrate. Sections were viewed and 
photographed in a Phillips 301 transmission electron microscope.
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Preparation of pure synaptic membranes
The cleaned cortices previously described were homogenized in 9 
vols, of 10^ (w/w) sucrose using a glass homogenizer with a teflon 
pestle. The homogenate was centrifuged at 1,000 rpm for 20 mins. and 
the pellet was discarded. The supematent was centrifuged at 9»000g 
for 20 mins. and the supematent was discarded. The pellet was 
resuspended in 10  ^sucrose'and recentrifuged at 9,000g for 20 mins. The 
pellet was dispersed in 2mls. of jmM Tris HGl pH 8.4 using a pasteur 
pipette and left on ice for 30 mins. The suspension was then homogenized 
by hand and 4 mis. of 48^ (w/w) sucrose was added to the tube. The 
contents of the tube were thoroughly mixed and in 15 ml. polycarbonate 
centrifuge tubes. 5mls of ZQ,^ % (w/w) sucrose and 4 mis. of 10% (w/w) 
sucrose were then added to the tube and the contents were centrifuged at 
60,000 g for 90 mins. The synaptic membranes collected at the interface 
between the two highest sucrose concentrations and this fraction was 
carefully removed with a pasteur pipette. The synaptic membrane fraction 
was made up to lOmls with 50mM potassium phosphate buffer pH 7.1 and 
centrifuged for 20 mins at 48,000g. The membranes, were then, 
resuspended in 50mM potassium phosphate buffer (pH 7.1) for use in the 
binding assay.
Protein concentrations were estimated by the method of Lowry et al 
using bovine serum albumin as standard.
CHAPTER 4
ESTABLISHING THE BINDING ASSAY
a) Separating bound ligand from free ligand
The theoretical considerations discussed in the previous section 
provided a basis for studies of the optimum conditions necessary for 
the investigation of glutamate binding to rat cortical membranes. 
Earlier reports of glutamate binding in rat cerebral cortex gave 
estimates of the Kd in the region of 10 (Roberts 1974» Michaelis 
et al.,1974). This indicated centrifugation as the method of choice 
for separating glutamate bound to brain tissue from the free ligand. 
However, Roberts (1974) did use filtration in these early studies. 
Filtration offers considerable advantages over centrifugation in terms 
of the large number of samples that can be handled, the greater speed 
at which they can be processed and the ease with which washing 
procedures can be carried out. Consequently,initial studies attempted 
to use this technique to separate bound from free ligand. Filtration 
was carried out using both cellulose filters and glass fibre filters. 
Unfortunately the filters retained very little of the radiolabel bound 
to membranes after 3 washes with ice-cold distilled water or 50 mM 
phosphate buffer. The amount of radiolabel remaining on the filters 
was equal to the level retained by filters in the absence of membranes
7)
and represented less than .01% of the total radioactivity. Unwashed 
membranes showed considerable variation between triplicates in the 
levels of radioactivity adhering to the filters and it was very diffionlt 
to systematically show any difference between total binding and non­
specific binding. In contrast,centrifugation at 48,000g for 10 mins. 
at 0°C proved a very effective and reproducible method of separating 
bound &-L-G1U from the free ligand and discriminating between specific and 
non-specific binding.^e concentration range of &-h-Glu utilized in the 
assay was sirçly arrived at from a consideration of the reported Kd values 
for glutamate. To test for the effects of other parameters on the binding 
a single &-L-Glu concentration of O.^Wwas routinely used. The concen­
tration of non-radioactive glutamate used in the experimental blank was 
arrived at from the consideration that it should be at least lOOx the Kd 
value (Burt, 1978) and was routinely at a final concentration of Q.lmM.
b) Incubation Temperature
As glutamate is a ubiquitous biochemical essential for many metabolic
processes, it is an enzyme substrate in many reactions. I therefore 
decided to minimise the risk of such reactions by carrying out the 
assay at 0°C by incubating the tubes in an ioe-water bath. In this 
way, it was possible to be fairly certain that the radioactivity 
measured at the end of the assay both bound and free, was indeed glutamate 
. and not another metabolite. These initial studies were carried out 
using, essentially, a P2 membrane fraction and 0.2 - 0.3 mg was 
routinely added to each of the assay tubes. The medium for these assays 
was potassium phosphate buffer at a neutral pH of 7.1. final ,
volume in each of the tubes was 2 mis. Initially, all estimations 
were carried out in triplicate, then duplicate tubes were used for 
pragmatic reasons and because these duplicate values were always wxthin
/z
5% of each other.
c) EstiTnating the amount of hound ligand
After termination of the assay by rapid centrifugation, an aliquot 
of the supernatant was taken to estimate free levels of radioactivity 
and the remaining supernatant carefully decanted. The pellets were then 
rinsed superficially with 2 x 5mls. of ice-cold distilled water to remove 
any unbound &-L-Glu. Although it is not possible to remove free 
glutamate trapped inside the pellet, this amount of free ligand will 
be present in both sets of tubes i.e. those measuring the total binding, 
containing only radioligand and those measuring nonspecific binding 
that contain, in addition to the radioligand, excess cold ligand.
Thus, subtracting non-specific binding from total binding will auto­
matically solve the problem. After pellet rinsing, the tubes were left 
to drain at 4°C and the pellet was then solubilized in 1ml. of O.IM NaOH. 
Scintillation fluid was added, together with 100//1 per vial of glacial 
acetic acid to eliminate chemiluminescence. Radioactivity was 
assayed in a Beckman 250 scintillation counter at ambient temperature 
with a counting efficiency of $0%..
d) Time course of the assay
The time course of the specific binding is shown in Fig. 41» As 
may be expected, at the low incubation ten^erature used for the assay^  
the reaction proceeded slowly, and attained equilibrium only after 
approximately 10—15 minutes. Non-specific binding on the other hand 
was essentially Instantaneous and remained at the same level throu^out. 
Consequently, an incubation period of 20 minutes was utilized for all 
binding assays reported in this thesis.
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e) The effect of pH
Fig. 4.2 shows the effect of pH on levels of specific binding
and demonstrates that there is a broad range of pH values at which
binding can be detected (pH4-pH9) although there is maximal binding
at around pH?. It was not possible to detect any specific binding
below pH4, or above pH9. This is in keeping with the proposed
mechanism of interaction between glutamate and its postsynaptic receptor
as a 5 point attachment between the two anionic carboxyl groups and
the cationic amino group of glutamate and opposite charged groups at
the acceptor site, ^urtis & Watkins i960). As the pki of these
three ionizable groups are 2.19, 4-25 and 9-67 respectively, the
glutamate molecule will not be in its fully ionized state either below
approx pH 4 above pH9«
f) The effect of protein concentration
Althou#i, wherever possible, I intended to standardize the amount 
of tissue used per tube in the binding assay, it seemed inevitable 
that variations in yield would arise, not only on a day to day basis, but 
also as a result of the use of brain tissue from rats varying in age. 
therefore, it was necessary to demonstrate that levels of glutamate 
binding were directly proportional to the amount of tissue utilized in 
the bin ing assay. Fig. 4.5 glTes the result of such an experiment 
and shows that specific binding is linear with protein concentraticns 
between 0.1 - 1.0 mg per tube.
g) Subcellular distribution of the binding
One of the main criteria for establishing a substance as a neuro- 
transmitter is that binding sites capable of specific interaction with 
the ligand should be concentrated at the site of transmission on the 
post-synaptic membrane. Thus it is a necessary condition to show that
'i-
the specific activity of the binding is enriched in a synaptic membrane 
preparation over that amount present either in a crude homogenate or in 
a P2 fraction. Accordingly, I further resolved the P2 pellet by 
density gradient centrifugation to yield purified Myelin, synaptic 
membranes and mitochondria according to the method of Jones and Matus 
(1974) and detailed previously. Specific glutamate binding was then 
analysed in all fractions i.e. in homogenate (s), 8^ , Pg' ®2’ 
synaptic membranes (SM) and mitochondria (Mit). The results of this 
study are given in Table 4l and show that the binding is almost exclusively 
located on a particulate fraction. In addition, there is almost a 
seven fold Increase in the specific activity of the binding in SM 
compared to that in a Pg fraction, which would seem to indicate that 
many of these binding sites are indeed associated with the synapse.
Some of the binding, thou#i, is present in the mitochondrial fraction 
which is contaminated with plasma membranes from extra^synaptic 
locations. This could be suggestive of the fact that a proportion of 
the binding sites for glutamate may be located extra-junctionally cn
the neuronal perikaiya.
Fig. 41
3
Time course of H - L - Glutamate binding.to cortical membranes.
Binding was determined at a (^ H*-L-Glu) of 0.6pM at 0-2°G. Results 
are means of 4 separate experiments which varied by less than 10%;specific 
binding ■ ; non-specific bindingo.
Fig. 42
The Effect of pH on the specific binding of H^-L-Glu to cortical 
membranes. The results are means of 4 separate experiments which 
differed by less than 5%. Assay conditions as stated in the text.
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Fie. 43
The effect of increasing amounts of cortical membranes on the
3specific binding of H-L-Glu. , Tissue is estimated as mg protein 
per assay tube. Results are means of 4 -6 separate experiments 
which differed by less than 10^ ,
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TABTiE 41 Distribution of glutamate binding in different
subcellular fractions.
Specific Binding (p mols/mg protein)
Fraction . K (P) Buffer Na(p) Buffer
H 2.75 ± 0.14 25.4 +0.8
S]_ 3.75 + 0.16 24.2 + 1.1
4.5 + 0.21 46.8 + 1.8
Sg 0.2 + 0.018 1.4 + 0.2
My 0.0 0.0
SM 31.0 ± 2.4 84.0 + 7.2
Mit 3.2 + 0.24 35.1+ 4.1
Synaptic membranes were prepared as previously described and 
results are means + S.E.M. of six experiments.
h) The Effect of Sodium
Table 4i_also shows the results of a similar experiment but, where 
the k(P) buffer used as the incubation médium in the assay was 
replaced with Na(p) buffer at the same pH of 7.1. This was in an 
attempt to recognise binding to trànsport sites for glutamate that may 
serve a transmitter function and that are highly dependent on the 
presence of Na**". Once again, activity is located solely in the 
particulate fraction. The binding, however, is not strongly associated 
with the synaptic membrane fraction for,although there is a two fold 
increase in activity in this fraction over the P^  pellet, there is also 
a significant proportion of the binding in the"mitochondrial fraction.'
Many of these putative high affinity transport sites are thought to 
exist on glial cell surfaces, and the plasma membrane of these cells 
will be present in the mitochondrial pellet as well as being a contaminant 
of the synaptic fraction. Levels of binding in the presence of sodium 
are approximately 6 x the level of binding demonstrable in the absence 
of sodium.
i) The dose response to potassium (K*^)
Potassium phosphate buffer was chosen as the incu'bation medium 
because, in contrast to other workers (e.g. Roberts, 1974), I could not 
detect any specific binding of glutamate using either 50mM Tris, citrate 
buffer (pH 7.1) or 50 mM Tris. HGl buffer (pH 7.1). Fig. 4.4 shows the 
effect of increasing concentrations of potassium on specific glutamate 
binding. The incubation medium used in the assay was Tris, citrate 
buffer and the potassium was added as the chloride saXt to control for 
any effect of increasing phosphate concentrations on the binding. As 
can be seen from the graph the binding seems to be quite markedly dependent
on the presence of potassium and reaches maximal levels at about 20 mM K**" 
when the p/mols of glutamate specifically bound per mg protein is very 
similar as in the presence of 50nM potassium phosphate buffer. This 
result is in stark contrast to studies performed by Sharif and 
Roberts on the cerebellum where they reported a marked inhibition of 
glutamate (and aspartate) binding by over a concentration range of
2-50mM (Sharif and Roberts, I98I). The differences in the two sets
of results are difficult to explain, but may possibly represent a 
regional variation in the modifying effects of cations.
An alternative explanation may be provided by more recent studies 
that report an enhancing effect of Chloride ions on L-glutamate binding 
to rat brain synaptic membranes (Mena et al 1982). As the potassium 
concentration in the incubation medium in my own studies was altered by 
the addition of the chloride salt it seems likely in the li^t of this 
recent work that the data shown in Rig. 4*4 reflects this dose dependent 
enhancement of glutamate binding by chloride ions, rather than a direct 
effect of potassium ions. The characteristics of the chloride enhance­
ment show strong similarities to the effect on glutamate binding shown 
in Rig. 4.4 in that the binding was saturable over the same chloride 
concentration range reaching a maximal at approx. 2QmMCl. The possible 
effect of ions on glutamate binding will be discussed further in the final 
chapter of this thesis, 
j) The dose response to sodium (Ma"^ )
This view is further strengthened from a consideration of the 
effects of sodium in the two preparations. Rig. 4«5 shows a biphasic 
response to sodium,with low concentrations producing a dose dependent 
inhibition of the binding. Higher concentrations produce a large 
increase in observed levels of specific glutamate binding. The change
Fig. 44•
The effect of increasing ionic concentrations of on the 
specific binding of ^ H-L-Glu, The tissue was incubated under 
conditions described in the text in 50mM. Tris-Gitrate buffer 
to which varying concentrations of K**” were added as the chloride 
salt. , The results are means of 3 separate experiments which 
differed by less than
Fig. 45
The effect of increasing ionic concentration of Na  ^on the 
specific binding of ^ H-L-Glu. Na*^ was again added'as the 
chloride salt. The results are means of 4 separate experiments 
which differed by less than 10%.
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from irhitition to stinnilation of binding occurs at a Na*** concentration 
of about lOmM. This effect of sodium parallels the situation found in 
hippocanq)us (Baudry and Lynch, 1979» Vargas and Costa, 1981), but is 
in contrast to the reported effects of Na"^  in the cerebellum where an 
inhibition of binding is apparent with sodium concentrations up to 
lOOmM (Poster and Roberts 1978; Sharif and Roberts, 1981). In 
addition, several workers have reported binding sites on cortical 
tissue that are sodium dependent and that can be distinguished from the 
sodium independent binding component on the basis of kinetic parameters 
(Roberts, 1974).
k) Tissue distribution of binding sites
If the specific sodium independent binding of glutamate is
attributable to interaction with a postsynaptic receptor then it-may
be expected that such sites would be limited to the nervous system.
Accordingly I investigated levels of Ra"^  independent glutamate binding 
to fractions prepared from whole brain, heart, kidney, liver, lung 
and peripheral (skeletal) muscle, as well as from cerebral cortex.
No binding was detectable in either the kidney, liver or lung. Binding 
to the whole brain was sli^tly lower than in the cortex. However, 
surprisingly and curiously, levels of specific binding were very hi^ 
in skeletal muscle and in heart muscle. The relative proportion of 
binding that was specific conrpared to non-specific fell to approximately 
20% in these tissues however. These results are summarised in Table 42. 
It is rather difficult to assign a function to these binding sites in 
heart and striate muscle, for althou^ both tissues are extensively 
innervated, glutamate has not been shown to be the transmitter 
utilised by the peripheral and autonomic nervous system.
TABLE 42 DISTRIBUTION OF GLUTAMATE BINDING BETW^T?n\r 
DIFFERENT TISSUES
Tissue
Cortex
Whole Brain
Heart
Kidney
Liver
Lung
Skeletal Muscle 
(from upper hind leg)
Binding (p mols/mg protein)
Specific Binding
3.8 + 0.14 
2.75 ± 0.12
7.4 + 0.36 
0.0 
0.0 
0.0
19.4 + . 1.1
Non-specific binding
2.5 + 0.13
2.4 + 0 • 13 
28.6 + 2.1
74.6 + 2.
96
Sharif and Roberts (198I) have reported that a 3 minute 
pre-incubation of membranes prepared from cortical tissue at 
causes an enhancement of specific glutamate binding of over 400%.
They attribute this finding to the presence of an endogenous inhibitor 
of glutamate binding which is released uring the pre-incubation step 
and is subsequently washed out. Accordingly, I looked at the effect 
of such a pre-incubation on the membrane fraction used in the binding 
assays reported here. Freshly prepared membranes, ready for use in 
the binding assay, did not seem to be affected by this treatment, 
although the experiment was repeated several times varying the number 
of subsequent washes from 2-6. It may be that the routine step 
of suspending membranes for 30 minutes at 0°C in hypotonic buffer 
(5nM Tris HCl pH 8.4) serves the same function as the 57°C incubation 
in the study by Sharif and Roberts, i.e. the releasing and washing out 
of endogenous ligands. An analysis of the wash supematent in an attempb 
to identify possible modulators may prove fruitful. Levels of binding 
were not significantly increased by subsequent washes of the pellet to 
be used in the assay over and above the two utilized routinely.
Similarly, further washes of the pellet at the termination of the assay 
did not decrease levels of radioactivity.
In summary, the binding assay was routinely performed as stated below:
Tissue sample: 0.3 - 0.6 mg protein, routinely Pg fraction.
Buffer: 301#  potassium or sodium phosphate, pH 7.1.
H^-L-Glu: 0.005 - 2.0 nM (0.2 - 0.4 nCi/tube approx.)
'Cold' L?Glu: O.lnM.
Total Tube vol: 2 mis.
Incubation: 20 mins at 0°C.
Termination: Centrifugation at 48,000g for 10 min.
CHAPTER 5
RESULTS
j.l Glutamate Binding to Adult Rat Cortical Membranes
Figure 5.1 shows the binding-of ^ H-L-Glu to cortical membranes
+
prepared from 50 day old rats, and carried out in the absence of Na . 
Specific binding is saturable over the concentration range of 0.005-1.6y M 
but non specific, binding was not saturable over the same concentration 
range, and increased linearly (r = 0.99). Replotting this data by 
Scatchard analysis (inset 5.1) shows this site to have an apparent 
dissociation constant (Kd) of 0.37 + 0.06jL>m with a site density (Bmax) 
of 5.20 + 0.57 pmols/mg protein. Standard errors of the mean of kd and 
Bmax were calculated throughout this thesis by grouping together the 
kinetic values from at least five individual experiments. In view of 
recent reports (Biziere et al, 1980; Roberts and Sharif,I98I) of very high 
affinity binding sites for glutamate on membranes prepared from forebrain
Fie. 51
The specific Na”^ independent binding of ^ H-L-Glutamate to 
cortical membranes (P^ ) prepared from adult (^ 0 day old) rata. 
^H-L-Glu concentrations varied between 5 % 10  ^and 1.6 x 10 M^. 
The results shown are the mean + SEM of 6-8 separate experiments. 
Kinetic paramaters were estimated from a Scatchard plot of the 
data which is shown as an insert. The line on the Scatchard 
plot was drawn by linear regression analysis.
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and striatum respectively with Kds of llnM (Biziere et al - forehrain) 
and 16,6 nM (Roberts — striatum) the initial part of the saturation 
isotherm (from 3nM - lOOp m) was analysed by linear regression. A plot 
oi* f iiipl bound/mg protein vs ^H-L-Glu gives a coefficient of deter­
mination of the slope of the line of 0.9, showing that the binding over 
this concentration range represented the initial linear part of the total 
binding isotherm and did not represent a separate saturation curve.
Figure ^.2 shows the binding of 3”H-L-Glu in the presence of 30mM 
Na . Specific binding is again saturable over the concentration range^  
while non-specific binding was linear. A Scatchard analysis of the data 
reveals a Kd of 1.34 + O.lépM and a Bmax of 210 + I9.2O pmols bound/mg 
protein (insert Figure 5.2).
Discussion
The presence of two high affinity binding sites for L-glutamate 
on cortical membranes fits well with currently accepted criteria for 
nGurotransmitter status. All amino acid candidates so far examined 
appear to be taken up into nerve endings by both a low affinity (Kd =
10 and a high affinity' (kd = lo"-^  - lo"^ M) transport system in contrast 
to other amino acids which are only transported by a low affinity system. 
These high affinity sites have a strict requirement for sodium and have 
been proposed for sometime as the mechanism by which neurotransmitter 
activity is terminated (Roberts, 1974; Bennett et al, 1973; Iversen, 1971) 
Since then, there have been reports of Na'*' dependent binding sites in many 
brain areas. _ These are summarised in Table 5.1. In addition it has been 
shown that sodium is necessary for the initial binding event .(Wheeler and 
Hollingsworth, 1978) and so in vitro studies on the interaction of
• Fig. 52
+ 3The specific Na dependent binding of H-L-glutamate to
cortical membranes (p^ ) prepared from adult (50 day old rats)
3h-L-G1u concentrations varied between 0.1 - 1.6 pM. The
results are means ^  SEM of 8 separate experiments, kinetic
parameters were estimated from a Scatchard plot of the data which
is shown as an inset.
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glutamate with its reuptake site should show a strict dependence on Na'*',
In view of the estimated affinity constant for this interaction being
very similar to the affinity constant for the transport of glutamate by
the high affinity process, together with the fairly high site density,
there seems a high probabilty that the binding demonstratable in the
presence of Na"^ is indeed to such.an uptake site. Kinetic determinations
alone, however, cannot be conclusive. Na"^ independent binding may
contribute up to %  of the Na dependent binding, although there have
+been reports that Na independent binding is greatly inhibited in the 
presence of low concentrations of Na ^ ^lOmM (Baudry and Lynchi 1979; 
Sharif and Roberts, I98I). Although the maximum degree of this inhibition 
was difficult to assess at concentrations of Na"*" in excess of 10 mM due to 
the appearance of Na^ dependent binding^ it may be that it is not possible 
to measure binding simultaneously to uptake and putative receptor sites.
It is much more difficult to estimate, on the basis of the kinetic 
evidence only,whether or not the Na"^  independent site is synonymous with 
a postsynaptic receptor site. Reports of such binding by other workers 
cover a wide range of kinetic parameters (Table 5.I) and in agreement 
with Roberts (I98I) it seems unlikely that they could all represent 
binding to a physiologically significant postsynaptic receptor. It 
is probable that the wide range of reported values is due to the different 
experimental methodology employed by various workers. Considered within 
the context of the two-state model of receptor theory previously discussed 
(Chapter 2) such differences could lead to widely differing ratios of 
receptor in the R and T states. Variation between different brain regions 
may reflect real differences in physiological function. Other differences, 
however, may be due to experimental variables such as the use of 
^^ t^ration as a separation method as opposed to centrifugation
(see section 2.3 for discussion) or to the use of frozen tissue in 
preference to freshly prepared samples. Foster and Roberts (I978) 
made the initial observation that glutamate binding, at least in the 
cerebellum, was very sensitive to dénaturation at low temperatures.
Later reports from the same laboratory (Sharif and Robert, I98I) have 
shown that lyophilization of freshly prepared membranes considerably 
enhances the binding, increasing the apparent Bmax. My own work (reported 
more fully in a later section) has shown that Na"^  independent and Na*^ 
dependent binding are differentially affected by freezing and thawing, 
although both exhibit different levels of binding to that found in fresh 
tissue. Other methodological differences that may contribute to anomalous 
kinetics include the purity of the membrane fraction used, the presence 
or absence of certain cations recently reported to affect glutamate 
binding (Baudry and Lynch, I98I), the specific activity of the radioligand 
utilized in the study, the presence of endogenous ligand, and many others. 
Clearly then there are many important factors that ought to be considered 
and controlled for whenever possible (as discussed in Section 2.3).
Despite the methodological problems there are indications that 
Na independent binding, as it has so far been characterized, is at least 
consistent with binding to a postsynaptic receptor. In particular, 
site densities are low and there is a considerable enrichment (up to 
eight times) of the binding in a synaptic membrane fraction as opposed to 
the homogenate. (Chapter 4).
5.2 . Ontogeny of Glutamate binding sites in rat cortex.
Having established the presence of binding sites for glutamate in the 
adult, the development of these binding sites from birth to 30 days was 
then investigated. This was motivated by three main questions:—
1) If the binding sites represent biochemical parameters mediating 
synaptic transmission of glutamatargic neurons, is their development 
co-ordinated or are there at least correlations between their 
patterns of development?
2) Do the binding sites appear in the mature form (i.e. exhibiting 
similar kinetic parameters as in the adult) at an early age or are 
there qualitative or quantitative changes?
3) Do the developmental profiles exhibit stages or discontinuities 
that may be correlated with specific morphological events?
The dissection preparation and subsequent handling of cortical 
membranes from neonatal and very young (up to 10 day old) rats proved 
problematic and tissue samples used to estimate levels of glutamate 
binding in rats age 0-10 days were pooled from littermates.
-j-
The ontogenetic profile of the Na. independent site is shown in
+Figure 3*3 and that of the Na dependent site in Figure 3*4. The 
binding is expressed both in terms of pmol bound per cortex and per mg 
protein. This reflects a primary interest in estimating changes in 
the total number of binding sites during development.' A change in 
p mois bound/mg protein during this time could simply be a reflection 
of variation in the relative amount of protein in the brain rather 
than a change in the absolute number of binding sites. The specific 
activity of the binding throughout development in terms of p mois 
bound/mg protein is shown as an inset on both graphs. In view of the 
complexity of brain maturation it is difficult to interpret these inset 
graphs in terms of morphological events,although it is an inter­
esting - observation that there is a dramatic fall in specific activity 
of the binding in both graphs at around 13 days. This could reflect
FIG. 53
+Developmental profile of specific Na independent
3
H-L-Glu binding to cortical membranes, prepared from rats 
of various,ages as shown., Binding was.estimated at a
3
H-L-Glu concentration of 0.6^ ;M. Each point represents 
the mean. + SEM of 4 - ? separate determination. The 
inset shows the specific activity of the binding in terms
3
of p mois specific H-L-Glu bound/mg protein. •
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FIG. 54
Developmental profile of the specific Na"^  dependent 
binding of H-L-Glu' (measured at a concentration of 
0.6 pM) to cortical membranes prepared from rats of 
various ages as shown. Each point represents the mean 
+ SEM of 4 - 7 separate determinations.
The inset shows the specific activity of the binding in
3
terms of pmols specific H-L-Glu bound mg protein.
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both the rapid proliferation of neuropil material beginning at around 
this time and the end of a dramatic phase of proliferation of the 
dendritic tree, expansion of some size and development of an extensive 
rough endoplasmic reticulum, indicative of enhanced protein synthetic 
capacity.
Expressed in terms of p mois bound/cortex, both binding sites were 
demonstrable from about days of age, albeit at very low levels.
Failure to detect binding from 0-5 days may be due to the difficulty of 
adapting the dissection and fractionation procedure to cope with small 
amounts of immature cortical tissue rather than an absence of binding 
per se.
Na"^ independent binding rises sharply to 20-25 days and then more 
gradually to reach adult levels at 50 days. Na"^ dependent binding on 
the other hand rises slowly to reach a peak at 20 days dropping 
significantly (p<0.01) over the next 10 days,before rising again 
(6 - fold) to reach adult levels at 50 days.
The 20 day age point seems to represent a recognizable stage in 
the development of glutamate binding sites and this age also corresponds 
with the time at which maximum rates of synaptogenesis are occurring 
in the cortex (Agahajanian and Bloom, I967). Consequently, the 
kinetic parameters defining glutamate binding of this stage were 
examined. Figure 5*5 shows a saturation curve for Na"^  independent 
glutamate binding to cortical membranes prepared from 20 day old rats. 
The binding does indeed saturate over the same concentration range as 
in the adult and a Scatchard plot of the data, shown as an inset,gives 
a Kd of 1.32 + 0.23 jUM and a Bmax of 8.4? + I.05 P mols/mg protein.
. fig. 5ô
+ ' 3The specific Na independent binding of ^ H-L-Glu to 
cortical membranes prepared from 20 day old rats measured 
at a L-Glu concentration of 0.6pM. The results show the 
mean + SEM of 6 separate experiments. The kinetic 
parameters were estimated from a Scatchard plot of the data 
which is shown as an inset on the graph.
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The saturation curve for Na dependent binding is shown in Figure 
5.6. Replotting the data as a Scatchard plot gives an estimate for Kd 
of 1»77 + 0.30^M and a Bmax of 82.4 + 4,19 P mols/mg protein (inset 
Figure 3,6). .
Discussion
The ontogenetic profile of both sites shows the simultaneous, 
development of Na'*’ dependent and Na"*" independent binding at similar 
rates until 20 days of age. Na"*" dependent binding continues to rise, 
albeit at a lower rate until the 50 day level is reached. It is not 
surprising to find such a rapid rise in the number of sites during 
the first three weeks of life if what are being measured are parameters 
of a transmitter system. This is because, as already stated, although 
the number of neurons have reached their full complement by birth, the 
development of the dendritic tree and synaptogenesis are largely post­
natal events in the cerebral cortex. As there is considerable 
evidence to show that excitatory post synaptic receptors are predom­
inantly located on dendrites, a rapid expansion of dendritic arborization 
would be reflected in a simultaneous rapid increase in the total number 
of binding sites. The slower rise in the number of Na"*” independent 
binding sites up to 30 days could represent a population of late - 
developing synapses.
In contrast,Na^  dependent binding shows a significant fall in the 
total number of binding sites from 20-30 days (p< 0.01). If these 
i^^ diiiS sites are subserving a reuptake function in glutamatergic 
transmission, then it may be that this fall could be due to a degeneration 
of presumptive uptake sites after commitment of others to functional
' FIG. 5.6 '
+ 3The specific Na dependent binding of H-L-Glu to 
cortical membranes prepared from 20 day old rats, measured 
at a L-Glu concentration of 0,6jjU, Each point represents 
the mean + SEM of 6 separate experiments, Kinetic • 
parameters were estimated from a Scatchard plot of the 
data which is shown as an inset on the graph.
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glutamatergic pathways "hard wired" at the time of synaptogenesis. The 
degenerating uptake sites could thus represent a surplus to require­
ment and "make way" for uptake sites subserving other modes of neuro­
transmission. The subsequent sharp rise in levels of binding up to 
50 days may be a consequence of the development of sites on rapidly 
proliferating glial cells surrounding glutamatergic synapses. There is 
considerable evidence to indicate that uptake by glial cells,rather than 
neuronal elements,is of prime importance to the termination of transmitter 
function (Balcar et al, 1977» Henn, I976; Benjamin and (guastel, 1975)* 
This is reflected in the large increase in site density from 82.4 
p mois bound/mg protein at 20 days to 210 p mois bound/mg protein at .
50 days, although the fact that the Kd values for Na"*" dependent binding 
are similar at both age points suggests that the same site is being 
measured in both cases.
A comparison of the kinetics of Na independent binding at 20 
days and 50 days shows rather unexpected results that are more 
difficult to explain. In contrast to reports on the development of 
other transmitter systems where the Kd remains the same throughout 
postnatal development, the Kd of Na  ^independent glutamate binding is 
twice the value (i.e. lower affinity) at 20 days than at jO days. It 
may be that what is being measured at this stage is not a binding site 
solely for glutamate but an acidic amino acid receptor that can loosely I 
bind either glutamate or aspartate. It may be only after efferent 
input and synapse formation that receptors become specific for either 
aspartergic or glutamateric transmission and will thus, show higher 
affinity for one or the other of these agonists. Although post­
synaptic receptor sites are present prior to synaptic innervation there
I0<]
is evidence that complete maturation of these receptors only takes place 
after functional commitment of pre and postsynaptic cells to a particular 
. mode of transmission (Changeur and Danchin, I976). Although the results 
presented so far do not permit a more detailed argument in favour of 
this explanation of changing affinity constants throughout development,a 
. discussion of this idea will he expanded upon in later sections.
5.3 Antagonism
The ability to demonstrate binding of glutamate to synaptic membranes 
that is saturable and of high affinity is not sufficient, in itself, to 
conclude the presence of specific post synaptic receptors. The case 
for doing so would, however, be considerably strengthened if it could be 
shown that the structural requirements forced on the ligand by the 
— binding site, were very similar, if not identical,to the physio­
logical receptor. Thus,pharmacological agents that are either agonists 
capable of mimicking the physiological effect,or antagonists capable of 
blocking or reducing the effect of receptor activation should displace a 
ligand bound in vitro to such a site with the same order of potency 
displayed in vivo.
Since the initial studies of the excitatory action of glutamate and 
aspartate by Curtis (I965) and Curtis and Watkins (1963)^other amino 
acids have been tested for their ability to evoke E.P.S.P.»s. Over 
100 such compounds have been identified in this way (Watkins, I978) 
and on the basis of a consideration of their structures, Curtis and 
Watkins (I96O) suggested that a 3 point attachment site is the most 
likely configuration of the receptor activated by these amino acids.
Of these 3 points, two will interact with anionic groups, one of which 
will be a carboxylate group and the 3rd will interact with a cationic
group which will (at physiological pH) he an associated amino group.
The 2nd anionic group can vary considerably (hence the large number of 
excitatory agonists). Structural alterations which abolish ionizability 
of any of these groups drastically diminishes excitatory effects.
Among the most potent of these excitatory amino acids are kainic 
acid, quisqualic acid (being approx. 50 times more potent than glutamate) 
and N-methyl D-aspartic acid,which is around 20 times more potent than 
glutamate (Watkins, I978). The crucial questions in terms of increasing 
our understanding of the mechanisms used in the GNS to mediate-transmission 
must be; are the excitatory effects brought about by interaction with, a 
single class of receptors or are there unique populations of receptors 
specifically activated by one or more of the very few of these amino acids 
that naturally occur in the GNS?
Glutamate, and to some extent aspartate, are very flexible molecules. 
Glutamate can assume configurations ranging from a fully extended form, 
where the separation of the two anionic carboxyl groups is at a 
maximum of approx. 0.46 nM, or a fully folded form where they are at a 
minimum of 0.18 nM from each other. The maximal separation of the. carboxyl 
groups in aspartate is 0.38 nM and the minimum is 0.25 nM. From such 
considerations the possibility arises that at least 3 subsets of physio­
logically relevant amino acid receptors may be present on neuronal cell 
membranes in the mammalian GNS. One may demand maximal separation of 
GOO groups and would therefore be glutamate preferring, aspartate being 
unable to extend to make the 3 point interaction. Another may accept 
glutamate in its fully folded form and a 3rd would be aspartate preferring, 
but would accept glutamate were it to assume an intermediate, partially 
extended configuration.
Kainic acid (ka) is a glutamate analogue that is fixed into a position 
where the GOO groups are maximally separated by the conformational 
restrictions imposed by a pyrollidine ring. Thus KA was originally 
proposed as a preferential agonist for the extended glutamate receptor 
(Johnson, 1974).
Quisqualate, (Quis), unlike the other potent amino acid agonists 
KA and N-methyl-D-Aspartate (MDA), possesses only one carboxyl group/ 
but has a secondary amino group adjacent to two carbonyl groups in an 
unusual oxadiazolidinedione ring system. The two carbonyl groups act as 
a strong influence, reducing the electron density over the N-atom of the 
amine group leaving the hydrogen atom only weakly associated so that, it 
acts as a functional acidic hydrogen with a pka of 4.15 (Takemoto, I976), 
very similar to the side chain carboxyl group of glutamate (pka 4.32).
Loss of this proton at physiological pH could result in a redistribution 
of the anionic charge throughout the ring,resulting in the oxygen atom on 
G3 becoming anionic. The anionic carbonyl in Quis is at the same distance 
from the primary amino group as the GOOH in glutamate from its own 
amino group. Quis can thus be considered, on these structural consid­
erations, as a glutamate analogue which, although retaining some degree 
of flexibility, sterically prefers a folded configuration and may have 
preferential affinity for the fully folded glutamate receptor.
N-methyl-D-Aspartate (NMDA) is an analogue of aspartate where the 
primary amino group has become a secondary amino group by the substitution 
of a methyl group. Although most compounds carrying substitutions in the 
amino group are considerably weaker as excitatory agonists than their 
parent compound, this is not true of NMDA. Because of its striking 
similarity to aspartate, NMDA may well act at postsynaptic receptors that 
are aspartate preferring but which may be capable of accepting glutamate
in a partially folded (or partially extended.* ) form.
McLennan et al, as early as I968, had shown a lack of parallelism 
in, the responsiveness of thalamic neurons in cat to L-glu and NMDA, and 
proposed at that time at least two different populations of receptors. 
Duggan (1974) suggested that L-Glu and L-Asp - may act on different 
receptors on the basis of the differential sensitivity of different 
groups of cat spinal neurons to the two agonists, McGulloch et al, 
also in 1974, confirmed these findings and demonstrated that the relative 
potencies of KA and NMDA parallelled the relative potencies of L-Glu 
and L-Asp respectively. This is certainly in keeping with the theoret­
ical considerations and in addition it is well established that in 
invertebrates several different classes of receptor, both excitatory and 
inhibitory, do exist (Gull Gandy, I976).
More evidence in favour of this discrimination between different
classes of amino acid receptors came from studies of the effects of
divalent metal ions on the depolarizing responses to amino acid agonists
in the frog spinal cord. Evans et al (1977) showed that responses to
NMDA were considerably depressed by low concentrations (threshold 10 pM)
of Mg*^ , Ga"*^  and Ni"^ , whilst responses to KA, L-Glu and Quis were
unaffected. Significantly, responses to L-Asp were more sensitive to
Mg than were responses tp L-Glu, confirming the belief that NMDA may be
acting preferentially at "aspartate preferring" receptors. Similar
results were obtained at around the same time using cat spinal cord as the 
test system.
Until this time, investigations of amino acid receptors were made using 
agonist properties only and positive discrimination between different 
types of receptor proved difficult due to the marked degree of overlap 
of agonist effects on different groups of neurons. The studies with Mg
at least suggested that differentiation of receptor types may be possible 
by exploiting agents that antagonise excitatory amino acid responses 
and a range of organic compounds, both naturally occurring and synthetic 
amino acid analogues, were screened for specific antagonistic properties. 
Continuing exhaustive studies of structure activity relations of amino 
acid excitants, mainly by Watkins and co'-workers in Bristol, but also by 
McLennan and co-workers in Canada and by Curtis and co-workers in Australia 
have subsequently led to developments in this area. Such studies have 
resulted in the recent discovery of selective antagonists that seem able 
to distinguish, not only between excitation produced by amino acid 
compared to non amino acid agonists, but also between the agonist action 
of different amino acids.
Of these antagonists, two proved initially most useful as tools for 
the investigation of receptor differences for the excitant amino acids.
One of these was the diethylester of glutamate (G.D.E.E,) and the other 
is one of a class of antagonists including longer chain mono - and 
diaminocarboxylic acids of which the best characterized is 
-D% Aminoadipic acid (DAA) (Biscoe et al, 1978» Evans et al, 1978;
Hicks et al 1978; Lodge et al, 1978; McLennan and Hall, 1978).
GDEE was originally reported to have a selective effect in 
abolishing excitations induced by L-Glu when contrasted with those 
produced by L-Asp (Haldeman et al, 1972; Haldeman / and McLennan, 1972).
In addition subsequent studies have shown that iontophoretically applied 
GDÊE blocks Quis induced,but not KA induced,responses of cat spinal 
neurons- (McLennan and Lodge, 1979; Davies and Watkins, 1979). Such 
initial studies strongly supported the view that GDEE may be selective 
for glutamate receptors, accepting glutamate in a folded configuration.
//f
In contrast DofAA proved ineffective in reducing glutamate induced 
excitations, but instead antagonised potently responses to L-Asp, and 
more particularly to NMDA. Investigation of the antagonist effects of 
DorAA and GDEE on several agonist responses show almost reciprocal effects 
as summarized in Table 52 (Taken from McLennan, I98I), McLennan has 
also suggested that substances appearing near the middle of each column, 
like homocysteate, D-Glu and L-Asp may be able to interact, to some 
extent, with both classes of receptor.
.The position with respect to D-Glu is particularly interesting 
because,although it is a neuronal excitant with about half the potency 
of L-Glu,its action is preferentially blocked by D“AA, unlike the action 
of L-Glu. L - and D-Glu can only "fit" the same receptor if they (and 
therefore the receptor.') are in a relatively extended configuration 
(McLennan, I98I). D-Glu cannot fit a fully folded L-Glu receptor and 
may therefore act as a L-glu antagonist at such a receptor by causing 
steric hindrance preventing the access of L-Glu although it cannot 
itself form an active complex with the receptor. The excitatory action 
of D-Glu then, may be mediated by its interaction with the partially 
extended, D«AA sensitive, glutamate receptor. These theoretical 
considerations have been confirmed by the demonstration that the action 
of D-Glu on Dx AA treated neurons is to antagonise the remaining response 
to L-Glu,although it does not do so in the absence of DocAA when it acts 
itself as a neuronal excitant (McLennan I98I).
Thus in summary, pharmacological studies of excitant amino acid 
receptoirs have indicated the possible presence of 3 subsets of receptors
1. Preferentially activated by NMDA, L-Asp, D-Glu and L-G lu in a partially
extended form (and in that order of potency) and antagonized by D*«AA.
TABLE 5 .2 Antagonism of amino acid-induced excitations
by GDEE by DaAA
L-glutamate
Quisqualate
D-aspartate
L-aspartate
D-glutamate
D-homocysteate
L-homocysteate
Ibotenate
ADCP
N-methyl-L-aspartate
N-methyl-D-aspartate
N-methyl-D-aspartate 
N-methyl-L-aspartate 
Ibo tenate 
ADCP
L-homocysteate
D-homocysteate
D-glutamate
L-aspartate
D-aspartate
Quisqualate
L-glutamate
J I
2. Preferentially activated by L-Glu in its folded form, and by 
Quis, and antagonized by G.D.E.E. (and D-Glu).
3. Preferentially activated by KA and possibly by Glutamate in a 
fully extended form.
On the basis of the above considerations the ability of D-Glu L-Asp,
KA, NMDA, D AA, and L-Glu to displace ^H-L-Glu was investigated. The 
displacers were added to the assay tubes in concentrations varying between 
10”  ^and 10"4y[ together with ^-L-Glu at a concentration of 0.6 M. 1009^ 
specific binding was the amount by which the binding of ^H-L-Glu (0.6 M) 
was reduced in the presence of 0.1 mM L-Glu compared to tubes containing 
only the radioligand. The displacing ability of the above named compounds 
was studied for L-Glu bound to both the Na"^  dependent and the Na’*’ 
independent sites at both the 50 and the 20 day age points.
Fig. 5J shows the structures of the compounds utilized in the displace­
ment studies- together with Quis which was not available commercially at 
the time.
BESIJLTS
Table 5.3 shows the 1050 values of the amino acids acting as displacers
of specific ^-Glutamate (0.6 M) binding to membranes prepared from rat
cerebral cortex at 20 days and 50 days of age. 1050 values were deter­
mined from log dose/percent inhibition plots, shown in Eigs. 58 (50 days) 
and 5.9 (20 days). Oonsidering first the displacement of L-Glu bound to the 
putative postsynaptic receptor site (i.e. the Na"^  independent site) in adult 
rats, it can be seen that although L-Asp can displace L-Glu bound to this 
site it does so with a potency 10 times weaker than L-Glu itself. The
comparable 1050 values are 6.4 M for L-Asp and O.65 M for L-Glu. None
of the other compounds, neither agonists nor antagonists, were effective 
in displacing glutamate from this site (all exhibiting considerably less 
than 50% inhibition at concentrations of 0.1 nM).
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FIG. 57
The structures of the amino acid agonists and antagonists 
used in the displacement studies reported in this thesis 
as probes for the structural requirements demanded by the 
L-Glu and L-Asp binding sites on rat cortical membranes.
Asp = L - Aspartate.
NMDA = N-methyl-D-Aspartate.
Glu =» L-Glutamate. .
KA = Kainate.
Quis = Quisqualate.
D&AA = D Amino-adipatew
I/o
ASP
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FIG . 58
llhe Inhibition of binding of H^-Ir-Glntamate by excitant amino 
an ids to membranes prepared from the cortex of 50 day old rats.
A - Inhibition of Na"^  independent binding.
B - Inhibition of Na"^  dependent binding.
■ - L - Glutamate.
O - Il - Aspartate.
O - D - Aspartate.
All other analogues displaced considerably less than 50% of the 
binding at the highest concentration tested (lO-^). Each point is 
the mean of at least 4 separate experiments which did not differ by 
more than 5%*
The displacement curves in (a) are essentially parallel to each 
other althou^ there is an order of magnitude difference between the 
displacement abilities of the two ligands.
In B the displacement curves for L-Glu and L-Asp are very similar 
and they exert their effect over the same order of magnitude indicating 
that they are probably interacting with the same site.
The results of all displacement studies with ^H-L-Glutamate are 
summarised in Table 5.3.
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Inhibition of the binding of H-L-Glutainate by excitant amino 
acids to membranes prepared from the cortices of 20 day old rats.
A - Inhibition of Na’^ independent binding.
B - Inhibition of Na*^  dependent binding.
■ - L Glutamate.
□ - L - Aspartate.
# _ p oc Amino Adipate.
A - N-methyl - B - Aspartate.
% - Glutamate diethyl ester.
Kainate and B—  Glutamate were ineffective as displacers of Na 
independent binding at 10 All other analogues not shown on B were
ineffective at displacing Na"^  dependent binding at a concentration of 
lO"^. See text for discussion.
Each point is the mean of 4 separate determinations which did not 
differ by more than 10^ .
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The results of all displacement studies with H-L-Glutamate are 
summarised in Table 5*3»
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In contrast L-Asp displaces L-Glu bound to this same site in 20 day- 
old animals with a potency twice as high as that of L-Glu itself. The 
respective IG50 values in this case are 0.78ym for L-Asp and l,6pM for 
L-Glu. Especially interesting is the observation that L-Glu can also be 
displaced from its Na^  independent binding site at 20 days by the agonist 
and L-Asp analogue NMDA,as well as by the antagonists GDEE and DL otAA with 
IG50 values around lOjuM. To reiterate, all 3 compounds are ineffective 
at displacing L-Glu at 50 days of age.
The pharmacological specificity of the Na^  dependent site changes 
markedly during the period between 20-jO days only in respect of its 
ability to recognise D-Glu . This biologically inactive stereoisomer of 
glutamate will not displace L-Glu bound to its Na^  dependent site 
(putative re-uptake site) at 20 days, but will do so at 50 days with an
1050 value of 1.0pM,some 6 times higher than the IG^ O value of L-Glu
itself. L-Asp shows a slightly higher ability to displace L-Glu from 
its Na"^ dependent site at 20 days than it does at 30 days. The IG O^ value
of glutamate itself is greater at 50 days than at 20 days (the respective
IG50 values are 6.5//M and 1.6//M) but neither the two agonists NMDA or KA 
or the two antagonists GDEE and DLc^ AA have any affinity for this binding 
site at either of the two age points. Interestingly KA alone of the 
test compounds will not displace L-Glutamate bound either in the presence 
or absence of Na"^ at either age.
Discussion
A consideration of the result that L-Glu is much more effective at 
displacing ^ H-L-Glu bound to the Na"^ independent site at 30 days than is
L-Asp implies that the L-Glu binding site is specialized to accept L-Glu 
either in its fully extended (maximal separation of GOGH groups) or
Ifully folded-(minimal separation of GOOH groups) forms. The adoption of 
an intermediate configuration hy the receptor would make it accessible to 
both L-Asp and L-Glu.
This view is reinforced by the fact that neither of the aspartate • 
analogues NMDA and D«AA displace glutamate. As these two substances 
have been shown to have very specific agonist and antagonist activity 
respectively on those neurons that are aspartate preferring (see e.g. 
Watkins, 1978; Johnson, 1978),glutamate would seem to be acting here at 
a different receptor or receptors than those sensitive primarily to 
A/MJDA or D»AA.
The glutamate antagonist GDEE has been proposed as an agent 
specifically antagonising those responses produced by L-Glu and by the 
conformationally restricted folded glutamate analogue,Quisqualate 
(McLennan, I98I). So it may be expected that if L-Glu is interacting 
with the reported Na"*" independent binding site on cortical membranes in 
a folded form it would be displaced by GDEE. This was not the case in 
this present study and may possibly be explained by the fact that most of 
the work characterising the effect of this antagonist has been carried 
out by looking at its effect on induced responses in the spinal cord where 
the structural requirements of the receptor may be different than in the 
cortex. It has been subsequently reported that there may be distinct 
regional differences in the effect of this antagonist in terms of both 
its potency and selectivity (Glarke and Straughn, 1977» McLennan and 
Wheal, 1978). Although GDEE seems to antagonise response to L-Glu in 
most situations, responses induced by L-Asp also seem susceptible to GDEE 
antagonism,albeit to a lesser extent (see e.g. Johnson, I978). This 
could imply that G.D.E.E. may in fact be acting to displace glutamate 
bound only to aspartate preferring sites, although its lack of effect on
NMDÀ responses would seem to preclude this explanation. -Nevertheless, 
there is some evidence from studies with rat spinal cord that in this 
tissue at least, sites of activity of L-Glu and G.D.E.E, may he different. 
Nistri and Constanti (1975) sjid Bailey and Phillis (I976) have shown in 
these studies that GDEE did not affect glutamate induced depolarization, 
but exhibited a depolarizing action of its own, suggesting an agonist 
affect at a separate site from that mediating glutamate responses.
Other observations that G.D.E.E. can influence the spontaneous 
activity of neurons (Bailey et al, I976; Altman, et al I976) may point 
to the fact that its actions may be relatively non-specific so that quite 
large doses may be necessary to demonstrate a displacement of any 
specifically bound ligand. This suggestion is upheld by the observation 
that depression of visually induced depolarization in the Lateral Geniculate 
Nucleus by GDEE is only achieved by doses of the antagonist, that are 
®^ *^iciently large to cause non-specific depression of chemically induced 
responses (Kemp and Sillito, 1979).
Because of the reported regional variations in GDEE effects it is 
obviously significant that excitations produced by the pyramidal tract 
projection into the cerebral cortex have been shown to be antagonized by 
GDEE (Stone, 1976). -
Comparable in vitro studies of the displacement of binding from its
4.
Na independent site show differing effects in, relation to the activity of 
GDEE.. Michaelis et al,(l97é)were among the first to report binding of
L-Glu to brain membranes and reported that GDEE was a very poor displacer
3 ?of bound H-L-Glu. Roberts, in the-same year, reported binding of ^H-L-Glu
to Synaptic membranes prepared from the cerebral cortex of rats that could
in contrast be inhibited by GDEE by 6ofo. De Plazas and DeRobertis (I976)
succeeded in extracting and isolating a proteolipid fraction from 
synaptic membranes prepared from the cerebral cortex of rats that had 
binding sites for L-Glu, L-Asp and the inhibitory amino acid GABA. 
Discrimination between the glutamate and aspartate sites was possible 
because GDEE did in fact inhibit the Na independent binding of L-Glu by 
65^ ,whilst the binding of L-Asp was only inhibited 2 %
Roberts and Sharif (I98I) have recently reported that GDEE is
3ineffective as a displacer Of H-L-Glu bound to cerebellar membranes, 
whilst Biziere et al (I98O) confirmed the earlier result of Michaelis 
et al (197^ ) that GDEE was relatively ineffective as a displacer of L-Glu 
bound to membranes prepared from whole brain.
Thus the relationship of GDEE to glutamate receptors is still very 
poorly characterized and accumulated evidence points to the use of 
caution in interpreting effects of GDEE on neurons in vivo or in vitro, 
(Johnson 1978). It is possible that further studies with GDEE may be 
more fruitful if carried out in conjunction with several very recently 
discovered antagonists that may prove more selective in their action 
and their relative potencies compared. The effects of these new 
antagonists will be discussed in later sections summarising the possible 
mode of interaction of glutamate with brain membranes.
If glutamate is not acting as its receptor in the folded (supposedly 
GDEE sensitive) format, it could therefore be interacting with a 
glutamate receptor accepting its ligand in an extended conformation.
K.A. has been proposed as a specific ligand for such a site but was 
ineffective in displacing ^ H-L-Glu in these studies.
Since it was first proposed as a specific agonist for glutamate 
preferring receptors,considerable neuropharmacological evidence has 
accumulated to indicate that KA binding sites may not in fact be 
synonymous with those for glutamate (Hall et al, 1978). In keeping with 
this, Michaelis et al (1980) have succeeded in separating binding sites 
for the two agonists. KA also has differential effects to glutamate in 
stimulating brain cyclic nucleotides (Schmidt et al, 1975) and an ion 
distribution and ATP levels in striatal slices (Bizfere and Goyle, 1978). 
Thus KA binding sites may represent either a very small population of 
glutamate binding sites that may in fact be extrajunctional or presynaptic, 
or, as suggested by Roberts (1981 )^ CA may be binding to receptors for an 
as yet Unidentified endogenous substance.
The failure ofo^GIu to displace specifically bound L-Glu is surprising 
in view of its very similar excitatory potency. This agonist action of 
D-Glu, as previously mentioned, is probably mediated by an interaction with 
the aspartate preferring NMDA receptor (DaAA sensitive) so this result may 
indeed suggest that glutamate is combining with its receptor in its folded 
or extended form. D-Glu may be a weak antagonist at the extended Glutamate 
receptor but may not be able to displace'L-Glu specifically bound, at the 
concentration used.
The fact that L-Asp and D-Glu are capable of displacing L-Glu bound to 
"t*
the Na dependent site in adults is quite consistent with the observation 
that these three substances share the same Na^ dependent transport process, 
as previously discussed.
The structural requirements of theL-Glu Na"** independent binding site 
are different at 20 days than at 50 days. This is especially evident when
the ability of L-Asp to displace the binding is compared at the two age 
points. L-Asp displaces L-Glu at 20 days with a potency twice that 
of L-Glu and 20 times higher than its ability to do so at 30 days. In 
addition,the agonist NMDA and the antagonists GDEE and D*AA all displace 
the binding at 20 days with an 1030 of about lOjuM. The fact that the 
binding .site at this age is capable of accepting both aspartate-like and 
glutamate - like analogues points to a considerable flexibility in the 
conformation of the receptor molecule that is not present at 30 days.
The receptor at this stage may exist in a form that is relatively Aiobile 
within the lipid environment of the membrane, due to a lack of sufficient 
hydrophobic interactions at its surface. This would allow the acceptor 
site of the receptor to assume slight changes in configuration so that the 
charged groups with which the different ligands interact can shift their 
position relative to each other depending on which of the ligands bind.
The shift to a conformation only capable of accepting glutamate, 
could be the result of increased activity of the presynaptic cell 
preferentially utilizing one or the other of the amino acid transmitters, 
in this case presumably glutamate. This in turn may initiate a chain of 
events in the postsynaptic cell that could lead to the covalent modifi­
cation of the receptor protein. This modification may result in the 
exposition of more hydrophobic residues capable of interacting with the 
surrounding hydrophobic (lipid) environment thus 'crystallizing* its 
local environment and stabilising the receptor in one configuration - 
in this case the glutamate preferring configuration. This speculative 
interpretation of the data is in keeping both with the mobile receptor- 
model for agonist action and also with the mechanism of selective 
stabilization of neuronal connections by functional verification,as 
proposed by Ghahgeux and Danchin (1976). The 20 day age point in the rat 
corresponds to the time at which maximum rates of synaptogenesis are
occurring and it is quite conceivable that presumptive synapses formed at 
this stage may later become utilized by a particular pathway and manifest 
themselves as subservient to a particular mode of transmission later in 
development.
In summary, the data reported on the effects of amino acid agonists
3and antagonists on the binding of, H-L-Glu to rat cortical membranes 
probably indicate that glutamate is binding to a class of receptors that 
is glutamate preferring as opposed to aspartate preferring. It was not, 
possible , however ,to discriminate between glutamate receptors accepting 
L-glu in its extended form or in its folded form. The glutamate antagonist 
GDEE, which has been proposed to specifically antagonise responses via the 
extended form of the receptor, was ineffective in adult rats although, 
together with the aspartate analogues NMDA and D«AA ^it did displace 
L-Glu bound to membranes from 20 day old rats. These results were mainly- 
discussed in terms of the development of a binding site for acidic amino 
acids that fulfills many of the neurochemical criteria for a postsynaptic 
transmitter receptor. Although relatively non-specific in terms of its 
discrimination between different amino acids at an early age, this receptor 
becomes specified for glutamatergic transmission later in development as 
shown by the changing affinity of this site to glutamate and aspartate 
analogues.
The agonist kainic acid, proposed originally as specific for the 
extended glutamate receptor,was ineffective at displacing any bound 
glutamate at either age. Interest in this molecule mainly arose because 
it is a powerful.neurotoxin, as well as being a potent neuronal excitant 
and glutamate analogue. Its neurotoxic activity is most pronounced after 
injection into the striatum where it destroys neuronal cell bodies whilst 
sparing axons passing through or terminating in that region. The
neuroanatomical effects of KA neurotoxicity very closely resemble the 
pathology of Huntingtons Chorea. Because of its similarity to 
glutamate,the possibility arose that this disease may be related to 
defects in the pathways mediating glutamatergic transmission. Many of 
the initial reports of the effects of KA strongly supported its candidature 
as a specific agonist for the glutamate receptor. This culminated in a 
report of the in vitro vinding of KA to brain membranes (Simon et al,
1976) and provided the initial stimulus and starting point for work on 
the problem of glutamatergic transmission as reported in the next section.
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5,4 Kainic Acid (KA)
One of the least effective of the amino acid analogues tested for 
their ability to displace either glutamate or aspartate from their binding 
sites was kainic acid. This naturally occurring amino anid was first 
isolated from the seaweed Digenea Simplex in 1955 by Takemoto. This 
seaweed (a red algae of the class Ehodomelaceae) had been used therapeuti­
cally for centuries as an antiascaris agent and Takemoto was able to 
demonstrate that the KA isolated from the seaweed retained these powerful 
antihelmintic properties and was indeed the active ingredient. There was 
evidence that KA acted by paralyzing ascarids and there were reports 
of a strong emetic action in dogs. The similarity of its chemical 
properties and structure to glutamate became of interest when neuro- 
physiological studies demonstrated the potent excitatory properties of 
glutamate both at he invertebrate M J  (Takeuchi and Takeuchi, 1964; 
TJsherwood, 1969) and at neurons in the mammalian G.E.S. (Curtis and
Watkins, 196$; Crawford and Curtus, 19^ 4).
Initial studies demonstrated not only that KA was an extremely 
powerful neuronal excitant but that it also potentiated the action of 
glutamate on mammalian CNS neuronal cell membranes. The relationship 
between the possible mechanism of action of glutamate and KA was further 
strengthened when it was discovered that, like glutamate, KA was a potent 
neurotoxin, some $00 x more powerful than glutamate itself, paralleling 
its greater effectiveness as a neuronal excitant (Olney, et al 1974). 
Kainic Acid causes lesions characterized by an acute degeneration 
and loss of neuronal perikarya and their dendrites, whilst axons 
either temination in the area, or passing through, are spared. In
addition these cytopathological and neurochemical changes associated with 
KA neurotoxicity in the striatum were strikingly similar to those found in 
patients with the neuro-degenerative disease, Huntingtons chorea. This 
observation strongly implicated some fault in the glutamatergic system as 
a major component of the disease, given the very strong evidence that the 
afferent cortico-striatal pathway does indeed utilize glutamate as its 
transmitter (McGeer at al, 1977) . Thus KA could be utilized as a 
tool to investigate the contribution of particular compartments to the 
neurochemical properties of specific brain regions (McGeer at al,
1978) .
The similarities to glutamate so far reported were strongly 
suggestive of the possibility that K.A. may be exerting its neuroexcitatory 
and neurotoxic effects via membrane components that in natural conditions 
respond only to the acidic amino acids. If this was so, then KA may prove 
a much more discriminatory ligand (given its greater potency) for probing 
tha localization and characteristics of glutamate binding sites in the CNS 
than glutamate itself. In addition, the conformational restrictions 
imposed on its structure by the presence of its pyrollidine ring means 
that it essentially corresponds to glutamate in an extended conformation.
It would therefore be unlikely to interact with binding sites for the 
smaller molecule aspartate <Johnston et al, 1974; McCulloch et al, 1974) 
although glutamate may be able to do so in a folded configuration.
3
From these considerations the characteristics of the binding of H - 
kainic acid to brain membranes was investigated by Simon et al (1975).
They reported that the binding exhibited many properties consistent with 
the binding to a postsynaptic receptor accepting glutamate under 
physiological conditions. In particular, binding was saturable, of high 
affinity (kd 59 nM) with a low concentration of binding sites
(3inax; 1 .-03 pmols/mg protein) that were restricted to nervous tissue and 
were differentially located in various brain regions. Also, displacement 
studies did indeed suggest that binding may be to a population of amino 
acid receptors highly specific for glutamate as opposed to other excitatory 
amino acids.
On. this basis kainic acid was implicated as an important pharmacological 
tool for the characterisation of endogenous glutamate receptors. The work 
reported in this thesis was initiated by a study of the binding of 
Kainic acid to membranes prepared from adult rat cortex. Tissue 
preparation and assay conditions were exactly as reported by Simon et al,
(1975).
. •
Results -
A saturation curve of the binding is shown in Figure 5.10. Although 
non-specific binding was linear over the concentration range shown it 
represents a high proportion (approximately 70%) of the total binding. In
addition there was considerable variation in the levels of binding to
tissue prepared from different rats. The relatively small.error bars are 
a reflection of the relatively high number (approximately N = 12) of 
separate determinations. The inset on Figure 5.10 shows a Scatchard plot 
of the same data and gives an estimate of the Kd = 72 nM and a gmax of 
661.0 fmois/mg protein. Non-specific binding was estimated by the use of 
excess (0. ImM) cold Kainic acid, but curiously L-Glutamate at the same 
concentration of 0.ImM displaced only about 10% of the total binding. In 
addition it was not possible to demonstrate specific kainic acid binding 
to membranes prepared from rats less-than 30 days old, despite the 
utilization of synaptic membranes of varying degrees of purity.
■ FIG 5,10
The specific binding of - Kainic Acid to cortical
membranes prepared from adult ($0 day old) rats. The 
assay was performed in KPO^  buffer under conditions stated 
in the text. Kainic acid concentrations varying between 
6-600nM were used to generate the saturation curve. The 
results are means + SEM of 8 - 10 separate experiments.
The kinetic parameters of the binding were estimated from 
a Scatchard plot of the saturation curve data which is 
shown as an inset on the Figure.
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Discussion
Although Figure 5.10 shows that binding sites for kainic acid are 
present at very low concentrations and exhibit a high affinity for their 
ligand, in keeping with binding to a postsynaptic receptor, kainate itself 
is not a constituent of brain. Its relevance lies in the possibility 
that it could be binding to receptors for the natural endogenous ligand 
glutamic acid. If this is the case, then it would be expected that 
glutamate would be equally as effective as kainate in displacing bound 
radiolabelled KA; However, this was not found. This observation is in 
contrast to the report by Simon et al (1975), although these authors did 
report that binding sites for glutamate were 10 times in excess of those 
for kainate. This report is in broad agreement with my own studies 
which show a density of glutamate binding sites of 6.^ paols/mg protein 
compared with 0.661 pmols/mg protein for kainate.
If glutamate is acting as a major excitatory transmitter then it 
could be expected that neurons would possess receptors for the amino acid 
at a fairly early stage in development. The inability to demonstrate KA 
binding to membranes prepared from young rats is therefore curious. One 
possible explanation could be that KA may be binding to a small 
subpopulation of glutamate receptors that only become apparent later 
on in development. It has been reported that neurons in the striatum of 
very young rats are not susceptible to the neurotoxic effects of injected 
kainic acid (Campochiaro and Coyle, 1978).
Subsequent experiments reported in Section demonstrated that KA
3 +was ineffective as à displacer of H-L-Glu bound in the absence of Na ,
inhibiting only 5% of the glutamate binding at a KA concentration of
10 M. Thus, it seemed unlikely that KA receptors are synonymous with 
those binding^utamate.
There have been many other recent reports of KA. binding to membranes 
prepared from various brain regions (Schwarcz and Fuxe, 1979» London and 
Coyle, 1979» Vincent and McGeer-, 1979) all exhibiting similar kinetic 
constants'. London and Coyle (1979) reported a duplicity of binding 
sites for KA in rat forebrain membranes, one with a very high affinity 
for KA with a Kd of 2.8 nM and a 6 max of 0.4 pmols/mg protein. Because 
all the reported kinetic parameters of KA binding show a 20-30 fold 
difference to those characterizing glutamate binding,it is probable that 
two different populations of receptors are being measured. This view is 
strongly supported by a report that binding sites for kainate and 
glutamate can be separated following treatment of membranes with cholate 
(Michaelis et al, I98O). The same authors also report that a reduction 
of the isopropylene side chain of kainic acid strongly decreases its 
affinity for the binding sites. This would be .unexpected if KA was binding
to the same 3 point attachment site thought to bind the 2 charged carboxyl 
groups and the amino group of glutamate (and Kainate). A possible 
explanation for this observation however, could be that a distinct KA 
receptor possesses a lipophilic region which interacts with the hydrophobic 
unsaturated KA side chain and thus stabilizes the ligand-receptor complex.
This strengthens the suggestion by Roberts (I98I) that KA receptors may 
be binding sites for an ,as yet,unidentified endogenous ligand.
Further insight into the possible site of action of KA comes from 
neuroanatomical studies of the toxic effects of KA. The neurotoxic 
potency of amino acids parallel their ability to depolarize neuronal cell • 
membranes, and on this basis a' excitotoxic hypothesis of neuronal death has beei
suggested- (olney - et al.^ l974). The postulate is that unphysiologioal 
concentrations of the amino acids cause a continuous depolarization and : 
a sustained increase in membrane permeability - this in turn would lead 
to ionic changes of such magnitude that the normal homeostatic mechanisms 
designed to maintain the resting potential (i.e. the membrane bound Na'*’/K^ 
ATI^ se) could not restore the balance. Cell death would be the result 
of drastic shifts in the.intracellular, ionic balance.
If glutamate receptors are responsible for mediating the neurotoxic 
effects of KA then areas receiving glutamatergic projections should be 
particularly susceptible. . Although this seems to be the case in the 
cerebellum:-, retina, pyriform cortex and hippocampus (McGeer & McGeer,1981), 
neuronal degeneration evoked by KA.in the striatum is highly dependent on 
the presence of an intact glutamate projection pathway from the cortex 
(McGeer and McGeer, 1978). This is not consistent with a direct 
interaction of KA with postsynaptic glutamate receptors and has led to the 
suggestion that KA may be acting presynaptically to cause glutamate 
release. Such an effect has indeed been reported by Cox and Bradford 
(1978). Alternatively, KA could be responsible for maintaining elevated 
levels of glutamate at the synapse by blocking its re-uptake into glia
+or'nerve endings. In this case KA would be expected to inhibit the Na 
dependent high affinity binding of glutamate to membrane preparations. 
Reports here are conflicting. Lakshmanan and Padmanaban (1974) and 
McGeer et al (I98I) both report such an inhibition whilst Roberts and. 
Watkins (1975) and Balcar and Johnston (1972) find no such effect. My 
own studies do not show any inhibition by KA of Na^  dependent glutamate 
binding. In addition, Na*^ independent binding of glutamate'is not 
affected by KA at least in the cortex (Sanderson and Murphy, I98I).
A consideration of all these data, together with evidence 
accumulated in recent years by Watkins and-his colleagues that shows that 
pharmacological agents have different inhibitory potencies towards glutamate 
and KA induced excitation, is suggestive of a presynaptic or extra 
junctional site of action for KA. So KA could be activating receptors 
for a glutamate—like endogenous ligand, which normally modulates the 
release of glutamate. Because of the conflicting evidence in the 
literature, though, some effect on uptake cannot be ruled:out. It is also 
possible to hypothesise alternative mechanisms. for the action of KA 
consistent with the experimental findings. For example, KA may be 
binding to ion channels in the presynaptic membranes that mediate the 
flow of Ca ' into the nerve endings. Or it may be affecting the activity 
of the low affinity glutamate transport site which may also play a crucial 
role in regulating synaptic levels of glutamate (and aspartate).
Discrimination between these modes of action is very difficult to 
assess at the present time, although very recent studies have been 
directed towards identification of a natural ligand for the KA binding 
site. A strong candidate for such a ligand emerged from a report that 
the naturally occurring folic acid derivative methyltetrahydrofolate 
(MTHF) is a potent and specific competitor for KA binding sites in rat 
cerebellar membranes (Ruck et al, 1980). These binding study results 
have not, however, been confirmed by recent studies of the neurotoxic and 
neurophysiological effects of MTHF. Although injection of folates into 
various brain regions produced brain damage, this damage was at sites 
somewhat distant from the site of injection and the folates did not mimic 
the specific local neurotoxic effects of KA (Olney et al, 1981). Similarly 
neurotoxic effects of MTHF in the cerebellum are much less pronounced than 
those evoked by KA (Roberts et al, 1981). Biochemical studies by the same
authors have demonstrated,in addition, that MTHF, unlike KA,did not 
stimulate an increase in cerebellar cyclic GMP levels. Very recent 
neurophysiological studies have also shown that MTHF does not evoke 
excitatory PSP's in the olfactory cortex,although KA is a potent agonist 
at these sites. The search continues!
5.5 Aspartate Binding
Much of the work directed towards elucidating a role in synaptic 
transmission for the dicarhoxylic amino acids has concentrated on defining 
the neurochemical effects and properties of glutamate. The neurophysio­
logical evidence,however, favours the candidature of aspartate no less 
than glutamate. Further support comes from studies of the specific 
release of aspartate from many brain areas, of the high affinity uptake 
of aspartate into GNS tissue,and more recently from neuropharmacological 
studies of the effects of amino acid analogues on the excitatory properties 
of aspartate (see Johnson, 1978;and DeFeudis, 1979,for reviews).
Simply from theoretical considerations it- seemed possible that if 
both amino acids had a role in synaptic transmission in the GNS, and 
particularly in the cortex, much of the effect might be mediated through 
shared or at least synergistic sites of. action on the post synaptic cell.
Because of the lack of effect of glutamate (as well as aspartate) 
analogues on the binding of L-Glu to cortical, membranes, some level of 
interaction of glutamate with aspartate binding sites could not be 
conclusively ruled out. Indeed a lack of some cross - reactivity would 
be surprising in view of the probable ability of glutamate to alter its 
shape to fit different 3 point attachment sites. Equally interesting is 
the reported finding (section 5.4) that although aspartate did not affect 
H^-L-Glu binding (Na"^ independent) to cortical membranes prepared from 
50 day old rats, its affinity for these Na"^  independent sites at 20 days 
was 2 times higher than that of glutamate.
It therefore seemed that an investigation of the interaction of 
L.Asp to cortical membranes using the binding assay may provide answers 
to these questions:-
3
1. Does H-L-Asp bind to coirtical membranes with kinetic parameters 
in keeping with a proposed neurotransmitter function for this 
amino acid?
2. Do any such binding sites represent a unique population of sites 
specific for aspartate or is there a degree of overlap with 
sites that bind glutamate?
3. Are there any changes in the structural requirements of these 
sites throughout development?
The assay conditions used to estimate aspartate binding were the 
same as those used for glutamate binding. Thus an assumption was made 
that due to the fact that glutamate and aspartate are very similar in 
terms of shape,structure and chemical reactivity the conditions 
necessary to demonstrate glutamate binding to cortical membranes would 
also hold for aspartate.
Results
Figure 5.|| shows the increase in specific binding of aspartate/mg
+protein under Na free conditions•to membranes prepared from 50 day 
old rats. The concentration range used varied between 0.1 - 2.0/jM
3
H-L-Asp. This binding saturates at a concentration of about 1.2juM 
Asp. As can be seen from the graph, non-specific binding does not 
saturate over the concentration range used, but increases linearly with 
a correlation coefficient of 0.99. This non-specific binding- 
represented about 30^ of the total binding — a smaller proportion than 
in the glutamate binding assay. Replotting these data from the 
saturation curve as a Scatchard plot (Figure 5.12i) provides an estimate
FIG. 5ll
+ 3The specific Na independent of H-L-Aspartate to cortical
membranes prepared from adult (50 day old) rats. Non-specific
binding is also shown on the graph. Binding was estimated at
L-Asp concentrations varying between 0.1 - 2.0^ M. The
results for specific binding are mean + SEM of 5-6 separate
experiments.
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FIG. 5^ t
Scatchard plot of the saturation isotherm shown in
Fig. 3.9 describing the Na*^  independent binding of 
3 .
H-L-Asp to adult rat cortical membranes.
FIG 5i2
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of the Kd as 0.5^M + .026 and a Booax of I9.4 + 1.6 p mols/mg protein.
The specific binding in the presence of 50 nM Na"^  is shown in 
Figure 5.IS, and again is saturable over the concentration range used, 
althou^ at much higher levels of binding. Non-specific binding is 
again linear. A Scatchard plot (Figure 5.1 )^ reveals a Kd of 1.5 + .09^ M 
and a ~Rma.-y of 56I + 18.4 pmols/mg protein.
Similar studies of the binding of ^H-L-Asp to membranes prepared 
from 20 days old rats gave very different results, however. Figure 
5.15 shows the binding isotherm in the absence of Na"^ . Specific 
binding was linear over the same concentration range used to generate 
the saturation curve in adult animals (r = 0.95) snd only saturated at 
concentration of L-Asp up to BmM. Not surprisingly, a Scatchard
analysis of this data (shown as Fig. 5.16) revealed very different ■ 
kinetic parameters than shown for the same site in adult animals. The 
site density increased to a value of 54.5 ± 2.8 p mols/mg protein and 
the affinity of L-Asp for this site was much lower with a Kd of 6.9 +
0.42^ M.
Na*^  dependent binding also exhibited different characteristics in 
20 day old animals than in 50 day old animals. Figure 5.17 shows the 
binding curve over the concentration range 0.2 - 2.0*M. As in the 
adult, binding does begin to saturate over this range althou^ non­
specific binding rises linearly. A Scatchard plot (Fig. 5.16) however 
gives an estimate of the Kd as 5*26 + . 08^M (compared to a Kd of 
1.5yC/M in the adult) and a site density of 1157 ± 57 pmols/mg 
protein i.e. approximately 5 times higher than in adults.
To see at which stage this transition to adult kinetics might 
occur, a further study of H^-L-Asp binding to cortical membranes prepared from 
50 day old rats was carried out, again in the presence and absence of Na"*".
FIG. 513
+ 3The specific Na dependent binding of ^H-L-Asp to cortical
membranes prepared from adult (30 day old) rats. The
binding assay was carried out under the conditions described
in the text. Binding was estimated at L-Asp concentrations
varying between 0.2 - 2.Op M . Non-specific binding is also
shown on the graph. The results for specific binding are
mean + SEM of 6-8 separate experiments.
FIG 513
250-1
200-
k ISO'
I  100
'O
20
FIG. 514
Scatchard plot of the saturation cniTve shown in Fig. 1^3
+ 3describing the Na dependent binding of H-L-Asp to adult
rat cortical membranes.
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FIG. 5rlS
Saturation curve showing the specific Na**" independent
3
binding of H-L-Asp to cortical membranes prepared from 
20 day old rats. Concentrations of L-Asp varying between 0.1 - 
8.0^M were used to generate the binding isotherm. The results 
are means + S.E.M. of 4 (estimates at 4.0^M and B.O^M) and 
8 (all other concentrations) separate experiments.
FIG. 516
Scatchard plot of the saturation curve shown above.
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FIG. 5-17
Saturation curve showing the specific Na**" dependent binding 
3of H-L-Asp to cortical membranes prepared from 20 day old 
rats. Non-specific binding is also marked on the graph. 
The results for specific binding are mean + SEM of 6-8 
separate experiments.
FIG. 5-19
Scatchard plot of the saturation curve shown above,
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Figure _$.19 & 20 shows that hoth the saturation isotherm and the
Scatchard plot for Na"*” dependent binding are practially indistinguishable 
from those found in the adult, generating an estimate of kd = 1.5j5pM 
(1«5^M in the adult) and a 6 max of 378 pmols/mg protein (36I pmols/mg 
protein in the adult.)
It was much more difficult to get any estimate of the Na"*" independent 
3
binding of H-L-Asp to cortical membranes prepared from 30 day old
animals. Results from many experiments gave widely different results.
These variations were not due to different laboratory procedures as
considerable efforts were made to standardize the preparation of the
tissue and the binding assay protocol. It is possible that they
represent real differences between individuals, if this stage coincides
with a time when biochemical mechanisms subserving neurotransmission
are being activated or modified in response to environmental stimulation.
A large sample size,coupled with a meticulous assay technique,allowed
+for the estimation of the kinetic parameters of Na independent 
L-Asp binding at 30 days of age, as well as at the 35 -^nd 45 day age 
points. The latter two ages proved easier to investigate.* The 
results of these determinations are shown on Table 5*4. They show 
that there is no significant change in the kd value of the binding 
site for L-Asp from 30-50 days, but that the Bmax increases 3-fold 
during this time.
Because of a growing interest in the stiructural requirements of 
amino acid binding sites, particularly throughout ontogeny, the 
ability of aspartate and glutamate analogues (with the addition of 
D-Asp) to displace ^H-L-Asp bound to both the Na"^  independent and Na"^
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FIG. 5-1^
Saturation curve showing the specific Na^  dependent binding
3
of H-L-Asp to cortical membranes prepared from 30 day old 
rats. Non-specific binding is also shown on the graph.
The results are means +SEM of 6-8 sep rate experiments.
FIG'. 5‘10
Scatchard plot of the saturation curve shown above,
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dependent sites was investigated at the jO day and 20 day age points.
The results of these displacement studies are shown in Tahle 5.5.
• 1050 values were again measured from log dose/percent inhibition 
plots. Shown in Figs. 521 and 522 for 50 day and 20 day respectively.
Considering first the displacement of L-Asp bound to the Na"^  
independent site in adult rats, it can be seen that this site is 
strictly stereospecific for the L-isomer of aspartate. D-Asp did
-hf
not displace any of the binding at all at a concentration of 10 M.
Inhibition of the specific binding of L-Asp by L-Glu was approximately
30^  at a glutamate concentration of 10 M. D-Glu was however quite
3
effective as a displacer of bound "^ H-L-Asp, although with a potency 
about 14 times weaker than.that of L-Asp itself. The potency of 
D-Glu was matched by the aspartate agonist NMDA and the aspartate 
antagonist D(%AA. In contrast,the proposed glutamate agonist kainic 
acid was totally ineffective at displacing this binding, as was the 
glutamate antagonist GLEE.
The pattern of the effectiveness of these compounds in displacing 
^H-L-Asp bound to the Na"^  independent site at 20 days was very 
different however. L-Glu was equally as effective as L-Asp in 
displacing the LiAsp binding at this age point with respective IGjO's 
of 2.0^M and 5.0pM. In addition the conformationally restricted 
glutamate analogue kainic acid showed some affinity for the Na 
independent site in these younger animals with an IGjO of approximately 
10fj M;very similar to that of the specific aspartate analogues NMDA 
and D A^k,
The Na*^  dependent site in contrast showed very little change in 
the comparative affinity for the different analogues between 20-^0 days.
TABLE
The kinetic parameters describing the specific Na^ independent
3binding of H-L-Asp to cortical membranes prepared.from rats 
between 30 - 50 days of age. The results show the mean + 
S.E.M. of the number of experiments shown in brackets after 
each value.
Age (days) Kd B Max (pmols/mg protein)
30 0.29+ 0.018 (12)
35 0.31 ± 0.026 (11)
45 0.27 + 0.02 (8)
50 0.30 + 0.026 (6)
6,6 + 0.8
14.8 + 2.1
18.6 + 1.14
19.4 + 1.6
FIG. 521
Inhibition of the hinding of L-^H-Aspartate by amino acid 
analogues on membranes prepared from the cerebral cortex of 50 day 
old rats;
A - Inhibition of Na^ independent binding.
B - Inhibition of Na'*’ dependent binding.
■ L - Aspartate
I  I I I  —  Glutamate
O D - Aspartate .
A N -  Methyl-D-Aspartate 
# DL and Amino-adipate
Kainic Acid and Glutamate-diethyl-ester were ineffective at 
displacing the binding at the highest concentration tested (10 ^).
Each point is the mean of 4-6 separate experiments which did not 
differ by more than 10^ . The results of these displacement studies 
with H^-L-Asp are summarized in Table 55*
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Inhibition of the binding of ^-L-Aspartate by amino acids to 
membranes prepared from the cortices of 20 day old rats.
A ■ - Inhibition of Na"^  independent binding.
B - Inhibition of Na"^  dependent binding.
- Il - Asp.
~ Il — Glu.
- I) - Asp.
All other amino acid analogues tested were ineffective as 
displacers of H^-L-Asp binding at the lowest concentration tested 
(10 - 4 M).
Althou^ the IC^ Q for the inhibition of the Na*^  independent binding 
are very similar for L-Glu and L - Asp, L-Glu is effective over a much 
narrower concentration range than L-Asp. ’
Their ability to displace Na"*" dependent ^H-L-Asp binding is very 
similar in the 20 day old animal.
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TABLE 5.^  IC50 values of amino acid analogues(concentration range 10~^ - 
10 %)acting as displacers of ^H-L-Asp (o .6uM)specifically bound 
to membranes prepared from the rat cerebral cortex at 20 and 
50 days.
50 DAY 20 DAY
Analogue Na Dep. Na^ Ind. Na*‘Dep. Na*" Ind.
LAsp 8.4 X 10"^ 7.2 X 10"^ 8.0 X 10"® 5.0 X 10"®
LG lu 8.0 X 10"^ “4>10 8.0 X 10"^ 2.0 X 10"^
□Asp 5.0 X 1G”^ -4>10 5 X 10"^ -4>10
DGlu 1.0 X 10"® -5>10 >'10~^ “4>10
KA >10 -4>10 >10""^
-5
> 10
GDEE -4>10. . -4>10 > io"^ -4■> 10
IMMDA > 10
— 5
• > 10 “4>10 > 10'2
DLaAA "4>10 —5>10 “4>10 ■ > 10‘®
D-Glu was the exception, as this was a weak displacer of %-h-Asp bound 
to the site at 20 days but was more effective than either L-Glu or 
L-Asp at 50 days. This Na"^ dependent site also showed some affinity 
for the D isomer of aspartate at both ages, but the potency of displace­
ment was considerably less than for D or L-Glu or L-Asp. L-Asp and 
L-Glu were equally effective at displacing L-Asp specifically bound to 
the Na^  dependent site at both age points.
Discussion
The presence of two high affinity binding sites for L-Asp on cortical 
membranes differing in their requirement for Na^ , is again consistent 
with a transmitter role for aspartate in the rat cortex. At the time 
of writing there has been only one report of the binding of L-Asp to 
tissue prepared from the rat cerebral cortex, although the binding 
assay was carried out using an isolated lipoprotein component extracted 
from synaptic membranes and not to whole membrane tissue. In that 
study^  3 binding sites for aspartate were reported (DePlazas and 
DeRobertis, 1976). The first, of very high affinity, has a Kd of
0.2|JM - very similar to the estimated aff^ity of the Na'*’ independent 
site for aspartate described here. The 3max was considerably higher 
however, at 280 pmols/mg protein ( 19.4 pmols, this study). This
higher site density is undoubtedly due to the considerable increase in 
purity of the binding component in the tissue sample. This isolated 
lipoprotein also exhibited a medium affinity site^  Kd lOjjMjfimax, 132 nmols) 
and a low affinity site( kd 59 jum; S max 6l2 nmols). It is 
curious that the binding to the medium and low affinity sites was ■ 
also in the absence of Na"**. It seems unlikely that these two sites could
be physiologically impoirtant in neurotransmission as a higher affinity 
and lower site density would be necessary for a postsynaotiç receptor
site, and a high affinity re-uptake site would be expected to show a
+ + strict requirement Ar Na . Alternatively, the independence from Na
could be due to a dissociation of the amino acid binding component of
the recognition/transport molecule from the, Na"** binding site during the
extraction and isolation procedure, although this would imply a fairly
loose association within the membrane.
Sharif and Roberts (I98I) have recently demonstrated H-L-Asp binding 
to cerebellar synaptic membranes and found a single site that was Na"*" 
independent and gave a Kd of 0.874^ M and a Biax of 44 pmols/mg protein. 
Foster et al (I98I) have also reported H-L-Asp binding to membranes 
prepared from whole forebrain. This binding was also Na"*" independent 
with, a Kd 1.26pM and a Bmax of 29 pmols^ although they also report that 
this binding was increased 4 fold in the presence of iQOmM Na"*" which 
would suggest the presence of a Na"*" dependent site as demonstrated in 
this report. • '
The structure of this Na independent L-Asp binding site would seem 
to favour binding of substances that are aspartate-like in structure rather- 
than glutamate-like. This is likely in view of the fact that the Aspartate 
analogues NMDA and D *=< AA can displace this binding with IG50 values of 
around lo""%. The IG50 value for L-Asp itself is 7-2 x 10 and the 
binding is not displaceable by the glutamate analogues KA and GDEE nor by 
glutamate itself. Interestingly the results also show that D-Glu has 
some affinity for this Na"*" independent site. This is consistent with 
theoretical arguments reported earlier, that D-Glu might be a preferential 
agonist for amino acid receptors that are aspartate-preferring or that 
accept glutamate in' a, partially folded form. It is surprising however.
that L-Glu did not exhibit any affinity for this site in adults^  as gluta­
mate is a flexible molecule and it would be expected to be able to inter­
act with aspartate binding sites in a partially folded form. These 
inhibition studies are very similar to those of DePlazas and DeRobertis 
(1976), who also showed a lack of effectiveness of L-glu in displacing 
binding from their high affinity site^ whilst NMDA inhibited the binding 
by kjfo at a concentration of 40|wiM. Their high affinity site was also 
stereospecific for the L isomer of aspairbate.
These results are contradicted by Sharif and Roberts (I98I) who 
reported that L-Glu was as effective as L-Asp in displacing L-Asp 
specifically bound to cerebellar membranes and that the Aspartate agonist 
NMDA was ineffective, together with the aspartate antagonist D*AA.
KA (corresponding to a glutamate molecule restricted to an extended
conformation) had no affinity for the Na independent binding site on
cortical membranes (this study). A similar result was obtained on the
effectiveness of KA as a displacer of L-Asp bound to cerebellar membranes
(Sharif and Roberts, I98I). The other differences in the structural
requirements of the binding sites in cerebellum and cerebral cortex may -
reflect a genuine difference in the type of binding site found in these
two brain areas. Those in the cerebellum may show a greater level of
cross-reactivity than those in the cortex which may be more restrictive
in their structural requirements - possibly arguing for a difference in
the functional demands made on different receptor types, reflecting the
complexity of input into the cortex.
+  ■The Na dependent site at jO days of age will bind L-Asp, L-Glu and 
D-Glu with high affinity^  which is very much in keeping with other evidence 
that these three amino acids share the same transport site. The IG^ O 
found by displacing either glutamate or aspartate from this site was the
same for all the effective ligands. D-Asp also displaces L-Asp bound to
this Na dependent site although its potency is 10 times weaker than for
the other 3 molecules. Both the kinetic data and the pharmacological
+data support the view that this Na dependent site may contribute to the 
removal of glutamate and"aspartate from the synaptic cleft when their 
activity is terminated. Ihe structural demands of this binding site are 
the same at 20 days as at 3^  days, with the exception of its ability to 
bind D-Glu which only becomes capable cf displacing aspartate bound to its 
Na"*" dependent site after the 20 day age point. Ihis effect of D-Glu was 
also found using L-Glu as the displaceable ligand and is rather difficult 
to explain.
In contrast,the structural specificity of the Na "independent 
aspartate binding site changes dramatically during the period 20-50 days^  
paralleling-the dramatic changes in the kinetic parameters of the binding 
over "the same period. The affinity of this site for L-Asp is much lower 
at 20 days than at 50 days, the relevant IG50*s being ?.2 x lo”"^M 
at 50 days and 5*0 x 10 M at 20 days. Ihe interesting observation,
though is that L-Glu has an even greater ability than L-Asp to 
displace H-L-Asp binding at this earlier age (IG50 2.0 x lO’^ M), in 
contrast to its ineffectiveness at displacing any of the binding at 50 
days. Ihis ability of L-Glu to displace L-Asp is reflected by kainic 
acid, a strict glutamate analogue that like glutamate has some affinity 
for the Na independent aspartate site at 20 days, but not at 50 days.
The fact that the Na**" independent L-Asp binding site is present at 
higher concentration and with a much lower affinity for its ligand at 20 
days than at’ 50 days, could mean that L-Asp is reacting with other 
populations of receptors at 20 days as well as with its own binding sites. 
The fact that this binding is of relatively low affinity could reflect
the fact that these different binding sites can adapt to the occupation by 
ligands that differ from each other slightly in their shape. Because of: 
this adaptive capacity the receptor component would not be fixed into any 
one rigid conformation, at least at its acceptor site, and rigidity of 
shape is probably a prerequisite for highly specific, high affinity 
interactions between a binding site and its designated ligand. This view, 
that the site binding aspartate is relatively unspecified at 20 days of 
age^  is reflected in the fact that it also has high affinity for L-Glu and 
more especially the conformationally restricted glutamate agonist kainic 
acid. This is not the case at 50 days when many fewer sites are available 
for L-Asp to bind to. In addition these sites will no longer bind L-Glu 
or kainic acid,showing preference for the aspartate agaonist MDA and its 
antagonist Dc<AA.
Thus,the kinetic and pharmacological data on the binding of Aspartate 
to rat cortical membranes support and strengthen its candidature as a 
neurotransmitter. At the same time the hypothesis is upheld, that binding
sites destined to subserve amino acidergic neiirotransmission are relatively 
unspecified for either one of their two possible ligands (glutamate and 
aspartate) at the time of initial contact between presynaptic elements^  
and that the postsynaptic cell only becomes committed to glutamatergic or 
aspertergic transmission (with the concommitant increase in specificity 
for one or the other) as specific pathways become activated. The onto­
genetic profile of the Na**^ independent L-Asp binding site shows the high 
affinity and low capacity characteristic of the adult only from 30 days 
of age.
5.6 Effects of freezing
The binding studies reported in this thesis were carried out using 
freshly prepared tissue only. Thus animals were killed in the morning, 
brain samples prepared, binding assay carried put and samples processed 
for scintillation counting as a continuous operation. The drawback is 
that a relatively quick method of fractionation of brain tissue had to be 
employed, yielding a crude preparation of synaptic membranes (essentially 
a purified fraction); instead of pure synaptic membraiie fractions that 
may be obtained following fractionation procedures taking 6-8 hours to 
perform. The heterogeneity of the membrane sample used in binding studies 
obviously raised the question of the exact brain compartment responsible 
for the binding. The use of pure synaptic membranes would have obviated 
some of these difficulties but would necessitate, because of the time 
involved, samples being frozen and stored before use in the binding assay.
There have been conflicting reports on the effects of freezing on 
glutamate binding. Biziere et al (I98O) reported that binding was 
not affected by freezing membranes from many different brain areas.
Similarly Vincent and McGeer (I98O) reported no loss of Na"*^ dependent binding 
in the striatum after membranes had been frozen and rethawed. In contrast 
there are reports that glutamate and aspartate binding to cerebellar 
membranes is severely decreased after freeze/thawing (Foster and Roberts, 
1978; Sharif and Roberts, I98I).
Consequently, the effects of using, frozen and thawed cortical 
membrane fractions in the glutamate and aspartate binding assays was 
examined. " . . .
Results
Initial studies were carried out using membranes prepared from adult
(50 day old) rats and showed that there was a dramatic increase in the 
+levels of Na independent glutamate, binding after freeze/thawing (Table 5.6Î
This substantial (x 9) increase represented a rise in the maximal number
of binding sites available, from 6.4 pmols/mg protein in fresh tissue to
54 pmols/mg protein in previously frozen tissue. There was no change in
the affinity of this Na^  independent receptor for glutamate. In contrast 
+
Na dependent binding of glutamate was decreased by about 50.% in frozen/ 
rethawed tissue. Na"*" independent aspartate binding was not affected by 
freezing whilst Na dependent binding of aspartate,like that of glutamate, 
was decreased by 50-60%.
The dramatic difference in the effects of freezing between the Na"*" 
independent binding of aspartate and that of glutamate in the adult was 
strongly indicative of the existence of. different binding sites for the 
two ligands. This prompted the question "Is this difference apparent in 
frozen membranes prepared from younger rats?"
The results of such an experiment can also be seen in Table 5.6 and 
shows that Na independent glutamate binding is slightly decreased in 
freeze/thawed membranes prepared from 20 day old rats, and that Na^ 
independent aspartate binding is effected in an identical way, i.e. a slight 
decrease in binding. The effects of freeze/thawing on the Na"*" dependent 
binding of both glutamate and aspartate in membranes prepared from these 
young rats is identical to that found in the adult, i.e. an approximately 
60% decrease.
TABLE 56
The effects of freeze-thawing on the subsequent binding of 
^H-L-Glu and ^ H-L-Asp to cortical membranes prepared from rats at 50 •
and 20 days of age. The control values are the levels of binding to 
freshly prepared tissue. Freeze/thaw tissue was frozen for 24 hours
as a suspension in 50mM KPO^  buffer pH 7.1,and was used in the binding 
assay directly upon thawing. The results are mean + SEM of 5 separate 
determinations.
Glutamate binding (B max:pmols/mg protein)
Na*" Independent 
Control Exp
50 dy 6.2 + 0.57 54.0 + 0.26
20 dy 8.47 + 1.05 6.2 + 2.1
Na dependent 
Control Exp
108 + 14.1210 + 19.2 
82.4 + 4.19 38.6 + 2.i
Aspartate Binding
Na IND
Control Exp
50 dy 19.4 + 1.6 18.9+1.4
20 dy 54.5 + 2.8 48.2 + 5.6
Na"*" DEP
Control Exp
361 + 18.4 152 + 16.0
1157 + 37.0 536 + 42.0
Discussion
One obvious interpretation of the results is that they provide 
additional support for the hypothesis that glutamate and aspartate 
bind to the same Na"*" independent (postsynaptic?) receptor in younger 
animals. This being the case,, their binding to such a receptor would 
be expected to be similarly affected by any modification procedure. 
However, by 50 days such receptors have become specified for either 
glutamate or aspartate and thus are now differentially affected by such 
procedures as freezing and subsequent thawing of membranes.
It is a little more difficult to explain the very large increase in 
Na"*" independent glutamate binding to previously frozen membranes prepared 
from adult rats. Rupturing of the membrane bilayer by freezing could 
expose many integral membrane protein components capable of binding 
glutamate. ■ It is difficult to assess a physiological role for such 
hidden binding sites, but they may be involved in long term 'plastic* 
responses of the neuronal cell surface such as supersensitivity or -long"- 
term potentiation (DTP). Such a physiological role is implicated by 
the fact that these uncovered binding sites, have the same Kd value 
(O.S'J^t/M) for glutamate as those exposed in fresh tissue. The latter 
phenomenon (DTP) has been shown to occur in the hippocampus following 
brief periods of high frequency stimulation Dunwiddie and Lynch, 1978). 
Glutamate is strongly favoured, on the basis of neurophysiological and 
neurochemical evidence, as the transmitter utilized by several afferent 
and efferent pathways to and from the hippocampus (Storm — Mathis en, 
1977). Baudry and Lynch (I98O) have suggested that the physiological 
mechanism by which DTP occurs may be an uncovering of hidden receptors by 
a Ga activated protease. The phenomenon of DTP may be expected to be
much more pronounced in areas that are likely to possess a high degree of 
functional plasticity reflecting their involvement in brain functions 
such as leanmng and memory. As a corollary^ brain areas that are essentially 
involved in the control of muscular coordination and. therefore exhibit a 
much more invariant wiring pattern throughout their ordered structure may 
not be capable of L.T.P. If this is the case then it may explain the 
presence of hidden receptors in the cerebral cortex and hippocampus capable 
exposure by freezing, and the absence of such receptors.in the cerebellum 
where L.T.P. would not be expected.
The findings that Na independent aspartate binding does not increase 
upon freezing adult membranes, whilst binding of glutamate does,could be 
a reflection of differing roles for the two amino acids in the mediation 
of synaptic plasticity, although other possibilities exist.
5.7 Localization studies - The Heeler Mutant Mouse
The binding studies reported here have utilized membranes prepared 
from the whole cortex cleared of underlying structures and white matter.
The reported results have provided a useful insight into the types of 
interaction that exist between the amino acids and their receptors in 
this part of the brain. However, the cortex itself is heterogenous both 
in terms of cell type and of the known functional demands made on various 
cortical areas by an enormous diversity of afferent connections. A 
more accurate quantitative assessment, and an analysis of the factors 
modulating the binding may be best studied in a more localised 
cortical area receiving a rich glutamatergic projection. In an attempt 
to identify such an area, cleaned cortices were dissected into four 
sections by tangential cross section dividing the cortex roughly into
visual cortex, motor cortex and two intermediate zones.
+ +Although several different estimations of Na dependent and Na
independent glutamate binding were carried out on each section (i.e. 
utilizing the cortices from several different animals) results were 
inconclusive. Variations in levels of binding to the same areas of 
individual rats was pronounced and statistical tests on pooled results 
showed no real differences in the levels of binding in these cortical 
areas. Several explanations for these disappointing experimental 
findings are plausible; glutamatergic neurons may project into all 
cortical regions and zone dissection may have to be extremely accurate, 
and coupled with a highly sensitive assay technique before major differences 
can be identified.
A promising line of investigation into the problem of localization of 
glutamatergic projections in the cerebral cortex was offered by a 
consideration of the abnormal brain structure of the autosomal recessive
mutant mouse Reeler. Reeler is alone amongst the neurologically abnormal 
mice,characterized by aberrations in cerebellar cytoarchitecture and wiring 
patterns^ in that the reeler mutation also affects^ detrimentally^ the normal 
distribution of cell types in the cerebral cortex.
The normal cortex of mice is separated into distinct lamina formed by 
a segregation of classes of cells into tang^ial strata. The cells in 
each of the laminae have in common a distinct somatic and dendritic 
morphology and a characteristic pattern of axon deployment as their 
anatomical features. In addition, all the cells in any one lamina share 
the same pattern of afferent and efferent connections and are all 
orientated in a particular way relative to other neurons.
Comprehensive studies by Caviness and colleagues have established 
that these general attributes of cellular organisation are essentially 
preserved in the cortex of reeler mutants (Caviness, 1977; Caviness 
and Rakic, 1978) despite the fact that the relative location of the laminae 
are reversed in the reeler cortex compared to the normal cortex. During 
the process of morphogenesis in the normal and in the reeler cortex^  cells 
at the earliest stages of cell proliferation, on embryonic day 11 (Ell), 
migrate to the pial surface of the immature cortex guided by radial glial
(Rakic, 1972) . In both normal and mutant mice migration is complete 
by El3. The next two days are characterized in the normal animal by two 
events. The first of these is the development of a cortical plate of cells 
delineated above and below by a cell sparse plexiform layer. Simultaneously 
the cells Subdivide into two distinct populations. The larger population 
migrates deep into the cortex, whilst the much smaller population remains 
superficial, constituting the plexiform layer of the mature cortex (Caviness, 
1977). These deeply directed cells differentiate into the 'polymorphous
and large pyramidal cell layers of the normal cortex. Cells subsequently 
arriving in the cortical plate region migrate to progressively more 
superficial layers to form a characteristic distribution of cell types.
Ihe developmental events at E13 are dramatically different in the 
reeler, however, as the cortical plate cells do not become subdivided • 
into separate populations, but remain together and occupy the most 
superficial layers of the cortex. Ihis means that a plexiform layer 
containing few cells does not arise. Ihe cells of the cortical plate 
in the reeler subsequently differentiate to give a superficial 
polymorphous lamina, and, immediately below, a strata of large pyramidal 
cells, . Ihus later generated cells are forced to occupy positions 
successively deep to these layers, essentially reversing the normal 
pattern of development.Delong and Sidman (1970) have hypothesized that 
the lack of division into sub-populations at E13, and the subsequent 
non-migration of predestined large pyramidal cells,may be due to an 
altered (increased) affinity of these cells for each other or for non- 
neural structures at the cortical periphery. Ihis explanation 
presupposes that the role of the gene at the reeler locus may be to 
specify levels of cell surface components mediating recognition phen­
omena.
Despite this reversal in lamina structure,efferent projections from 
the cortex arise in a similar manner and innervate the same target zones 
as in the normal mouse. Axons terminating in the, cortex from other 
brain regions, and constituting the main afferent cortical pathways,are 
also very similar in the normal and reeler mice in that they synapse with 
- the same target cells in both animals.
By necessity these are alterations in the route followed by neural 
elements entering and leaving the cortex of reeler mutants, but
specificity of connections is maintained, on the whole, with remarkable 
accuracy.
Ihere is however, one afferent system where abnormal connectivity 
is apparent. Axons from the olfactory bulb of normal and reeler mice 
travel in the lateral olfactory tract (LOT) and their terminals are 
then distributed densely to lie superficial in the pyriform cortex. . From 
here, in the normal animal, they contact with the distal portion of the 
dominant apical dendrite arising from pyramidal cells immediately 
below, i.e. in the layers of smaller pyramidal cells. . Ihese cells, in 
contrast, lie in the deepest strata in the reeler and,although some of 
their apical dendrites may be radially aligned,they may be descending as 
well as ascending. In addition, many of these cells are tangentially 
aligned. Ihis is also the case for the larger pyramidal cell types 
lying more superficially in the‘reeler cortex. Ihese tangentially 
oriented or descending dendrites do not penetrate into the superficial 
cortical zone of terminals emerging from the L.O.T. Additionally, and 
in contrast to other afferent systems,the olfactory fibres do not 
penetrate deeper into the cortex to meet tangential dendrites of the 
small pyramidal cells. Ihus the number of synaptic-connections made by 
afferent LOT fibres in the cortex of reelers is considerably reduced, 
being restricted to the relatively small number of radially orientated 
ascending apical dendrites arising from deeply placed pyramidal cells.
In normal, animals these terminals usually synapse on one dendritic 
spine where a strong, anatomically distinct connection is formed. In 
contrast, in the reeler, the terminals are. much larger and may span 
three or four dendritic spines, although forming much looser,and therefore 
less stable,synapses (Caviness et al, 1977). • This abnormal situation 
may also be characterised by transient synapses, i;e. the continual
regeneration and degeneration of weak synaptic connections with the 
equilibrium in favour of degeneration.
The acidic amino acids are strong candidates for the role of
transmitter utilized by the cells of the olfactory bulb terminating in the
pyriform cortex. This candidature is based on many types of evidence,
but there does seem to be a species difference in the usage of either
glutamate or aspartate. Thus, in the rat, LOT stimulation causes an
increased release of aspartate only, in a Ga'*"*’ dependent manner (Collins,
1979). This amino acid is therefore suggested to be the prime transmitter
of the afferent path into the olfactory cortex (Collins and Probett,I98I)
although there is some indication that glutamate may be released at some
of the L.O.T. fibre terminals (Harvey, et al, 1975* Collins, I98O;
Collins et al.,1981). In contrast there is considerable evidence that
glutamate, not aspartate, is the transmitter utilized by this pathway
in the guinea pig. Electrophysiological studies have demonstrated
the présence of nerve cells within the target area of the L.O.T. fibres
that are particularly sensitive to glutamate (Richards, 1977)* in
addition, glutamate content of the piriform cortex is considerably reduced
after olfactory bulb ablation (Bradford and Richards, I976). Stimulation
++of the L.O.T. also causes an increased Ca dependent release of 
glutamate from the piriform cortex (Yamamato and Matsui, 1975; Bradford 
and Richards, I976). Although there are no reports in the literature 
of such studies in the mouse brain^ the similarity between the murine and 
rodent olfactory system would suggest that the amino acids may also be 
transmitter candidates in the species. If this hypothesis is correct, 
then it may be expected that binding sites for glutamate on cortical 
membranes prepared from reeler would be severely reduced in number
compared to those in normal animals. Although the pyramidal cells 
that normally receive the innervation are present they cannot form 
synapses with the incoming olfactory fibres. A common feature of the 
developing nervous system is that cells deprived of their normal 
afferent innervation will not develop receptors for the afferent 
transmitter or will •internalize* receptors formed. Because this 
abnormality is restricted to the. olfactory system as opposed to other 
afferent inputs any differences that were found in glutamatergic 
parameters would be strongly indicative of a transmitter role for 
glutamate in that system.
From these considerations membranes prepared for the cerebral 
cortices of reeler and normal mice were used to carry out binding 
studies. The results are shown in Table 5,7.
i o ^
TABLE
Results Values given are mean + SEM.
+
Normal mice 
Reeler
Na independent Binding 
(pmols/mg protein)
14.5 ± 1.2 (5) G 
11.25 ± Û.3 (6) D
+
Na dependent Binding 
(pmols/mg protein)
79.3 + 4.6 (5) A 
75.9 ± 3.4 (6) B
n values in brackets.
Differences in means A and B non significant. 
Differences in means G and D-p .023.
The arguments put forward earlier in this section suggest that if 
glutamate is the transmitter of the olfactory pathway into the cortex, 
then levels of glutamate binding to membranes prepared from the cortices 
of the reeler mutant mouse may be expected to be considerably reduced.
In the presence of Na"*^, binding of glutamate is very similar in both 
normal and mutant mice. Although binding in the presence of Na"*" is 
usually associated with binding to a transport site involved in the 
active high affinity uptake of transmitter from the synaptic cleft, 
this uptake may also subserve other functions. Even in the absence 
of transmitter glutamate, an efficient uptake system may be necessary 
not only to accumulate the amino acid for metabolic purposes, but also 
to prevent extracellular levels of this potent excitatory amino acid 
reaching thresholds evoking polarization. Such a function may be 
carried out by a high capacity low affinity transport system in addition 
to the low capacity high affinity system, that may also function in 
glutamatergic transmission. Loss of binding sites within this second 
system may therefore be masked by the much greater number of low affinity 
sites, especially when binding is measured at a single concentration of
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ligand as is the case here. A loss of binding sites might only be 
detected following a detailed study of binding kinetics in the presence 
of Na"*" utilizing a wide range of ligand concentrations.
On the other hand, Na'*' independent binding is significantly reduced 
in the mutant compared to the normal mouse (p<0.025)» corresponding 
to a 22.5% reduction. However, from a consideration of the drastic 
reduction in synaptic connections in the olfactory cortex then a much 
greater drop in levels of Ha"*" independent binding mi^t be expected if 
glutamate is indeed the transmitter of this afferent system. There are 
of course many possible explanations for this finding. First of all, 
glutamate may be utilized as a transmitter by many of the afferent pathways 
into the cortex and for communication between different cortical areas.
In this case, loss of synapses in one system only would not make such a 
large difference in overall levels of binding. This is quite in keeping 
with a ubiquitous role for the amino acid as excitatory transmitter in 
the CHS. It could also be that glutamate may exert an excitatory 
effect by a synergistic action with the putative excitatoiy transmitter 
aspartate (Collins, 1976). A similar analysis of the differences in 
aspartate binding between reeler and normal mice would then produce a 
similar result. The additive loss of glutamate and aspartate binding 
sites in reeler may represent a very large decrease compared to the 
number of glutamate and aspartate binding sites in the normal animal.
A further possibility is that loss of synaptic connections and 
therefore degeneration of presumptive receptor complexes in olfactory 
cortex may initially be considerable in the reeler. The response to 
this situation, however, may be a marked increase in receptor number at 
the small number of synapses that do form, or an increased affinity of 
receptors for this- lignad. This evoked supersensitivity of some cortical
neurons for the olfactory transmitter could partially compensate for the 
loss of receptor capacity in the majority of normally receptive cells 
leading to a decrease in levels of binding only of the proportions 
found in this study.
Although these results are not as conclusive as were hoped, they 
do raise many possibilities for future studies and establish the reeler 
as an important experimental tool in the search for specific amino 
acidergic pathways. The use of congenital mutants in this type of 
work is especially attractive as it avoids the need to manufacture 
disruption in cortical synaptology either by mechanical or chemical 
lesioning techniques/or by the use of sensory deprivation. Any of 
these methods may produce changes in neurochemical parameters that are 
primarily trauma-related as well as raising ethical problems relating 
to animal experimentation. The results do not contradict the view 
that glutamate may be the transmitter of the cortical afferents carried 
in the L.O.T. of the mouse.
CHAPTER 6
GENERAL DISCUSSION
6.1 CRITIQUE OF BINDING DATA
Ihe experiments reported in this thesis were initially carried 
out to test the hypothesis that the acidic amino acids glutamate and 
aspartate are neurotransmitters utilized by afferent pathways to the 
cerebral cortex and perhaps for communication between different 
cortical areas. If the amino acids are transmitters they must fulful 
accepte.d criteria for neurotransmitter status. One of these criteria 
is that receptive neurons must possess high affinity, low capacity • 
receptor sites for the putative transmitter, as it is almost certainly 
through the interaction with such membrane bound receptors that 
transmitters exert their physiological effect, evoking changes in the 
postsynaptic cell that lead to a shift in transmembrane potential,
I have demonstrated that such sites exist for both glutamate and 
aspartate on cortical membranes prepared from adult rats . (Section
5.1 and 5*5)• Ihe binding to these sites is not dependent on the
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presence of sodium and therefore cannot represent binding to transport 
sites that have a strict requirement for this ion.
Post synaptic receptor sites, from theoretical consideration;, 
should show high affinity for their ligands^  to enable them-to respond 
to very small changes in the concentration of the transmitter in the 
synaptic cleft. The affinity constants for the binding of glutamate 
and aspartate to their Na"*" independent sites are very similar at 
around 0.3jL/M. This is very much in-keeping with Kd values found by 
many other workers, and, in addition, the reported affinity constants 
show remarkable agreement between different brain areas. The crucial 
consideration here then is not that there are binding sites for glutamate 
in the brain, but whether or not these binding sites fulfill the criterion 
of high affinity. A major problem here is that any definition of 
•high affinity' must be either arbitrary and subjective (depending on 
whether one believes glutamate to be a neuro transmitter or not.' ) or 
.must have a standard of comparison.
The affinity constants commonly reported for the interaction between
glutamate and its two transport sites in brain tissue are about 2-3pM
and respectively. Compared to these values a kd of 0.3yUM
certainly represents a dramatic increase in affinity of at least 10 fold.
This difference in affinity between glutamate binding sites in the brain
must represent different physiological functions. As the Na"^
independent sites do seem to be concentrated in the synaptic membrane
fraction of brain tissue (Section 4g) it is quite conceivable that they
could be subserving a function in neurotransmission, with these "high 
//
affinity sites synonymous with the postsynaptic receptor.
However, if the Kd of this site is compared to the affinity constant
of the receptor sites for the classic transmitters acetylcholine and 
GABA, then the concept of high affinity becomes a little clouded.
Ihe nicotinic receptor for Ach has a Kd of 4nM and the GABA receptor 
of roughly 50 times higher affinity than the glutamate or aspartate high 
affinity site.
In the introductory chapter of this thesis, I argued that it may 
be misguided and therefore uninformative to apply criteria of neuro- 
transmission based on the mechanism of action of Ach, to the search for 
new transmitter molecules. Ihis is especially true when the acidic 
amino acids are considered, because of their importance as metabolites 
in the cell, being most intimately involved in protein synthesis and in 
the control and regulation of nitrogen metabolism.’ Ihese amino acids 
are ubiquitously present in the body and,although they do not easily 
cross the blood/brain barrier,they are nevertheless present in the G.S.F. 
in high concentrations. Although estimates of this concentration vary 
considerably, an average free glutamate concentration in GSF of 21mM has 
been arrived at (Johnston,1978; McGabe et al.,1977). ' Electrophysiological
studies have shown that iontophoretically applied glutamate can depolarize 
GNS neurons at concentrations of lo"^  or lo”^  in vivo (Gurtis,l965) 
or in vitro (Hosli et al.,1979).
Obviously^ post-synaptic receptors triggering intracellular events 
leading to membrane depolarization should not be responsive to levels 
of excitatory ligand normally occurring in the extracellular space, or 
more particular in the synaptic cleft where the receptors occur. A low 
affinity constant for glutamate receptors in the range of the Ach 
receptor would result in continual high levels of activation at all ’ 
times ^which could lead to cell death via the excitotoxic mechanism 
proposed by Olney (1975) 3-nd mentioned earlier. A lower affinity constant
then, far from being an argument against glutamate being a transmitter, 
would be an absolute requisite if glutamate were fulfilling such a role.
The same situation applies to the role of aspartate as neurotransmitter, 
with an estimated GSF concentration of 6.6mM.
As already discussed in Ghapter 2, the kinetic parameters, describing 
the in vitro binding must at least be compatible with the dose dependancy 
of the electrophysiological effect. The estimated Kd values for glutamate 
and Aspartate for the Na*^  independent sites are approx. 0.3y/M - of the 
same order as the concentrations needed to evoke EPSP*s. Discrepancies 
between exact values can not only be easily explained^  but also expected 
from a'consideration of the unknown contributions of such factors as 
spare receptors and different, receptor sites (discussed under receptor 
theory Ghapter 2) to the in vivo results.
Nevertheless, despite this relatively low affinity for glutamate, 
minimal levels of this amino acid needed to evoke EPSP’s are of the 
same order (if not lower)as,the concentration of glutamate normally 
circulating in the G.S.F. This suggests the possibility üiat glutamate 
continually exerts a depolarizing influence on receptor neurons so that 
the EM of the membrane is shifted considerably towards zero and maintained 
at a value just sub-threshold for depolarization. In these circumstances, 
as pointed out by Johnson (I978), the post-synaptic cell could be 
extremely responsive to very small increases in excitatory transmitter in 
the synaptic cleft and released from the presynaptic nerve ending in 
response to the arrival of a nerve impulse. If this is indeed the case, 
it raises questions as to the physiological significance of release 
studies üiat show large changes in the concentration of extracellular 
amino acids after stimulation of the presynaptic input. It is also 
possible of course that this depolarizing influence of glutamate is its
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only contribution to synaptic function and it therefore potentiates or 
modulates the activity of an as yet unidentified excitatory transmitter.
Pertinent to this line of thought is the question of whether or 
not the binding sites being measured in in vitro studies have a solely 
synaptic location. IXly own studies, and those by other workers (Cotman 
et al, I98I), demonstrate a dramatic increase in the concentration of 
Na*** independent binding sites in a purified synaptic membrane preparar- 
tion. However, iontophoretic studies demonstrate conclusively that 
perikaryal membranes are highly responsive to applied glutamate and 
aspartate although the synaptic excitatozy receptors are thought to be 
dendritically located. Further purification of this synaptic plasma 
membrane fraction to give a preparation enriched in synaptic junctions 
yields a recovery of only 11% and 26% of the glutamate and aspartate 
receptors respectively compared to their levels in SPM's. In addition,
Ha*^  independent binding sites are easily demonstrable at hi^ levels in 
a Pg fraction suggesting some extrasynaptic location. Interestingly, the 
kinetic constants defining the binding are the same, whether a P^ fraction 
or a purified synaptic membrane fraction is used, suggestive of a 
similarity of function. Again, the preceeding discussion is equally 
applicable to aspartate.
So there is evidence that physiologically relevant receptors for 
glutamate exist both at the synapse and at much more widespread 
extrasynaptic locations, most probably on the perikazyal membrane. The 
fact that extracellular levels of the amino acids are sufficient (without 
evoked neuronal activity) to maintain a EM considerably shifted towards 
the depolarization threshold suggests a role for the Ha dependent binding.
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There is very strong evidence that such binding is to an uptake site 
that is predominantly located on glial cell membranes (Henn^  I976 ; Hertz ,1979).- 
My own studies on the subcellular location of the binding show that 
whilst there is an 8-fold purification of Ha"^  independent binding sites 
in the synaptic membrane fraction there is only a 1^  times purification 
of the putative uptake sites. Although this could be a reflection of 
the fact that transport sites for the rapid uptake of glutamate could be 
present to some extent on synaptic membranes it could also be explained 
by their presence in increased concentrations on membranes from glial 
cells surrounding the synapse. The preparation of crude synaptic 
membranes yields samples that are contaminated with membranes from cell 
types intimately associated with the synaptic region in vivo. Veiy 
recently the compound 4-acetamino-4-isothiocyano-2,2 disulphonic acid 
stilbene (SITS) has been suggested as a specific glial inhibitor of 
glutamate uptake (Waniewski and Martin, 198$). The use of this compound 
in binding studies may also inhibit the glial congionent of the binding, 
although its mechanism of action has not been fully clarified.
Nevertheless, the fact that the purification factor is so low when 
comparing a to a SM fraction indicate that a vast proportion of the 
sites are not associated with the synapse. The function of these 
extrasynaptic high affinity uptake sites could, then, be two-fold. They 
could maintain normal levels of the excitatory amino acids within 
narrowly defined limits, acting as a fine control of the modulatory effect 
of the amino acids in eliciting shifts in E.M. towards the depolarization 
threshold. In addition, high levels of glial uptake at elevated G.S.F. 
concentrations could be a vital protection mechanism against the 
excitotoxic effects of these amino acids.
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It may be that this 'fine tuning' of the synaptic levels of 
glutamate and aspartate by the high affinity transport mechanism is 
the only role for such systems.
Uptake studies show many anomalies. Althou#i many workers have 
maintained that a hi^ affinity transport mechanism for Glycine occurs 
in the spinal cord where it is a transmitter, but not in the cerebral 
cortex where it is not thought to have a transmitter function,
(Logan and Snyder 1972) there has been one report that questions this. 
Using synaptosomal fractions of rat cerebral cortex Peterson and 
Eagbupathy (197$) reported a transport process for Gly with a KM of 
2.5 X 10"%. Later, the same authors reported the presence of high 
affinity transport mechanism showing strict Ha**" dependency for the 
non-transmitter amino acids serine and threonine in brain cortical 
synaptosomes from newborn rats (Peterson N.A. and Raghnpathy E. 1978). 
Other workers too have found evidence of hi^ affinity transport of non­
transmitter amino acid. Thus high affinity mechanisms exist for 
arginine, serine, leucine, ■tryptophan and Tyrosine in purified synaptosomes 
prepared from cerebral cortex (Balcar and Johnston 1974)» Althou^ 
these transport systems were not dependent on sodium the hi^ affinity 
transport of proline was. Balcar and Johnston (1975) also reported the 
Ha+ dependent high affinity transport of glutamine into rat brain slices.
The transport of the inhibitory amino acid G.A.B.A. by both hi^ and 
low affinity systems is well documented in many brain regions. However 
a similar hi^ affinity process for the accumulation of G.A.B.A. has 
also been demonstrated in rat sympathetic ganglia that contain very 
little G.A.B.A. or its related metabolizing enzymes (Bowery and Brown 
1972). Similarly, as previously mentioned, Roberts and Keen (1974)
have shown that a high affinity transport mechanism exists for glutamate 
in the dorsal root ganglion, where it is not a transmitter. Thus it 
may he dangerous to assume that demonstration of a Ha dependent high 
affinity "binding site in a particular region is evidence of a transmitter 
role for the endogenous ligands of such sites. Blockers of the high 
affinity transport site, such as Threo-$ hydroxy-aspartate and 
dihydrokainic acid, do seem to enhance responses to L-glu and L-asp 
applied in vitro, "but not to HMBA or kainic acid which are not 
transported (Johnston et al 1980; Lodge et al I98O). In addition, 
however, is the fact that histidine, which competes only for low 
affinity transport sites, is also able to prolong L-Glu and L-Asp 
responses (Lodge, 1976). D-Glu and Ir-Homocysteate are excitatory amino 
acids that have the same onset and cessation of action as L-Glu and 
L-Asp even though they are removed only by a low affinity system (Cox
et al., 1977).
So differential distribution of these transport systems (Ha 
dependent hi#i affinity) may simply reflect differences in susceptibility 
of neurons to the excitotoxic effects of the putative transmitters. 
Alternatively, these hi#i affinity systems could he a reflection of the 
important metabolic function of the amino acids. IRÏP and OSE in 
partioular are precursors for the biogenic amine transmitters. Tery 
recently an endogenous peptide with high affinity for brain glutamate 
receptors has been reported (Zaczek et al 1983) • is N-acetylas
partylglutamate and if it is subserving a synaptic function glutamate 
and aspartate accumulated by their hi^ affinity active transport systems
may be serving as precursors.
m  addition, interpretation of data on the uptake of 1-Glu and L-Asp
is complicated by factors such as the extent of metabolism of the 
accumulated amino acid, although this can be overcome by using low 
temperatures or short incubation times. A more serious consideration 
is the extent to which exogenous amino acids exchange with endogenous 
pools. It has been shown that if synaptosomes or tissue slices are 
pre-labelled with ^-L-Glu addition of cold Glu (at concentrations in 
the range of hi^ affinity uptake) will increase ^-Glu release in a 
saturable, concentration dependent manner (Levi et al 1976, Jones and 
Mcllwain 1971). As stated by Be Feudis (1975) > this homoexchange 
process (of labelled amino acid for cold endogenous stored) could 
explain double affinity systems, in that at low concentrations ( 10 ^ )
of added amino acid the stimulation of an exchange mechanism would lead 
to a significant increase in the amount of labelled amino acid entering 
which would be observed as a hi^ affinity system. So net accumulation 
of amino acid is actually the sum of three processes; uptake, exit and 
exchange, all of which must be quantified. Only in the case of Glycine 
has net uptake of amino acid been demonstrated at low concentrations of 
substrate (Cox and Bradford 1978). All‘other reports of net uptake can 
be accounted for by low affinity systems (Cox and Bradford 1978).
Heteroexchange between endogenous and exogenous pools of different 
acidic amino acids may also occur. Levi et al (1976) showed that low 
concentrations of unlabelled glutamate stimulated synaptosomal release 
of endogenous labelled aspartate. If these high affinity mechanisms 
are indeed predominantly exchange processes then they are unlikely to be 
involved in the inactivation of released transmitter. • The ubiquitous 
low affinity transport systems may be the major influence in modifying 
responses to excitatory amino acids (Cotman et al 1981).
6.2 Distinct Glutamate and Aspartate Receptors?
Electrophysiological studies have demonstrated very little difference 
in either the excitatory potency or the physiological response 
characteristics of the two dicarhozylic amino acids. Iontophoretic 
application of either glutamate or aspartate to feline motomeurons, 
for example, gave depolarizations with fast onset and recovery, 
accompanied by a small increase in membrane conductance (Lambert et al, 
I98I). Both are equally strong claimants for a role as central 
excitatory neurotransmitters. The data reported in this thesis show 
that binding sites exhibiting kinetic parameters compatible with neuro­
transmission exist for both amino acids. The question that arises then 
is, are the binding sites indicative of physiologically distinct roles 
for the two amino acids, do they mediate transmission into the cortex 
from different afferent pathways? Alternatively is their action 
synergistic? Are they both released from the same nerve endings to 
' interact with the same receptors, their subsequent effect on ion move­
ments across the post synaptic cell membrane being additive? It is 
also possible that only one of the amino acids is utilized in vivo as 
a transmitter and that in vitro electrophysiological and binding studies 
demonstrate only that one is an agonist of the other.
Such questions are not merely academic. If both compounds are 
transmitters utilized by different pathways this has important implica­
tions for trying to pinpoint the malfunction in pathological conditions 
and in the design of specific therapy. Pharmacological agents must (or
should) only be effective where required!
A precedent for the hypothesis that glutamate and aspartate may 
work synergistically is found at the crustacean HMJ, where there is
considerable evidence to show that glutamate and aspartate are released 
together upon electrical stimulation of the presynaptic nerve (Freeman 
et al, I98I). Convincing experiments show that when L-Glu and L-Asp 
are applied simultanéously to enuromuscular preparations of the lobster, 
the dose response curve is shifted to the left, although no effect on 
the maximum response elicited by glutamate is seen (Shank et al, 1975).
The application of L-Asp alone did not exert a depolarizing action on 
the postsynaptic cell even at concentrations 10 times higher than those 
potentiating the glutamate effect (Freeman et al, I98I). Even in 
preparations where aspartate alone does cause EPSP's, the postsynaptic 
response to simultaneous application of glutamate and aspartate is 
greater than the sum of the responses when each amino acid is applied 
alone (McBumey and Crawford, 1979). The only argument concerns the 
mechanism by which this,potentiation is brou^t about. One group, 
working with lobster Homarus Americanus, favour the explanation that 
aspartate activates allosteric binding sites on the postsynaptic 
receptors, which induces an increase in the affinity between glutamate 
and its binding sites on the same receptors (Freeman et al, I98I).
McBumey and Crawford (1979) have evidence from crab Maia squlnado, 
that seems more compatible with the explanation that aspartate exerts 
its potentiating effect by inhibiting glutamate uptake causing a prolong­
ation of glutamate evoked synaptic currents. So is it possible that 
in the mammalian CHS too, glutamate and aspartate may be released together 
and may function as a transmit ter/modulât or pair?
It may of course be impossible to give a simple 'yes or no' answer, 
in that the putative transmitters may well work synergistically in a 
particular brain area whilst the innervation to a different brain area
may be solely glutamatergic or aspartergic. Although there have been 
many studies of the electrophysiological effects of microiontophoretic 
application of the amino acids and their analogues in the CHS (Krnjevic 
and Phillis, 196$; Curtis and Watkins, 196$; Curtis, 1965; Duggan 1974; 
Hicks and McLennan, 1979) > there has been no report of synergism.
However, although virtually all cells respond to administration of 
glutamate or aspartate showing very similar effects on membrane conduc­
tance and firing rate, it is possible in some areas to demonstrate 
differences in the levels of the amino acids needed to evoke the response 
(Duggan, 1974; Hicks and McLennan, 1979). This would suggest that, 
although linked to the same ion channels, there are far fewer receptors 
for one of the amino acids than for the other. Alternatively, the 
receptors may be specific for the more active of the putative transin-tters, 
the other acting as a partial agonist at these specific sites and thus 
evoking the same postsynaptic response only at much hi^er levels. This 
thesis baa been particularly concerned with the nature of the transmitter 
released from afferents of the cerebral cortex. The kinetic parameters 
describing the binding of glutamate and aspartate to cortical membranes 
do not in themselves offer any insist into the problem of whether or 
not the two amino acids are binding to the same receptor. The affinity 
constants for the binding of both ligands are almost identical. The 
density of the binding sites is greater for aspartate than for glutamate, 
however, this could indicate that different populations of receptors
are being measured.
The displacement studies summarized in Tables 5^  and . $5 were 
carried out to distinguish between glutamate and aspartate binding sites 
on the basis of their, pharm c logical requirements. From a considéra-
tion of these results it is possible to distinguish between the 
independent binding sites for glutamate and aspartate on adult rat 
brain membranes. Aspartate bound to its hi^ affinity (Ha"^  independent 
site can only be displaced by itself and by the aspartate analogues 
HMDA and DL AA and not by glutamate analogues G.D.E.E. or K.A. 
Reciprocally, L-Glu cannot be displaced from its binding site by L-Asp 
or aspartate-like analogues.
N.M.D.A., together with kainic acid and quisqualic acid, is one 
of the most potent excitatory amino acids. In the frog spinal cord 
a close parallelism has been demonstrated between the relative abilities 
of amino acid antagonists of the mono- and di-amino dicarboxylio acid 
series (characterized by D«^ AA) to antagonize HKDA-induced responses 
and their relative potencies as depressants of dorsal root evoked 
synaptic excitation. Thus it seems very likely that HMDA is activating 
receptors that are physiologically activated by an excitatory amino 
acid. In addition, there is considerable evidence that is suggestive 
of these HMDA receptors being aspartate preferring (Watkins, 1981). 
Investigations of the structural features of agonists acting on HMDA 
receptors have suggested a $ point attachment site with spatial parameters 
(separation of carboxyl groups) that could, however, accommodate either, 
aspartate or glutamate. Until recently D aminoadipate (D<xAA) offered 
the best choice as an antagonist at these intemediate receptors. Recent 
reports, however, have shown that the W-phosphono-analogue of 
D «C aminoadipate, (2, amino-phosphonovalerate, I A^PV) is over 100 times ,
more potent than D^AA (Watkins, 1981; Olney et al, 1981). Very 
recently binding sites on rat brain membranes have been labelled with 
T^T—TuATV (Olveiman.et al 1984). D—AEV binding sites were present in all
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areas of the CHS tested but particularly high in the hippocanipus and
cerebral cortex. The kinetic parameters describing the binding to
cortical membranes show KD and MAX values of 0.47//M and 4.I pmols/mg
protein respectively. These values are very similar to the KD and
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B MAX values for the binding of ^H-L-Glu and H^-L-Asp to adult cerebral 
cortical membranes. The authors suggested on the basis of displacement 
studies with antagonists that &-D-AEV binds to the HMBA - type receptor 
identified in electro-physiological studies, and indeed of the three 
amino acids considered to be selective receptor agonists, HMBA was 
25 and 80 times more potent than Qjiis and KA respectively at inhibiting 
the binding. However, L-Glu was as potent an inhibitor of ^H-B-AP7 
binding as AEV itself and more than lOx as potent as HMBA or L-Asp.
This study concludes that L-glutamate must be considered a strong 
candidate for the transmitter acting at HMBA receptors as well as 
Quisqualate receptors!
Although the work reported in this thesis supports earlier views 
that HMBA receptors are separate from glutamate receptors (see e.g. 
Watkins I98I McLennan 198I) in that HMBA was totally ineffective at 
displacing glutamate bound to its Ha*^  independent site, there are other 
anomalies. Despite the fact that HMBA has a much greater excitatory 
potency than L-Asp it was approximately 10 times less effective than 
L-Asp in displacing ^H-L-Asp from its putative post synaptic receptor 
site on cortical membranes. A direct characterization of HMDA binding 
sites using radiolabelled HMBA and therefore a knowledge of the kinetic 
parameters describing the interaction between this ligand and its 
receptor would be useful. However, althou^ there has been one report 
of binding studies, using HMBA and cerebellar membranes from mouse^
(Snodgrass, I98I), Roberts and co-workers were unable to repeat this 
work (Sharif, personal connnunication).
It is interesting to note that HMBA was also ineffective in 
inhibiting L-Asp binding to cerebellar membranes (Sharif and Roberts,
I98I) and these workers also suggested that HMBA may not interact 
directly with aspartate recognition sites in this brain region.
A further explanation is given by the view that the interpretation 
of in vivo responses to L-Asp and HMBA are complicated by the fact that 
L-Asp is avidly taken up by hi^ affinity transport mechanisms into 
brain cells surrounding the synapse, whilst HMDA is not transported.
This would lead to a considerably reduced concentration of L-Asp at 
the synapse whilst the concentration of HMBA may not differ from that 
applied. Thus the relative differences in potencies may simply be a ’ 
reflection of the differences in concentrations of ligands reaching the 
synapse.
Thus the usefulness of HMBA as an aspartate-preferring agonist in 
the brain as opposed to the spinal cord must therefore be questioned.
The antagonist G.B.E.E. did not have any effect on either 
L-Asp or L-Glu binding and therefore could not be used as a discriminatory 
tool. Studies using this antagonist as a displacer of binding may in 
anyway be complicated by the fact that high concentrations of G.B.E.E. 
exerts local anaesthetic effects on membranes (Roberts personal 
communication). In addition many commercial preparations of G.B.E.E. 
have bemËiown to be contaminated with Glutamate (Roberts, personal 
communication).
Other results reported in this thesis, however, are highly suppor­
tive of the view that glutamate and aspartate do indeed interact with
distinct binding sites. If the binding assays are carried out using 
membranes that have previously been frozen and thawed then there is an 
8 - fold increase in the amount of binding (pmoles bound/mg protein) of 
L-Glu measured at a single concentration, whilst levels of binding of 
If-Asp to its Na"^  independant site are unaffected. This would seem to 
be totally incompatible with the proposal that glutamate and aspartate 
are binding to the same receptor complex.
The recent identification of glutamate binding sites that are 
Ca^ *^ /Cl~ dependent and sensitive to inhibition by the phosphonic acid 
derivative of glutamate L-2-amino - 4 phosphonobutyrate (irAPB) (Fagg 
et al 1982) may also be relevant to these results. It has been shown 
that this population of receptors are abolished by freezing whilst the
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smaller proportion of Ca /Gl~ independent sites are not affected by 
freeze-thawing (Fagg et al^ l98$). The binding studies reported in this 
thesis were carried out in a medium buffered by potassium phosphate so 
that the binding sites measured were probably of the Ca^ '%/Cl independent 
type, which do not seem to be affected by freezing procedures. However 
it is still difficult to explain why there should be an increase in 
these sites on freeze/thawed membranes.
In addition, the developmental profile of the Ha*^  independant 
binding sites are different for the two ligands. Binding sites for 
glutamate exhibiting a low site density (6.2 pmols/mg protein) and 
a high affinity (kd l.$2|i/M) are present at 20 days of age. This 
affinity constant for L-Glu increases to an adult value of 0. $7// M, 
although the maximal number of binding sites remains similar over this 
period. If aspartate is binding to the same receptor then it might be 
expected that the Bmax in young animals would also be similar to adult
levels. This is not the case. The binding of L-Asp to cortical 
membranes prepared from 20 day old rats is in fact highly anomalous,
• exhibiting a high density of 54*5 pmols/mg protein and a low affinity 
Kd 6.9 which is difficult to equate with a physiologically signifi­
cant post-synaptic receptor. The high affinity site Kd 0.$yi/M can only 
be detected from $0 days of age, albeit at a lower site density than 
in the adult. The Bmax increases gradually over a time period when 
the density of glutamate, binding sites remains constant. This suggests 
that the ability to specifically bind either glutamate or aspartate 
resides in different membrane components.
Nevertheless, these observations alone are inconclusive. As stated 
in 02 of this thesis, knowledge of the physiological significance of 
receptors identified throu^ binding studies can only be arrived at 
following exhaustive studies linking these in vitro experiments with 
in vivo responses to the amino acids. Very recently, discriminatory 
agents have been discovered or manufactured that seem to specifically 
mimic or alter electrophysiological responses to one of the amino acids, 
whilst having no effect on responses to the other. The way forward in 
determining the separate transmitter roles for the dicarboxylio amino 
acids, together with their function throughout ontogeny, would be to 
use these agents to identify isolate and characterize the binding sites 
at various stages in development. This approach will be discussed in 
the final chapter of this thesis.
CHAPTER
THE WAY ABEAB
In vitro binding assays of the kind reported in this thesis have,
I believe, provided an invaluable contribution to the problem of 
clarifying the kinds of interaction that occur between putative neuro­
transmitters and their recognition sites on brain cell membranes « I 
have shown that the dicarboxylio amino acids glutamate and aspartate 
bind to recognition sites that, on the basis of qualitative and quanti­
tative criteria, are at least compatible with a role for them as 
neurotransmitters in the cerebral cortex. In support of this view, the 
developmental profile of these binding sites can at least be tentatively 
explained both in terms of the known morphological development of the 
brain and in terms of hypotheses that attempt to understand and explain 
the events that lead to specification of functional synapses to 
particular modes of neuro transmission.
Many problems remain, however,some actually generated by binding 
studies. In particular, there are many contradictions between 
information gleaned from in vitro studies and those obtained during 
neurophysiological investigations in vivo.
There are many contradictions in the literature concerning the 
discriminatory abilities of pharmacological agents acting at amino 
acid receptors (See e.g. McLennan 198$).
Nevertheless, it is essential to probe the structural requirements 
of excitatory amino acid receptors in the cortex for many reasons, not 
the least being because it is the first step in the design of specific 
therapy for brain malfunction. In addition, such studies may provide 
probes for investigating the different mechanisms of activation of the 
physiological response. As far as my own work is concerned, analogues 
with extreme specificity for the various types of amino acid receptors 
would be invaluable tools for the study of the development of transmitter 
systems in the brain. Any continuation of this work would have the 
pharmacological characterization of binding sites throughout ontogeny
as its central theme.
Althou^ aspartate and glutamate are relatively specific for their 
own Na*^  independent binding sites in adult rats (see Chapter $), the 
situation is much more complex in the developing rat where a large 
degree of cross-reactivity between amino acid binding sites is apparent, 
TTiaVi-ng identification of the various components of the binding difficult, 
to say the least. Even in the adult, it is not easy to determine the 
exact configuration (either folded or extended) with which the amino
acids interact with their receptors.
What then are the analogues that are likely to be of use in further 
studies probing the pharmacological requirements of amino acid receptors? 
Although the antagonist glutamate di-ethyl ester (G.B.E.E.) did not have 
any affinity for the glutamate binding sites reported in this thesis, 
this may simply imply that at the age points studied, glutamate may be
reacting with its receptors in an extended or partially extended 
configuration. G.B.E.E. may still he useful in identifying binding 
sites +.bTmighout development that can accept glutamate in a fully 
folded fozm (minimum separation of carboxyl groups 0.2nm). GBEE is 
especially potent at antagonizing the responses to the excitatory 
amino acid MPA (oC - amino - 5 - hydroxy-5 - methyl - isoxazole - 4- 
proprionic acid) which is a glutamate analogue restricted in its separation 
of carboxyl carbon atoms to the mininium (0.2nm) by the steric inter­
ference from the methyl group on the 5 position of the isoxazole ring 
(McLennan 198l), see Fig. Tq. Thus the simultaneous use of these two 
compounds (MPA and GBEE) would provide a useful marker of amino acid 
receptors in the folded configuration. Recently, a report of the 
binding of ^H-MPA to brain membranes (Honore et al, 1982) shows that 
MPA binding sites have no affinity for confounds known to interact with 
HMBA receptors in vivo. Curiously though, G.B.E.E. which is a potent 
antagonist of MPA induced excitation in vivo did not inhibit the binding, 
which could imply that there are different antagonist and agonist states
for the receptor.
Again, from a consideration of the separation distances of the
carboxyl groups, the glutamate analogue and naturally occurring amino 
acid, ibotenate, may prove a very useful marker for binding sites 
accepting glutamate in a fully extended foim, the degree of flexibility 
varying only between 0.46nm and 0.42 nm (Fig. ?i). As aspartate can 
only extend to 0. $8nm, aspartate receptors will not be able to bind 
ibotenate whilst the glutamate molecule can easily extend to the same
Tna.viTmim as ibotenate.
More recently, studies of the cyclic amino acid analogues, 2, 5 and
Fig. ?i
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2,4 piperidine and piperazine dicartozylic acids have suggested that 
they may he important tools in the characterization of amino acid 
receptors. Althou^ two of these compounds, cis 2, 3 piperidine 
dicarhoxylate (cis 2, 5 PDA) and cis 2, 3 piperazine dicarhozylate 
(cis 2, 3 PZDA)^  were antagonists of KMDA induced responses, and two 
others (the trans forms of 2, 3 and 2, 4 PDA) had ÎMDA - like agonist 
activity, the corresponding glutamate analogue, cis 2, 4 PDA, was 
inactive at the M)A receptor (Watkins, 1981). As this compound also 
corresponds to glutamate in an ezrbended position, it may prove to he a 
very specific marker for receptors accepting the fully extended glutamate 
molecule. All of these compounds are shown in Pig. 7i«
The choice of pharmacological agents to prohe the intermediate forms 
of the amino acid binding sites (and possibly corresponding to aspartate 
preferring receptors) is much wider. M)A and trans 2, 3 PDA are both 
potent aspartate-like agonists. Trans 2, 4 PDA and amino dicarbozy- 
cyclopentate (ADCP), although glutamate-like analogues, correspond to a 
glutamate molecule in its partially folded form and are again potent 
agonists. Cis-ADCP is in fact pharmacologically indistinguishable 
from mOA (Hicks et al. 1978) and is a more powerful excitant of neurones 
than is glutamate (Hall et al. 1979). The compounds cis,QC-carbozycyclo- 
propylglycine (cis CPG) and 3 aminoglutarate may also be useful here. 
Although these compounds do have some affinity for Quis receptor types they 
have a strong preference for M)A receptors (McLennan, 1983) • Doth 
molecules (cis CPG and 3 aminoglutarate) are indistinguishable from 
aspartate (McLennan et al. 1982) pharmacologically. Discrimination 
between the relatively extended HMDA receptor type and the folded Quis 
receptor may also be possible by use of the antagonist Trans 3,
aminohex, -2-enedioic acid (AEED). This compound is structurally 
similar to Do^AA hut has a double bond between its y  and â carbon 
atoms. It is exclusively an HMDA antagonist (McLennan, 1982) with an 
identical pattern of action to D oc AA(McLennan et al. 1982). However 
unlike D ot AA it is conformationally restricted by its double bond in 
an extended configuration. Recently, the most extensively studied group 
of amino acid analogues are those in which the CX> carbozylate group has 
been replaced by a phosphonic acid moiety. These compounds have both 
agonist and antagonist properties, the latter of which is perhaps best 
characterized by 2-amino-3-phosphonovalerate (APV) which is a potent 
antagonist at the’ HMDA receptor. There is. considerable evidence to 
show that the longer chain phosphono-dérivâtives,APV and 2-amino-3- 
phosphonoheptonate (AEH),are very different in their effects to the 
shorter chain derivatives, in particular 2 amino 4-phosphonobutyrate (AEB). 
ARB (which is the derivative of glutamic acid) was ineffective as a 
displacer of AF7 bound to receptor sites on brain membranes (Olverton 
et al. 1984) whilst A W  and APH were equipotent. Roberts et al. (1982) 
showed that APB was an effective inhibitor of glutamate binding to 
cerebellar membranes althou^ it did not inhibit aspartate binding.
More significantly ARB has been used to identify a new class of 
glutamate receptors which shows a different pharmacological profile 
than the 3 classes of glutamate receptors characterized by Q?iis, HMDA 
and KA. (Pagg et al.,1982; Mena et al.,1982). These authors have shown 
that whilst APT is the most effective of the phosphono-analogues at 
inhibiting glutamate binding in the absence of added ions (Ca^ "^  and Cl ), 
this population of receptors accounts for only 20% of the total 
binding in the presence of these ions. The 80% of binding sites for
2+  -
glutamate that are dependent on the presence of Ca and Cl are,in 
contrast,much more strongly inhibited by APB. Significantly the binding 
of L-aspartate was not affected by any of these substances, either in the 
presence or absence of CaCl2. There is strong evidence based on 
pharmacological studies that these Ca/Cl dependent APB sensitive 
glutamate binding sites in purified SM*s are the same as the receptors 
mediating synaptic transmission in the hippocampus. (Koemer et al.,
1982). In contrast,the inhibition of the synaptic response in the 
spinal cord, which is mediated by an HMDA type receptor,has a pharma­
cology much more similar to the Ca/Cl" independent receptors,where APT
is the more powerful antagonist.
Thus, a thorough and exhaustive investigation of binding sites at 
all stages during ontogeny using these compounds in particular, together 
with the natural amino acid ligands L-Asp, L-Glu and homocysteate, may 
allow a description of the process of development and specification of
aminoacidergic transmitter systems.
Another approach to the characterization of amino acid receptors
could be a classification in terms of the ability of certain cations
to affect the binding of either aspartate or glutamate. The divalent
cation Mg^’^ was one of the first agents that was found to discriminate
2+
between different amino acid excitants. Low concentrations of Mg 
depressed responses to HMDA in the frog spinal cord whilst having little 
or no effect as responses to L-Glu, Quis, or EA (Evans et al, 1977)* 
and Hi^ "*’ were even more potent than Mg^ "^  in exhibiting the same 
effects,whilst Mn^ "^  was less potent than Mg^"*". The monovalent 
cations Li"*", Cs"^  and Rb"^  all produced a dose dependent inhibition 
of glutamate binding in the cerebellum (Roberts and Sharif, 1981), and
in the hippocampus (Baudry and Lynch, I98O). In addition, these ions 
had a similar effect on aspartate binding in the cerebellum (Roberts 
and Sharif, I98I). It is difficult to say exactly what the role of 
these cation effects are; they may be part of a regulatory mechanism 
controlling either the affinity or the numbers of the binding sites.
If this is so, then these ions may have different effects on glutamate 
and aspartate sites at different stages in ontogeny and may help to regu­
late the developmental process, even though differences in their effects 
in the adult are not that apparent. Ra*^  and however, do show
differences in their effect on glutamate and aspartate binding.
Poster et al. (198I) have demonstrated that L-Asp binding is increased 
4^fold to rat forebrain membranes in the presence of Na'*', whilst 
glutamate binding is unaffected by Na"^ . Althou^ Na dependent binding 
may in some cases be synonymous with binding to a re-uptake site, this 
would also effect glutamate as the two dicarboxylic amino acids share 
the same hi^ affinity uptake site. In the li^t of this, the authors 
suggest that the effect of on aspartate binding is due to a 
regulatory mechanism on the receptor site. Althou^ the Na dependent 
binding of glutamate and aspartate in the cortex does seem to be related 
to an uptake site, a full study of the dose dependent effect of Ra 
at various age points may prove interesting.
The greatest difference in effect on glutamate and aspartate 
binding is exhibited by Ga^ "^ . In rat forebrain, a Ga^"*" concentration 
of 2.5mM resulted in a 5» 5 fold increase in L—Glu binding while L—Asp 
binding was unaffected. (Poster et al, I98I). An exactly analogous 
situation was found in hippocampus (Vargas and Gosta, I98I). In all 
cases, Ga^"** evokes, an increase in the number (B MAX) of binding sites
whilst their affinity remains constant. Baudry and Lynch (i960) were 
the first to suggest, on the basis of their experiments, that the 
effect of Ca^**" is to activate endogenous membrane-associated thiol 
proteases which then uncover additional glutamate receptors. In 
contrast, on the basis of pharmacological evidence. Poster et al.(l98l) 
suggest that, in the presence of Ca^ "^ , ^H-L-Glu labels a different 
population of receptors than in its absence.
The interesting point of this work,thou^, is that these effects 
of Ca^"** are present in some brain regions and not in others. In the 
cerebellum, Ca^'*' produces an enhancement of binding at low concentrations, 
but an inhibition at concentrations above 5nM,and has the same effect 
on glutamate and aspartate. Baudry and Lynch (198O) have further 
suggested that Ca^ "^  dependent proteases may be responsible for the 
long term potentiation of synaptic transmission found in hippocampal 
synapses after brief periods of hi^ frequency stimulation, and that 
it is therefore glutamate receptors that are responsible for this long 
term synaptic facilitation. If this theory is correct, then it may be 
that the effects of Ca^'*’ would only be expected in areas that need to 
possess a high degree of synaptic plasticity such as the cerebral cortex, 
but not in essentially hard-wired circuits such as the cerebellum.
It would, therefore, be extremely interesting to investigate the 
effect of Ca^ *^  on glutamate and aspartate binding throu^out ontogeny 
in the cortex, and to relate any effect to neurophysiological studies 
charting the development of L.T.P. The effects of freeze thawing 
reported in Section 5.6 show that there is indeed a population of 
glutamate receptors that are normally hidden, althou#i hidden aspartate
receptors do not exist.
2+In addition to any effect of Ca in the activation of proteases, 
this ion has recently been shown to enhance glutamate binding that is 
stimulated by the presence of Cl ions. (Pagg et al 1982). Unlike
previous studies reported earlier (e.g. Poster et al.,1981), these later
_ 2+ 
studies demonstrated that Cl“ ion was an absolute requirement for Ca
stimulation, as Ca^ "^  alone did not affect glutamate binding (l/Jhittemore 
et al.,1985). The explanation for the difference in those results 
probably resides in the fact that the earlier binding studies were 
carried out in 50nM Tris/HOl buffer so that the concentration of 01 
was sufficient to allow expression of the Ca^ ’^/Cl dependent sites.
This work has two exciting implications, as previously mentioned. The 
first is that Ca^'*' or Cl” ions have no enhancing effect on aspartate 
binding, so it may be that in their presence, only one particular type 
of amino acid receptor is being measured. Secondly^  unlike the Ca /Cl 
independent sites,the ion dependent sites are potently antagonized by 
the glutamate analogue APB. The pharmacological requirements of this, 
site, explored by displacement studies with a range of amino acid 
agonists and antagonists,exactly parallels the pattern of the pharma­
cology of inhibition by AEB of several neuronal pathways (see mittemore 
et al.,1985). So these Ca^ :*'/Cl” dependent^  APB sensitive ,Ra'^  indepen­
dent sites are strongly implicated as postsynaptic receptors mediating 
transmission in the CRS. Again,it would be valuable to use these 
discriminatory ions in binding studies throughout development.
There is increasing evidence from many in vivo studies that cGMP 
may be the second messenger involved in the translation of the initial 
transmitter/receptor interaction to the physiological response. In 
addition, it has been shown,using cerebellar slices and cell suspensions, 
that different amino acid agonists vary in their ability to stimulate
c(MP production (Schmidt et al, 1975; Garthwaite and Balazs, 1981).
.As a corollary of this, Sharif and Roberts (198O) have demonstrated 
that guanine nucleotides produce a substantial inhibition of E-glutamate 
binding and that this effect was not observed with adenine nucleotides. 
Thus, guanine nucleotides may be regulating receptor sensitivity by 
their effects on a mechanism that is also directly linked to the 
production of the physiological effect. The concept of a receptor ■ 
modifying protein, the G protein, sensitive to the guanine nucleotides, 
was further discussed in Chapter 2. If the ability of GTP to affect 
amino acid binding is indicative of the presence of functional amino 
acid receptors,then a study of the effect of these nucleotides on different 
types of amino acid binding sites at different stages in development may 
give some insight into when exactly such binding sites become functional.
All of these studies may be more fruitful if they were carried out 
using cell membranes from cortical areas that were known to be rich in 
glutamatergic or aspartergic nerve endings. It may be possible to 
identify such projection pathways into the cortex by using sensoiy 
deprivation, chemical and surgical lesioning techniques and congenital 
mutants, and correlating the effects of such techniques with changes in 
biochemical parameters relevant to glutamate or aspartate transmitter 
systems.
One of the long term aims of neurochemical studies designed to 
characterise physiologically relevant, synaptically active binding 
sites for neurotransmitters must be to isolate and characterize the 
receptor complex itself, and to describe its chemical nature. The 
first step in such studies would be to probe the relationship between
the receptor complex and its membrane environment, and the structure 
of the receptor molecule itself. This could be aohieved by an 
examination of the effects of protein and membrane modifying agents on 
amino acid binding. Similar work carried out on glutamate receptors 
in the cerebellum (Sharif and Roberts, 1980),and in whole brain 
(Michaelis, 1975; Michaelis, 1979; Michaelis et al, I980),have led 
to the suggestion that the glutamate receptor may be a metallo-glyco- . 
protein with an iron sulphur (Re^ Sg) at its centre. It would be 
very interesting to use these methods to investigate the nature of 
glutamate and aspartate binding sites in the cortex, and, given my 
prime interest in development, to apply the techniques to a study of 
the amino acid receptors throu^out development. This approach may 
shed some li^t on the problem of how, and when, receptor complexes 
reach maturity and become stabilized in their lipid environments.
Again in the long tem, pharmacological agents may emerge with 
specific affinity for amino acid receptor sites at different develop­
mental stages. These agents could then be used to label receptor 
proteins which may then be directly visualized by the application of gel 
electrophoresis. As the glutamate receptor is a glycoprotein, lectins 
may also provide a useful label. If receptor complexes can be separated 
from other membrane components, then the possibility arises of raising 
antibodies to these receptors, which would provide a very specific marker 
for visualization of these binding sites throu^out the process of 
development.
These then are the main directions in which the work reported in 
this thesis could proceed. These approaches also demand an integration 
of research across related disciplines. Reurophysiological, neuro-
anatomical and immunological techniques all need to be used, alongside 
classic neurochemical studies, I believe a more multi-disciplinary 
approach to the problem of how neurotransmission is mediated in the GNS, 
and the factors governing the development of such systems,is not only 
desirable, . but essential. Ihe implicationfof an increased knowledge in 
this area are enormous. My work,and studies by many other groups,make 
the case for involvement of glutamate and aspartate in neurotransmission 
in the GNS very strong indeed. In addition, the glutamatergic and 
aspartergic systems may provide an excellent model for the investigation 
of the processes by which specification of pathways is brought about.
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